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Exocytosis, the fusion of intracellular vesicles with the plasma membrane, is 
fundamental to intercellular communication in multicellular organisms. This pathway 
facilitates the release or secretion of molecules from the cell. In addition, exocytosis 
is essential for delivery of resident proteins to the plasma membrane. There are two 
different pathways of exocytosis, constitutive and regulated exocytosis. Constitutive 
exocytosis occurs without regulation, e.g. pathways regulating the delivery of lipids 
and ‘house-keeping’ proteins to the plasma membrane or the secretion of antibodies 
and extra-cellular matrix components from the cell. In contrast, regulated exocytosis 
facilitates the controlled release of extra-cellular molecules or insertion of new 
membrane components only in response to a physiological signal. The most common 
signal for regulated exocytosis is an increase in intracellular Ca2+ concentration.  
Several proteins function in exocytosis, and the membrane fusion step is widely 
believed to result from an interaction between SNARE (SNAP receptor) proteins on 
the vesicle membrane and plasma membrane. In neuroendocrine cells, these SNARE 
proteins are VAMP2, which is bound to vesicle membranes and syntaxin1A and 
SNAP25, which are associated with the plasma membrane. Several proteins have 
been implicated as SNARE regulators, such as NSF (N-ethylmaleimide-sensitive 
factor) and its cofactor α-SNAP, Munc18 and synaptotagmin. Another possible 
SNARE regulator is the cysteine string protein (CSP). 
CSPα was first identified in Drosophila melanogaster and was later identified in 
Torpedo as a possible Ca2+-channel regulator. Inactivation of the CSPα gene in 
Drosophila is lethal at an embryonic stage and in embryos synaptic vesicle 
exocytosis was decreased by ~50% at 22°C and was abolished at higher 
temperatures. These results provided strong evidence that CSPα has an important 
role in presynaptic neurotransmission. However, more recent work on CSPα null 
mice uncovered an important neuroprotective function for CSPα in brain, but also 
challenged the proposed function of CSPα in neuronal exocytosis, as no defect in 
this pathway was evident, at least in young animals. The only reported 
developmental abnormality of CSPα null mice was bilateral cryptorchidism, a failure 
of testicular descent during development. Interestingly, two additional CSP isoforms 
 
 II
were recently identified in mouse and human testis, CSPβ and CSPγ. One 
consequence of the identification of CSPβ and CSPγ is that they may complicate 
analysis of CSPα knockout mice. 
Here, we have used a combination of techniques, cell systems and human brain 
samples to examine the function of CSPα in exocytosis, the expression of novel 
CSPα isoforms in testis, and expression changes of CSPα and its partner proteins in 
neurological disorders. Furthermore, we have initiated studies to examine how CSPα 
function is linked to cryptorchidism at the molecular level. My results show that 
CSPα depletion perturbs regulated exocytosis in neuroendocrine cells, but has no 
consistent effect on constitutive exocytosis. CSPα has been reported to have an 
important neuroprotective function; however, no significant changes in CSPα 
expression were detected in brain samples for schizophrenia, depression and bipolar 
disorder. Nevertheless the expression of specific CSPα binding partners was found to 
be significantly changed in some of these disorders. In addition to these studies 
focussing on CSPα function and expression in neuronal and neuroendocrine cells, 
studies were undertaken to analyse expression profiles of CSP isoforms in testis. This 
analysis found that CSPβ and CSPγ are exclusively expressed in testis, and that 
mRNA transcription of both isoforms is initiated with sexual maturation. 
Furthermore expression of both isoforms is restricted to germ cells, whereas CSPα is 
expressed throughout testes. Previous work has shown that the secretory hormone 
INSL3, which is exclusively expressed in testicular Leydig cells, is involved in the 
development of cryptorchidism. Confocal microscopic analysis revealed that CSPα 
and INSL3 colocalise on vesicles in Leydig cells, suggesting the intriguing 
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CHAPTER ONE: INTRODUCTION 
 
 
 - 2 -
1.1 The secretory pathway 
The invention of the electron microscope facilitated a detailed characterisation of 
compartmentalisation in eukaryotic cells. Seminal work from George Palade (1975) 
paved the way for a description of the ‘secretory pathway’ (Palade, 1975). Proteins 
destined to be secreted from cells are translocated across the endoplasmic reticulum 
(ER) membrane, and their correct folding and maturation begins at this stage. The 
proteins are then packaged into membrane–bound vesicles that bud out from the ER 
membrane and subsequently fuse with Golgi membranes. In the Golgi, secretory 
proteins may undergo additional processing steps, such as glycosylation. Classical 
secretion models suggest that proteins then move through the Golgi stacks in a 
directed fashion (cis → medial → trans) (Rothman and Orci, 1992). Budding of 
membrane vesicles from the trans Golgi is followed by fusion with the plasma 
membrane, which releases or ‘secretes’ soluble proteins to the cell exterior. This 
secretory pathway is not only a mechanism to deliver proteins to the cell exterior, but 
also functions to transport membrane proteins to various locations in the cell 
including Golgi, endosomes, lysosomes and the plasma membrane (Rothman and 
Orci, 1992). 
The secretory pathway is fundamental to generate and maintain subcellular 
compartments and organelles, and for cell growth and division. Genetic and 
biochemical analyses have demonstrated that many of the components of the 
secretory pathway are universal and highly conserved from yeast to humans 




Exocytosis occurs when an intracellular membrane-bound organelle fuses with the 
plasma membrane. Exocytosis is a fundamental process that allows insertion of 
proteins into the plasma membrane, and mediates the secretion of soluble cargo to 
the cell exterior (Kelly, 1985). Fusion with the plasma membrane occurs in all cell 
types without temporal regulation; this particular type of fusion is called constitutive 
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exocytosis. Constitutive exocytosis mediates the delivery of newly-synthesised 
‘housekeeping’ proteins to the plasma membrane and mediates the secretion of 
molecules such as plasma proteins, antibodies and extracellular matrix components. 
In specialised cells, such as neurons, neuroendocrine, endocrine and exocrine cells, 
sperm and eggs, an additional form of exocytosis occurs, termed ‘regulated 
exocytosis’ (Burgoyne and Morgan, 2003). This process ensures the controlled 
release of vesicle/granule contents following a physiological signal. Most commonly 
this signal is a rise in intracellular calcium concentrations (Llinas et al., 1981; Adler 
et al., 1991; Neher and Sakaba, 2008).  
Two main types of vesicles typically undergo regulated exocytosis. On one hand 
there are so-called secretory granules, which contain mostly larger molecules, such 
as polypeptides, hormones or proteins. Secretory granules are typically > 100 nm in 
diameter and may contain a mixture of molecules. Upon a signal almost the entire 
pool of storage granules might be emptied, allowing sustained secretion for seconds 
or minutes. Secretory granules containing protein cargo form at the trans Golgi 
network (Tooze et al., 2001). Another type of vesicles are smaller secretory vesicles, 
such as synaptic vesicles, which typically have a clear morphology when visualised 
by electron microscopy (Katz, 1969). These vesicles are generally < 50 nm in 
diameter. After nerve terminal depolarisation, synaptic vesicles release their content 
almost instantly (Bruns and Jahn, 1995). In neurons, synaptic vesicles are thought to 
form distinct pools: the ready-releasable pool, where vesicles are docked at the 
plasma membrane and are immediately ready for release, and the reserve pool 
(Schweizer and Ryan, 2006). 
Although secretory vesicles and granules display distinct kinetics of fusion, both 
types of vesicle undergo similar steps in exocytosis. ‘Priming’, which is dependent 
on ATP hydrolysis, is a poorly-defined process that may involve reorganisation of 
the actin cytoskeleton (Roth and Burgoyne, 1994) to recruit vesicles to the 
plasmalemmal space, and also the modification of SNARE proteins by α-SNAP and 
NSF (Chamberlain et al., 1995; Banerjee et al., 1996) (see 1.4.1). Dependent upon 
the specific system of regulated exocytosis, priming may occur before or after vesicle 
‘docking’, the term used to describe vesicles that are physically attached to the 
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plasma membrane. Docked vesicles likely undergo several maturation steps 
(priming) before they fuse with the plasma membrane following an increase in 
intracellular calcium concentration. This is suggested because only a subset of 
docked synaptic vesicles exocytose in response to nerve terminal depolarisation 
(Schikorski and Stevens, 2001). The fusion of vesicles occurs by the formation of 
fusion pores that can open transiently and reclose rapidly (termed ‘kiss and run’), or 
the fusion pore can expand and lead to full exocytosis where the vesicle completely 
collapses into the plasma membrane (Valtorta et al., 2001). These different kinds of 
fusion events allow a controlled amount of release that occurs per secretory 
granule/vesicle. There is considerable controversy in the field over how prevalent 
‘kiss-and-run’ exocytosis is, particularly for synaptic vesicle fusion (Rizzoli and 
Jahn, 2007).  
A very large number of proteins have been shown to function in exocytosis, and the 
membrane fusion step is widely believed to result from an interaction between 
SNARE (SNAP receptor) proteins on the vesicle membrane and plasma membrane 
(Jahn and Scheller, 2006)(see 1.3).  
 
 
1.2.1 Exocytosis pathways occurring in testis 
Testes execute two basic functions, sperm production and testosterone secretion. 
Three major cell types are located in testis; germ, sertoli and leydig cells. The adult 
mammalian testis contains several types of germ cells. Spermatogonial stem cells are 
located at the luminal side of the basal membrane, where they undergo mitotic 
divisions to become spermatogonia and primary spermatocytes. After further rounds 
of meiotic divisions, haploid spermatids are produced, which eventually form 
spermatozoa. Sertoli cells are essential to organise and orchestrate spermatogenesis 
during puberty (Mruk and Cheng, 2004). Depletion and loss of function of Sertoli 
cells lead to massive degeneration of haploid cells and an almost complete loss of 
germ cells (Russell et al., 2001) and the number of Sertoli cells present in the testis 
determines the number of sperm produced in adulthood. Leydig cells secrete 
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testosterone, which is required for the development of internal and external male 
genitalia, and is essential for male sexual differentiation (Shalet, 2009).  
Endocrine control of testicular function is mediated by the hypothalamic-pituitary-
testicular axis. The hypothalamus secretes gonadotrophin-releasing hormone, which 
stimulates the pituitary gland to release luteinizing-hormone (LH) and follicle-
stimulating hormone (FSH). FSH accelerates the rate of Sertoli cell proliferation. LH 
stimulates testosterone biosynthesis, by binding to the luteinizing-hormone receptor 
(LHR) (Dufau, 1998; Scott et al., 2009). This activates adenylate cyclase, leading to 
an increased production of intracellular cAMP (Dufau, 1988) and mediates the 
transport of cholesterol to the inner mitochondrial membrane, where the first enzyme 
is localised that initiates the conversion pathway from cholesterol to testosterone. 
The initial step is the conversion of C27 cholesterol to the C21 steroid, pregnenolone, 
which is catalysed by the cytochrome P450 enzyme cholesterol side chain cleavage 
(P450SCC). Pregnenolone diffuses across the mitochondrial membranes and is further 
metabolised by enzymes associated with the smooth endoplasmic reticulum. 
Pregnenolone is catalysed to progesterone by 3β-hydroxysteroid dehydrogenase/Δ5-
Δ4-isomerase (3βHSD). The next enzyme, cytochrome P450 enzyme 17α-
hydroxylase/C17-20 lyase (P45017α), catalyses two distinct reactions; the 
hydroxylation of progesterone at C17 and subsequent cleavage of the two-carbon 
side-chain to obtain the C19 steroid androstenedione. The final reaction is the 
reduction of the 17-ketone of androstenedione by 17-ketosteroid reductase to form 
testosterone (Payne and Youngblood, 1995). The level of testosterone secreted from 
Leydig cells is thought to be directly correlated with the level of synthesis (Shalet, 
2009). Testosterone interaction with the androgen receptor expressed on Sertoli cells 
activates meiosis and maintains spermatogenesis.  
Failures in testes development can cause infertility or expose the individual to risks 
of germ cell tumours. Cryptorchidism is a failure of one or two testes to descend into 
the scrotum (Jocelyn and Setchell, 1972) and is one of the most frequent congenital 
abnormalities in humans, occurring in 2-12 % of male births (Hutson et al., 1994). 
Testicular descent from abdomen to scrotum occurs in two distinct phases; the trans 
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abdominal phase and inguino-scrotal phase (Hutson, 1985; Hutson et al., 1994; 
Satokata et al., 1995).  
It has previously been shown that null mutations in Leydig cell insulin-like hormone 
(INSL3) cause the testes to be visibly absent at the scrotum, indicating bilateral 
cryptorchidism. The testicular size of INSL3-/- adult mice was also decreased, 
although at birth INSL3+/+, INSL3+/- and INSL3-/- testes did not differ in size. 
Histological analysis revealed that the cryptorchid testes were normal at P0 but 
degenerated rapidly and progressively. The number of primary spermatocytes was 
also reduced and no spermatozoa were identified, indicating that INSL3 may be 
required for normal mature testicular function in addition to testicular descent. Serum 
analysis showed that testosterone levels in INSL3-/- mice were similar to wild type 
mice and INSL3-/- male mice exhibited androgen-dependent behaviour, such as  
normal mounting and copulatory behaviour. Furthermore, after copulation with 
female mice ejaculate was found in female vaginal plugs, indicating that INSL3 is 
not involved in androgen production. Scanning electron microscopy (SEM) showed 
that INSL3-/- neonate testes remained adjacent to the lower pole of kidneys compared 
to wild type mice, in which testes descend and are located caudal to the bladder neck 
in the inguinal region. The wild type gubernaculae in male mice, which are 
embryonic structures that attach to the caudal end of the gonads, have a large bulb 
and a thick cord, however, INSL3-/- male mice had flat gubernaculae with a thin bulb 
and an elongated cord, which is similar to that found in females. Overall, the results 
from analysis of INSL3-/- mice are consistent with the notion that Leydig cells of the 
testes secrete INSL3, and that the gubernacular bulb is the target organ; furthermore 
the results revealed a key requirement of INSL3-/- for testicular descent. Similar to 
testosterone secretion, very little is known about the mechanisms of INSL3 secretion. 
In contrast to INSL3-/- male mice, INSL3-/- females were morphologically normal, 
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1.2.2 Vesicle cycling and endocytosis 
Synaptic vesicle exocytosis has been extensively investigated. The central nervous 
system contains in the region of 100-200 vesicles in each synaptic terminal, and a 
mechanism is required to maintain this number of vesicles, particularly during 
sustained action potential firing. After fusion with the presynaptic plasma membrane, 
vesicles are recycled by endocytosis into a vesicle cluster at the active zone 
(Ceccarelli et al., 1973; Ales et al., 1999). Clathrin-dependent endocytosis is the 
major mechanism of synaptic vesicle retrieval, which involves a number of 
molecules, including clathrin, clathrin adaptors and dynamin (Murthy and De 
Camilli, 2003; Royle and Lagnado, 2003). Following retrieval, clathrin coated 
vesicles are uncoated, refilled with transmitter and returned to the active pool of 
cycling vesicles. In addition to conventional clathrin-mediated endocytosis, vesicle 
retrieval can also be achieved by bulk endocytosis. This type of endocytosis occurs 
only during intense neuronal activity (Cousin, 2009), and does not retrieve a single 
synaptic vesicle, but rather recruits a large area of the plasma membrane, which then 
forms new vesicles by budding from this bulk endosome compartment (Richards et 
al., 2000; Evans and Cousin, 2007).  
Physiological stimulation promotes the fusion of only a small number of vesicles 
located at the presynaptic terminal. These fusion-ready vesicles were identified as 
being morphologically ‘docked’ at the plasma membrane, and were termed the 
readily releasable pool (Schikorski and Stevens, 2001). Further experiments at the 
NMJ demonstrated that vesicles previously labelled by FM1-43 (indicating previous 
exocytosis) were released preferentially during subsequent stimulation, indicating the 
existence of a distinct recycling vesicle pool. After strong stimulation (5–10 Hz in 
frog NMJ, 30 Hz in Drosophila larval NMJ or prolonged high potassium application 
at the Calyx of Held) and FM1-43 uptake, only a subset of the vesicles are labelled, 
whereas others are resilient to labelling; these non-labelled vesicles are classified as 
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1.3 SNARE proteins: regulators of membrane fusion 
The driving force and key elements behind membrane fusion are widely believed to 
be the SNARE proteins (soluble-N-ethylmaleimide-sensitive factor attachment 
protein receptor).  
The consensus view of membrane fusion is that SNARE proteins localised on 
opposing membranes drive fusion by using the free energy that is released during the 
formation of the highly stable four-helix SNARE bundle (Jahn and Scheller, 2006). 
The formation of the four helical bundle, which occurs as a zip starting from the N-
termini towards the C-terminal membrane anchors, forms a tight connection between 
the plasma membrane and the vesicle, and formation of this complex is sufficient to 
drive fusion of lipid bilayers in vitro (Sutton et al., 1998; Weber et al., 1998). 
SNARE proteins are found in all eukaryotes from yeast (e.g. Saccharomyces 
cerevisae), over plants (e.g. Arabidopsis thaliana) to humans. All SNARE proteins 
have a highly conserved SNARE motif in common, which is stretched over 60-70 
amino acids in heptad repeats (Chapman et al., 1994). Heptad repeats are composed 
of 7 amino acids where positions 1 and 4 are occupied by hydrophobic residues. 
When these heptad repeats form a helical secondary structure, the hydrophobic 
amino acids align on one face of the helix. The core SNARE complex is a coiled coil 
bundle of four such helices, with the centre of the bundle containing 16 stacked 
layers of interacting side chains (Sutton et al., 1998). These layers are predominantly 
stabilised by hydrophobic interactions, but the central or ‘0’ layer contains three 
highly conserved glutamine (Q) residues and one highly conserved arginine (R) 
residue (each provided by a different SNARE motif). 
The majority of SNARE proteins have a single C-terminal transmembrane domain, 
however SNARE proteins can also be attached to membranes via post-translational 
lipidation. Originally the SNARE proteins were classified based upon their 
localisation. v-SNAREs were present on vesicle (‘donor’) membranes, and t-
SNAREs were associated with acceptor (or target) membrane compartments. 
However, certain SNAREs function in several membrane fusion pathways and also 
with different interacting partners, and some fusion reactions involve identical 
membrane compartments (‘homotypic’) and thus the use of ‘v’ and ‘t’ SNARE was 
not always appropriate. Thus, it was proposed that SNAREs  be re-classified 
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dependent upon the amino acid they have at this zero layer position (Fasshauer et al., 
1998). 
Seminal work from Rothman’s group first proposed that idea that the interactions 
between SNARE proteins on opposing membranes were important for membrane 
fusion. Sollner et al. (1993a,b) identified a complex containing syntaxin 1 (Q-
SNARE), SNAP25 (Q-SNARE) and VAMP (R-SNARE) which associated with α-
SNAP and NSF (see 1.4.1), proteins that had already been identified as performing a 
key function in intracellular fusion pathways (Sollner et al., 1993b). The syntaxin : 
SNAP25 : VAMP complex was isolated from brain and Rothman proposed that this 
specific  SNARE complex was required for synaptic vesicle exocytosis. In support of 
this idea, work around the same time found that these three SNARE proteins were 
specifically cleaved by botulinum (BoNT) and tetanus neurotoxins (TeNT) (Blasi et 
al., 1993a; Blasi et al., 1993b; Schiavo et al., 1993). BoNTs penetrate motor neurons 
at the neuromuscular junction and are inhibitors of acetylcholine release (Simpson, 
1989). Schiavo et al. (1993) discovered that BoNT B and BoNT F, as well as tetanus 
toxin (TeTx) specifically cleave VAMP in rat brain homogenates. Botulinum 
neurotoxins A and E were shown to cleave SNAP25 near the C-terminus (Blasi et 
al., 1993a; Schiavo et al., 1993). In the same year it was also detected that BoNT C1 
directly and selectively proteolyse syntaxin, which led to an inhibition of 
neurotransmission (Blasi et al., 1993b). The potent inhibitory effects of these toxins 
on synaptic vesicle fusion pathways is strong evidence that SNAREs are essential for 
membrane fusion (Sollner et al., 1993a; Sollner et al., 1993b). 
Rothman initially proposed that synaptic vesicles dock when vesicle-localised 
VAMP binds to its complementary Q-SNARE (syntaxin and SNAP25) at the plasma 
membrane. Indeed specific interactions mediated by SNAREs were proposed to 
determine the specificity of intracellular membrane fusion pathways (Sollner et al., 
1993a; Sollner et al., 1993b). Interestingly, Sollner et al. (1993a,b) also identified 
synaptotagmin binding to SNARE complexes; this interaction was mutually 
exclusive with α-SNAP binding to the SNARE complex. Thus, a model for 
membrane fusion was proposed whereby vesicles dock at membranes by virtue of 
SNARE complex formation. Synaptotagmin binding to the complex was suggested to 
act as a clamp and prevent the vesicle from fusing with the membrane. Following 
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stimulation, Ca2+ binding to synaptotagmin was suggested to dissociate it from the 
complex allowing SNAP to bind recruit NSF (N-ethylmaleimide-sensitive factor). 
Subsequent ATP hydrolysis by NSF, which drives dissociation of the SNARE 
proteins, was proposed to drive membrane fusion (Sollner et al., 1993b). However, 
this model was inconsistent with several reports published around the same time 
showing that membrane fusion/exocytosis could be triggered by Ca2+ in the absence 
of ATP, as long as previous ‘priming’ in the presence of ATP had occurred (Holz et 
al., 1989). Indeed, later work demonstrated that R- (VAMP) and Q-SNAREs 
(syntaxin and SNAP25) were sufficient to drive fusion of membrane vesicles in vitro 
(Weber et al., 1998). It was assumed that R- and Q-SNAREs might exist in a 
thermodynamically metastable state and that SNARE assembly leads to a lower 
energy status. The remaining energy could therefore be used for fusion. Current 
models now place NSF/SNAP action in SNARE disassembly and reactivation of 
SNAREs following membrane fusion (Jahn and Scheller, 2006).  
 
 
1.3.1 VAMP2 (Synaptobrevin 2) 
Vesicle-associated membrane protein (VAMP; also termed synaptobrevin) was 
initially isolated from a cDNA expression library from Torpedo californica 
electromotor nucleus mRNA and was found to be neuron specific (Trimble et al., 
1988; Sudhof et al., 1989). Among several identified VAMP isoforms which 
function as R-SNAREs in membrane fusion, VAMP2 has been shown to be involved 
in regulated secretion in neuronal and neuroendocrine cells (Baumert et al., 1989). 
VAMP2 is composed of 118 amino acids arranged into a short N-terminal proline 
rich sequence, a central SNARE motif and a C-terminal transmembrane region (Jahn 
and Sudhof, 1999). BoNT B and BoNT F, which specifically cleave VAMP (Link et 
al., 1992; Schiavo et al., 1992), penetrate motor neurons at the neuromuscular 
junction and block acetylcholine release, but some residual fusion is still observed 
(David et al., 1998; Ashton and Dolly, 2000). It was not clear whether this remaining 
fusion was due to compensation by related R-SNAREs or if a low level of fusion 
events could occur independently of SNARE proteins. VAMP2 knock out mice 
(VAMP2-/-) (Schoch et al., 2001) die immediately after birth with the newborn mice 
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exhibiting a rounded appearance and a shoulder hump, with this striking body shape 
possibly indicating a function for VAMP2 in endocrine and fat cells (Lowe et al., 
1988; Baumert et al., 1990; Olson et al., 1997; Foran et al., 1999). No changes were 
observed in expression of other synaptic proteins or the closely related isoforms 
VAMP1 and cellubrevin (VAMP3). In VAMP2-/- mice fast Ca2+-triggered fusion of 
synaptic vesicles with the presynaptic membrane was decreased more than 100-fold 
in knockout cultures, confirming a key role for VAMP2 in synaptic transmission. 
However, spontaneous miniature excitatory currents showed only a 15 % reduction 
in frequency in mutant mice compared to control. This suggested that the synaptic 
release apparatus was still present, working at a lower efficiency, which was also 
observed previously in Drosophila and C. elegans VAMP2 null mutants (Deitcher et 
al., 1998; Nonet et al., 1998). These results suggested that VAMP2 may not be 
absolutely essential for vesicle fusion, but is a key player that controls the rate of 
fusion, especially for the fast Ca2+-triggered fusion. Quantification of the rate of RRP 
(ready releasable pool) refilling in neurons in VAMP2-/- mice, revealed that depletion 
of VAMP2 showed a delay in refilling of the pool, perhaps also highlighting a 
function for this protein in synaptic vesicle endocytosis and recycling (Deak et al., 
2004). The defects shown in VAMP-/- mice indicate that VAMP2 may be an 
important component in the tight coupling of exocytosis and endocytosis. The 
differential effects of VAMP2 knock out on evoked and spontaneous release might 
suggest that these fusion events are not identical at the molecular level. 
 
 
1.3.2 Syntaxin 1A 
Syntaxin 1 was first identified by its co-immunoprecipitation from rat brain with a 
monoclonal antibody to the protein p65 (synaptotagmin) (Bennett et al., 1992). 
Amino acid analysis identified a hydrophobic site at the C-terminus, which was 
proposed to be a possible membrane anchor. Further immunoprecipitation, 
fractionation, and indirect immunofluorescence experiments indicated that syntaxin 1 
is an integral membrane protein localised on the plasma membrane site and oriented 
towards the cytoplasm (Bennett et al., 1993). Two syntaxin 1 isoforms, syntaxin 1A 
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and syntaxin 1B were described, and syntaxin 1A has been the most thoroughly 
investigated of these isoforms. Syntaxin 1A is composed of 288 amino acids, with 
the SNARE motif flanked by an independently folded N-terminal domain (Habc) and 
a single transmembrane domain at the C-terminus (Inoue et al., 1992). There are 15 
members of the syntaxin family in mammals; all isoforms display a broad tissue 
distribution and are targeted to different subcellular compartments (Bennett et al., 
1993; Teng et al., 2001). 
The N-terminal Habc domain of syntaxin appears as a flexible arm in electron 
micrographs (Hanson et al., 1997) and is common throughout the syntaxin family 
(Fasshauer et al., 1999). Syntaxin interacts intramolecularly by folding its N-terminal 
domain onto the SNARE motif, resulting in a ‘closed’ conformation which inhibits 
SNARE assembly (Calakos et al., 1994; Nicholson et al., 1998; Dulubova et al., 
1999; Fiebig et al., 1999). Munc13 and Munc18 have been shown to bind to the N-
terminal domain of syntaxin (Pevsner et al., 1994; Betz et al., 1997). 
 
Microinjection of the monoclonal antibody against syntaxin (HPC-1) in PC12 cells, 
demonstrated a reduction in Ca2+-regulated secretion (Bennett et al., 1993), 
confirming that syntaxin plays a role in regulated secretion. Surprisingly however, 
syntaxin 1A knock out mice (Syx1A-/-), in which the protein was deleted at exons 9 
and 10, unexpectedly exhibited normal glutamatergic and GABAergic fast synaptic 
transmission (Fujiwara et al., 2006), but fear memory was impaired, suggesting that 
syntaxin 1A may be involved in synaptic plasticity. However, more recent work 
showed that syntaxin 1A knockout, by deletion of exon 3, resulted in embryonic 
lethality (McRory et al., 2008). Four out of 204 offspring were born, and these 
Syx1A-/- mice showed only mild behavioural deficiencies, but were reduced in body 
weight, suggesting that syntaxin 1A might be important in embryonic development 
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1.3.3 SNAP25 
To investigate the expression and developmental regulation of neuronal specific 
genes, the cDNA clone pMuBr8 (Branks and Wilson, 1986) was used to screen an 
adult mouse hippocampal cDNA library (Oyler et al., 1989). One clone, which 
contained nearly the full-length DNA, was isolated, subcloned and sequenced. This 
clone encoded for a 206 amino acid protein and immunoblotting experiments 
recognised a 25 kDa synaptosomal protein (SNAP25) (Oyler et al., 1989). SNAP25 
is an unusual SNARE protein in that it contains two SNARE motifs on its C- and N-
terminal domains, which are separated by a linker region (Hong, 2005). Electron 
microscopy revealed that SNAP25 is a presynaptic protein found throughout the 
CNS. SNAP25 is a hydrophilic protein and, in contrast to VAMP and syntaxin, lacks 
a transmembrane domain; SNAP25 is palmitoylated at cysteine residues in the linker 
domain which facilitates membrane attachment (Hess et al., 1992). Two distinct 
SNAP25 isoforms have been identified, termed SNAP25A and SNAP25B (Bark and 
Wilson, 1994). These isoforms are splice variants, which differ only in 9 amino 
acids, but appear to have distinct functions (Sorensen et al., 2003). 
SNAP25 interacts with sxyntaxin1A and VAMP2 in neurons and neuroendocrine 
cells to promote membrane fusion (Sutton et al., 1998). It was also shown that 
SNAP25 association with synaptotagmin 1 and 9 during Ca2+-dependent exocytosis 
seems to be essential for triggering membrane fusion (Zhang et al., 2002b; Rickman 
et al., 2006). 
Deletion of SNAP25 (SNAP25-/-) in mice caused immediate death after birth 
(Washbourne et al., 2002). Homozygous SNAP25-/- mutants were smaller in size 
than their wild type littermates at E18.5. It was observed that the mutant mice failed 
to exhibit either spontaneous movement or sensorimotor reflexes in response to 
mechanical stimuli, which indicated a loss of neuromuscular function. The SNAP25-
/- foetus showed no EPPs (end-plate potentials) nor evoked contraction, however, 
surprisingly spontaneous mEPPs could be constantly recorded. Other work also 
showed that replacing SNAP25B with an extra copy of SNAP25A led to 
developmental abnormalities, seizures and early death, demonstrating that expression 
of both isoforms is important (Johansson et al., 2008). 
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1.4 SNARE protein regulators 
 
1.4.1 NSF and α-SNAP 
NSF (N-ethylmaleimide-sensitive factor) was originally identified as a factor that 
reconstituted intra-Golgi vesicular transport after inactivation of membranes with the 
alkylating agent N-ethylmaleimide (NEM) (Block et al., 1988; Beckers et al., 1989). 
NSF contains two homologous AAA domains, which are signature modules of AAA 
(ATPases Associated with diverse cellular Activities) ATPases (White and Lauring, 
2007). NSF is a soluble protein that forms hexamers (Fleming et al., 1998).  
It was shown that NSF required a membrane protein adaptor to bind to Golgi 
membranes and stimulate its ATPase activity (Weidman et al., 1989; Clary et al., 
1990; Clary and Rothman, 1990; Morgan et al., 1994). This protein was identified as 
SNAP (soluble NSF attachment protein), comprising three isoforms, α-, β- and γ-
SNAP (Whiteheart et al., 1993). The first nine α-helices of α-SNAP form an N-
terminal sheet whose positively charged residues interact with the surface of the 
SNARE complex (Marz et al., 2003). A role for NSF and SNAPs in neurotransmitter 
release was first indicated by their binding to SNARE proteins (Sollner et al., 1993b; 
Jahn et al., 1995; Poulain et al., 1995). α-SNAP binds to the syntaxin/SNAP25 
heterodimer, and association of VAMP with syntaxin/SNAP25 generates a third 
binding site for α-SNAP which induces the interaction with the hexameric NSF and 
forms a transient 20 S complex (Hanson et al., 1995; Hayashi et al., 1995; Wimmer 
et al., 2001). NSF then drives the disassembly of the SNARE complex through ATP 
hydrolysis (Sollner et al., 1993a). Binding to α-SNAP increases the ATPase activity 
of NSF to promote complex disassembly (Barnard et al., 1997). NSF/SNAP action 
induce a conformational change in syntaxin (Hanson et al., 1995), but are also 
capable of large conformational motions that may drive SNARE complex 
disassembly (Neuwald, 1999; Yu et al., 1999). It is generally believed that NSF and 
SNAP may act as molecular chaperones, regulating the conformation of SNARE 
complexes by dissociating cis-SNARE complexes (Morgan and Burgoyne, 1995a); 
in contrast, trans-SNARE complexes were suggested to become functionally resistant 
to NSF/SNAP (Weber et al., 2000).  
 
 - 15 -
Presynaptic injection of inhibitory NSF peptides into the squid giant synapse reduced 
nerve-evoked neurotransmitter release in an activity-dependent manner, and 
increased the number of docked vesicles, suggesting a post-docking pre-fusion role 
for NSF in exocytosis (Schweizer et al., 1998). Similarly in PC12 NSF has been 
proposed to function in the priming stage (Banerjee et al., 1996). Deletion of α-
SNAP is embryonic lethal (Chae et al., 2004; Hong et al., 2004) but other 
experiments revealed that presynaptic injection of recombinant α-SNAP into squid 
giant synapse increased transmitter release, however injection of peptides which 
mimic α-SNAP inhibited release and reduced the number of cytoplasmic vesicles, 
indicating a requirement of SNAP in replenishing this vesicle pool (Chamberlain et 
al., 1995; DeBello et al., 1995; Morgan and Burgoyne, 1995b; Poulain et al., 1995; 
Kibble et al., 1996; He et al., 1999; Xu et al., 1999). These studies showed that the 
defects obtained with α-SNAP were similar to the effects seen with NSF (see above), 




The calcium sensor synaptotagmin was identified by two different monoclonal 
antibodies as a 65 kDa protein (Matthew et al., 1981). Immune competition 
experiments showed that synaptotagmin is expressed throughout neuronal and 
neuroendocrine cells on synaptic vesicles (Matthew et al., 1981), and so far 16 
members have been identified in vertebrates (Craxton, 2004). Synaptotagmin 
contains a single N-terminal transmembrane domain and two cytoplasmic repeats 
that are homologous to the C2 domain of Ca2+/phospholipid-dependent protein 
kinase; the C2 domains in synaptotagmin are termed C2A and C2B (Perin et al., 
1990). Later work demonstrated that synaptotagmin binds to calcium and 
phospholipids in a ternary complex (Brose et al., 1992; Davletov and Sudhof, 1993), 
suggesting that synaptotagmin may be involved in Ca2+-triggered neurotransmitter 
release. This assumption was confirmed by microinjection of synaptotagmin mutants 
into neuronal cells, Drosophila (DiAntonio et al., 1993; Littleton et al., 1993) and C. 
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elegans (Nonet et al., 1993), demonstrating an impaired function in neurotransmitter 
release.  
Synaptotagmin I has been shown to display both Ca2+-dependent and -independent 
interactions with SNARE proteins (Tucker et al., 2003; Bowen et al., 2005; Dai et 
al., 2007), and these interactions together with lipid and Ca2+ binding are likely to be 
at the heart of synaptotagmin function in exocytosis. More recent work has also 
suggested a role for synaptotagmin-SNAP25 binding in vesicle docking (de Wit et 
al., 2009). 
Synaptotagmin null mice die within 48 hour after birth (Geppert et al., 1994a) and 
analysis of neurotransmitter release in preparations from these animals revealed that 
Ca2+-dependent exocytosis was decreased, whereas spontaneous synaptic activity 
was unaffected. Synaptotagmins are the prime candidates to couple intracellular 
increases in free calcium upon an action potential to exocytosis of synaptic vesicles 
(Geppert et al., 1994b; Fernandez-Chacon et al., 2001; Bai and Chapman, 2004); 
indeed mutations that decrease the Ca2+ affinity of synaptotagmin lead to an 
increased level of Ca2+ being required to stimulate synaptic vesicle exocytosis 




Munc18 belongs to the family of cytosolic SM (Sec1p/Munc18) proteins which were 
initially discovered during genetic screens for mutants in yeast and C. elegans 
showing defects in membrane traffic and secretion (Brenner, 1974). Mutations in the 
yeast SM protein Sec1p and the C. elegans homologue Unc18 led to deficits in 
secretion (Brenner, 1974; Novick and Schekman, 1979; Novick et al., 1980); other 
identified genetic alterations in these proteins also showed deficits in membrane 
fusion (Cowles et al., 1994; Harrison et al., 1994; Schulze et al., 1994; Verhage et 
al., 2000; Voets et al., 2001). 
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A major focus has been on the interaction of Munc18 with syntaxin, and this 
interaction was originally demonstrated to inhibit the ability of syntaxin to form the 
ternary SNARE complex (Pevsner et al., 1994). Munc 18 is composed of three 
domains that form an arch-shaped molecule with a central cleft (Misura et al., 2000), 
and Munc18 is thought to prevent SNARE complex assembly by wrapping around 
syntaxin and holding it in a ‘closed’ conformation. However, more recent work has 
shown that Munc18 also binds by a different mode to short region of the N-terminal 
domain of syntaxin (Chen et al., 2008). The interaction with syntaxin in its ‘closed’ 
conformation has been termed mode 1 and interaction with the N-terminal motif of 
syntaxin has been termed mode 2/3 (Burgoyne and Morgan, 2007; Dulubova et al., 
2007; Rickman et al., 2007; Shen et al., 2007). Mode 1 binding masks the SNARE 
motif of syntaxin (Burkhardt et al., 2008), suggesting that this mode might be 
important to shield syntaxin from forming inappropriate SNARE interactions as it 
traffics through the ER and Golgi to reach the plasma membrane following its 
biosynthesis (Medine et al., 2007). It has been also shown that binding of Munc18 to 
syntaxin in the 2/3 mode increases the rate of membrane fusion and SNARE complex 
formation in vitro (Khvotchev et al., 2007; Shen et al., 2007).  
Knockout of Munc18 expression in mice resulted in a normally developed nervous 
system, but there was a complete loss of both spontaneous and stimulated secretion 




Complexins are a family of four proteins in mammals (Reim et al., 2005) and were 
identified as proteins which bind to SNARE complexes in a 1:1 stoichiometry 
(Ishizuka et al., 1995; McMahon et al., 1995; Ishizuka et al., 1997; Chen et al., 
2002). Complexins interact through a central α-helical domain with the assembled 
four helix bundle of SNARE complexes, binding to the groove between the VAMP 
and syntaxin helices (McMahon et al., 1995; Pabst et al., 2000; Bracher et al., 2002; 
Chen et al., 2002). Complexin-1 is expressed specifically in the central nervous 
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system, complexin-2 is also expressed in non-neuronal tissues and complexin-3 and -
4 are predominantly expressed in retina (Reim et al., 2005).  
Complexin-1/complexin-2 double knock out mice die shortly after birth and further 
analyses suggested that these proteins regulate a late post-priming step in synaptic 
vesicle release, possibly by stabilising assembled SNARE complexes (Reim et al., 
2001; Xue et al., 2007; Xue et al., 2008). It has also been suggested that complexins 
act as a pre-fusion clamp that arrests SNARE complexes to prevent fusion (Giraudo 
et al., 2006; Carr and Munson, 2007; Melia, 2007). This hypothesis was supported, 
since spontaneous fusion of cells expressing flipped SNARE components was 
blocked by soluble and membrane anchored complexin-1. The block was reversed by 
Ca2+ in the presence of synaptotagmin (Giraudo et al., 2006; Schaub et al., 2006; 
Tang et al., 2006; Huntwork and Littleton, 2007). It should be noted however that 
other studies have indicated a positive role for complexins in the fusion process (Cai 
et al., 2008) and thus the precise function of these proteins in membrane fusion 
remains to be determined. 
 
 
1.4.5 Rab proteins 
Rab proteins are small (20-29 kDa) ubiquitously expressed monomeric GTPases, 
which belong to the Ras GTPase superfamily (Grosshans et al., 2006; Lee et al., 
2009). So far 11 members are known in yeast and more that 60 have been identified 
in mammalian cells (Schultz et al., 2000; Pereira-Leal and Seabra, 2001; Seabra et 
al., 2002). Rab proteins cycle between the cytosol and the membrane of the 
trafficking organelle, controlled by conformational changes that are regulated by 
guanine-nucleotides. Rab proteins are also termed ‘molecular switches’, with the 
membrane bound GTP form being ‘on’ and the GDP-form being ‘off’ (Pfeffer, 2001; 
Segev, 2001; Lee et al., 2009). GTP-Rabs bind to proteins named effectors, which 
only recognise Rabs in their GTP-bound state (Pereira-Leal and Seabra, 2001; 
Eathiraj et al., 2005; Pfeffer, 2005; Lee et al., 2009) and are specific for a single Rab 
or a small subset of Rabs (Shirane and Nakayama, 2006). 
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Fusion can only occur if membrane contact is established and there has been 
evidence that contacts are engineered by Rabs, regulating SNARE-dependent 
membrane docking and fusion (Grosshans et al., 2006). Rab3A, one of the most 
abundant synaptic Rab proteins, is vesicle bound and undergoes a synaptic vesicle 
association and dissociation cycle coupled to calcium stimulated exocytosis and 
recovery. Geppert et al. (1994) showed that Rab3A knock out mice were viable, 
fertile and showed no abnormalities in synaptic transmission, however synaptic 
depression was significantly increased after reiterating stimuli and the Rab3A 
binding partner rabphilin was decreased by 70 %. The results suggested a key role 
for Rab3A and its effectors in supplying fusion-competent vesicles during repetitive 
stimulations (Geppert et al., 1994a).  
 
 
1.5 Cysteine String Protein (CSP) 
 
1.5.1 Discovery of CSP 
A molecular understanding of synaptic function has been driven by the identification 
and characterisation of key synaptic proteins in mammals and model organisms. 
Cysteine-string protein (CSP) was first identified from the use of hybridoma libraries 
generated against Drosophila heads. The antibodies from these libraries were thus 
used for screening cDNA expression libraries to identify clones coding for brain 
proteins. Zinsmaier et al., 1990 used one monoclonal antibody (mab) “mab49” 
derived from the hybridoma library to identify, through immunohistochemical 
staining, novel proteins expressed in the adult nervous system of Drosophila. This 
antibody selectively bound strongly to all neuropil regions, motor neurons and 
synaptic terminals of all neurons. In-situ hybridisation to Drosophila brain also 
demonstrated specific hybridisation to retina and the brain cellular rind. Through 
western blot analyses of homogenised Drosophila brain, two proteins were 
recognised at the sizes of 29 kDa and 32 kDa. To detect the cDNA sequences that 
code for the antigen, a lambda gt11 head cDNA expression library was screened 
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using the mab49 antibody. cDNAs encoding for two different proteins of 249 and 
223 amino acids in length were identified. Interestingly, both proteins had a 
conspicuous feature, the presence of 11 cysteine residues in a span of 22 amino 
acids. For this reason these proteins were named ‘cysteine-string protein’ 
(abbreviated to CSP); the Drosophila proteins were designated CSP-29 and CSP-32, 
according to the size of the protein bands detected by immunoblotting.  
Interestingly, a homologous protein to Drosophila CSPs was independently 
discovered in Torpedo californica (Gundersen and Umbach, 1992). The aim of this 
study was to identify subunits or regulators of presynaptic Ca2+-channels through a 
suppression cloning technique. For this, Xenopus oocytes were injected with mRNA 
from the Torpedo electric lobe, which resulted in the expression of a novel Ca2+-
channel current that could be differentiated from endogenous currents. The 
suppression cloning technique employed antisense copy (c)RNA to block the 
Torpedo ω-conotoxin GVIA (ω-CgTx)-sensitive Ca2+ currents in Xenopus oocytes. 
This approach led to the identification of a 1.55 kb cDNA with a 585 nucleotide open 
reading frame, and the encoded protein was termed candidate Ca2+ channel subunit 1 
(CCCS1). The authors also noted a local abundance of 13 cysteine residues, and in 
vitro translation and labelling with 35S cysteine revealed a single protein band of 27 
kDa. The Torpedo CCCS1 protein is 69 % - 70 % identical at the amino acid level to 
the two CSPs expressed in Drosophila. Hydropathy analysis suggested that CCCS1 
may have a single membrane spanning domain centred around the cysteine-string 
region and flanked by lysine residues, and that most of the cysteine residues might be 
embedded in the lipid environment of the membrane. Due to its linkage to Ca2+-
channels it was also proposed that CCCS1 might be involved in regulated exocytosis 
(see 1.5.3). 
The high abundance of cysteine residues in the cysteine-string domain (Figure 1.1) 
was of particular interest to researchers and it was suggested that these residues may 
be important for post-translational modification of the protein. Indeed, SDS-PAGE 
analysis of 35S-cysteine labelled T-CSP revealed a band at 27 kDa, as expected, but  
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Figure 1.1: Schematic diagram of the domains of mammalian Cysteine String Protein 
(CSP). The amino acid numbers corresponding to domain boundaries are indicated. 
 
also a second band at 34 kDa, suggestive of a modified form of the protein 
(Gundersen et al., 1994). Fractionation of homogenised Xenopus oocytes revealed 
that the 34 kDa band associated with membrane fractions, whereas the 27 kDa CSP 
was entirely cytosolic. As the higher molecular weight form of T-CSP was 
membrane-associated it was suggested that CSP might be modified with hydrophobic 
fatty acids. To test this idea, membrane fractions containing the 34 kDa T-CSP were 
treated with hydroxylamine or methanolic KOH, which cleave thioester-linked fatty 
acids from cysteines. Both treatments converted the 34 kDa T-CSP to a 27 kDa form, 
the same size as cytosolic CSP. Furthermore, T-CSP was shown to incorporate [3H]-
palmitate, and the mass of [3H]-palmitate-labelled T-CSP was similar to endogenous 
34 kDa T-CSP. A time course of hydroxylamine treatment of T-CSP disclosed that 
the majority of (12 out of 13) cysteine residues were palmitoylated.  
Subsequent work identified expression of an homologous CSP protein in mammalian 
species (Figure 1.2) (Braun and Scheller, 1995; Mastrogiacomo and Gundersen, 
1995; Chamberlain and Burgoyne, 1996). In addition, a second CSP isoform with a 
truncated C-terminus was identified (Chamberlain and Burgoyne, 1996). These 
proteins were termed CSP1 and CSP2 (CSP isoforms are discussed in more detail in 
section 1.5.10). Although CSP1 is enriched in brain in mammals, it is expressed in 
all tissues that have been examined (Chamberlain and Burgoyne, 1996). 
In addition to the cysteine-string domain another defining feature of CSP is the J-
domain (Figure 1.1) (Silver and Way, 1993), an ~ 70 amino acid region located at the 
N-terminus of the protein. The J-domain is the signature motif of the DnaJ family of 
co-chaperones, a group of proteins that function in concert with HSC70 (Heat-Shock 
Cognate protein of 70 kDa) and its homologs to regulate many cellular processes.  
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Figure 1.2: Alignment of CSP in a section of vertebrates. Amino acid sequences of CSP 
from several species (as noted in the figure) were aligned. Conserved amino acids present in 
all species are highlighted green, conserved residues present in 80 % of the species are 
coloured light green and conserved residues presenting 60 % of the species are coloured 
yellow. The blue box highlights the highly conserved J-domain and the red box the highly 
conserved cysteine string domain.  
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Subsequent work showed that the J domain mediates binding of CSP to HSC70 and 
activates the ATPase activity of HSC70 several-fold (Braun et al., 1996; 
Chamberlain and Burgoyne, 1997a; Zhang et al., 1999). Other domains of CSP 
include the short N-terminal region that precedes the J-domain and the “linker” 
domain, which lies between the J-domain and the cysteine string (Figure 1.1). 
Important functions of these domains have also been suggested by mutational studies 
(Zhang et al., 1999; Arnold et al., 2004). In section 1.5.6 all domains and their 
proposed functions will be discussed in more detail. 
 
 
1.5.2 Intracellular distribution of CSP 
As Torpedo CSP was proposed to be an essential subunit or regulator of presynaptic 
calcium channels (Gundersen and Umbach, 1992), it was expected that this protein 
would be localised to the plasma membrane. To examine T-CSP intracellular 
distribution, electric organ was fractionated into cytosol and membrane fractions 
(Mastrogiacomo et al., 1994a). T-CSP was mainly detected in the membrane 
fraction. Consistent with this membrane localisation, 80 % of T-CSP separated into 
Triton X-114 detergent phase suggesting that endogenous T-CSP has a high 
hydrophobicity. Surprisingly however, CSP was found to be associated with synaptic 
vesicles following subcellular fractionation of Torpedo electric organ 
(Mastrogiacomo et al., 1994b). In agreement with this observation, a subsequent 
study showed that CSP was also enriched in a synaptic vesicle fraction purified from 
rat brain (Braun and Scheller, 1995). 
Subsequent studies in different cell types confirmed that CSP localised 
predominantly to vesicular structures. CSP was enriched in a zymogen granule 
fraction from rat pancreas (Braun and Scheller, 1995), and associated with 
chromaffin granules in adrenal medullary chromaffin cells as determined by a range 
of approaches including cell fractionation, immunofluorescence and electron 
microscopy (Chamberlain and Burgoyne, 1996). CSP is also present on insulin-
containing granules in pancreatic beta cells (Zhang et al., 1998). The 
neurohypophysis holds two types of vesicles, small synaptic vesicles (SSVs), which 
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store glutamate, actylcholine and GABA, and large dense core vesicles (LDCVs), 
which secrete peptides and hormones. CSP was shown to be localised to SSVs in 
peptidergic terminals of the neurohypophysis, and was also detected in fractions 
containing arginine vasopressin (AVP), which is found in LDCVs, following 
fractionation of neurohypophyseal nerve endings (Pupier et al., 1997). However, in 
contrast to the vesicular/granular localisation observed for CSP in several cell types, 
CSP associated with the plasma membrane in 3T3-L1 adipocytes (Chamberlain et 
al., 2001). This observation was surprising as adipocytes contain a well-defined 
regulated exocytosis pathway involving the fusion of vesicles containing the glucose 
transporter GLUT4 with the plasma membrane in response to insulin stimulation 
(Bryant et al., 2002). CSP was not detected on these vesicles. 
 
 
1.5.3 The role of CSP in exocytosis and as possible Ca2+-regulator 
Drosphila CSP was detected presynaptically at larval and adult neuromuscular 
junctions (NMJ) and also in synaptic boutons, suggesting an important function at 
presynaptic regions (Zinsmaier et al., 1990; Zinsmaier et al., 1994). To examine the 
function of CSP in Drosophila, a site-selected P-element mutagenesis was performed 
to target the CSP gene and induce its mutational inactivation (Zinsmaier et al., 1994). 
The resultant mutants showed a semilethal embryonic phenotype and only 4 % 
survived to adulthood and died within four to five days at 22°C. When the mutants 
were exposed to higher temperature (29°C) they presented increasingly sluggish 
behaviour, intense spasmic jumping, uncoordinated locomotion, paralysis and died 
soon thereafter. To further investigate the CSP mutant, the cspx1 mutant was used, 
which showed some residual expression of CSP. Electroretinograms of wild type and 
CSP mutant flies were compared at increasing temperatures ranging from 19°C to 
38°C. At higher temperatures it was observed that the mutants lost their on/off 
transient which was rescued by returning to low temperatures. This transient is 
dependent on synaptic transmission from photoreceptor terminals to lamina neurons. 
Electromicroscopic comparison of synaptic regions in lamina revealed that synaptic 
vesicles in the mutant were barely visible; terminals were filled with electron dense 
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debris, which might have been caused by neuronal degeneration. These results 
suggested that CSP might have a role in presynaptic neurotransmitter release or 
synaptic vesicle cycling. To examine this at the cellular level, neuromuscular 
transmission was studied in csp null mutant larvae, flies rescued by P-element 
transformation and wild type Drosophila via electrophysiological experiments 
(Umbach et al., 1994). The nerve-evoked excitatory junctional potentials (EJPs) of 
mutants were found to be reduced by a half at 22°C and almost completely abolished 
at 29°C. There was also a decline detected in the spontaneous excitatory junctional 
potential (MEJP) amplitude in the mutant flies compared to rescued and wild type 
flies. In summary, these studies indicated that CSP might play a specific role in 
regulated exocytosis (Schwarz, 1994; Umbach et al., 1994; Broadie, 1995; Poage et 
al., 1999). Independently from Zinsmaier’s work, CSP was discovered as a possible 
subunit or regulator of presynaptic Ca2+-channels (Gundersen and Umbach, 1992). 
However, as CSP was found on synaptic vesicles (Mastrogiacomo et al., 1994b) it 
was proposed that shortly after vesicle docking at the plasma membrane CSP 
activates presynaptic calcium channels, enhancing calcium-secretion coupling. 
As neurotransmission in CSP null mutant Drosophila only failed completely at 
higher temperatures, it was subsequently examined if there were any differences in 
evoked release at low ‘permissive’ temperatures of 16°C-18°C in CSP mutant flies 
(Heckmann et al., 1997). Here it was seen that the quantal content was normal, 
whereas the time course of release is disturbed at ‘permissive’ temperatures in CSP 
mutant flies. These findings confirmed that CSP is involved in neurotransmitter 
release and that impairment of neurotransmitter release is not specifically present 
only at higher temperatures, but already at permissive temperatures. A review 
published around this time hypothesised CSP to be involved in synaptic vesicle 
recycling (Sudhof, 1995), and this hypothesis was investigated (Umbach and 
Gundersen, 1997; Ranjan et al., 1998). Stimulation at 21°C and 32°C by α-
Latrotoxin, which forms ion-permeable pores in the membrane, released a sizable 
pool of quanta in wild type flies and in CSP null mutants. Shibire mutant flies on the 
other hand, which are known to be defective in endocytosis due to dynamin 
inactivation, did not retain abundant releasable quanta (Umbach and Gundersen, 
1997). An intact endocytotic machinery was also elegantly verified by a study 
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demonstrating that CSP mutant Drosophila neurons were able to effectively take up 
FM1-43 dye at 22°C, as an indicator of endocytosis (Ranjan et al., 1998). In contrast, 
subsequent release of FM1-43 (indicative of exocytosis) was blocked at 32°C, further 
confirming a selective loss of exocytosis in CSP null Drosophila.  
Umbach and Gundersen (1997) suggested that the failure of quantal secretion in CSP 
mutants might occur due to an inhibition of presynaptic calcium channels activity. 
This observation was experimentally supported, given that high external Ca2+ 
concentrations, potassium concentrations and nerve stimulations failed to restore 
evoked responses, whereas Ca2+ ionophores where reported to bypass the block of 
transmitter release in CSP null mutant Drosophila. It was therefore suggested that 
CSP regulates an important step in calcium-secretion-coupling (Umbach and 
Gundersen, 1997). However, it is important to note that there have been conflicting 
experimental evidence concerning the role of CSP in modulating presynaptic Ca2+-
channel activity in fast neurotransmitter release. On one hand, Ca Crimson was used 
to monitor stimulus dependent changes in cytosolic Ca2+ at motor nerve terminals of 
CSP null mutant Drosophila (Umbach et al., 1998). Here it was shown that the 
inhibition of neuromuscular transmission is correlated with a block of Ca2+ ion entry 
at nerve endings in CSP null mutants, which would support the hypothesis of CSP 
mediating a regulatory interaction between synaptic vesicles and presynaptic calcium 
channels. Then again, the same hypothesis was tested using the calcium indicator 
fluo-4 AM in neuromuscular junctions in Drosophila CSP null mutants (Dawson-
Scully et al., 2000). This study reported that in control and CSP mutant flies, loaded 
with fluo-4 AM or Ca Crimson, presynaptic calcium signals firmly increased 
following stimulation at temperatures above 30°C. Indeed, mutant boutons displayed 
a slower time course of decay for calcium signals, especially at higher temperatures. 
This suggested that CSP null mutant boutons are physiologically less able to cope 
with calcium loads than control boutons. Indeed, further experiments disclosed that 
the relative increase in intraterminal calcium is generally larger in CSP null mutants 
than in controls and that the reduction in neurotransmitter release in these mutants 
cannot therefore be explained by a loss of calcium entry into nerve terminals. One 
possible explanation for the defect in calcium triggered exocytosis in CSP null 
mutants might be that the resting calcium concentration is actually lower in these 
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mutants, but measurements of the resting values of calcium concentrations revealed 
no differences between control and mutant flies at room temperature, with the 
exception that the resting level was higher in mutant flies at 34°C. This study 
concluded that the loss of neurotransmitter release in CSP null mutants is primarily 
caused by a defect of a direct step in calcium regulated exocytosis and not as a result 
of a defect in Ca2+ channel activation. 
Overall the study by Zinsmaier’s group supported the findings of Chamberlain and 
Burgoyne, 1998, who reported a direct function of CSP in exocytosis in PC12 cells. 
CSP over-expression (~ 13-fold) (see Table 1.1) caused an ~50 % increase in Ca2+-
stimulated [3H] dopamine secretion, with no difference could be seen in cytosolic 
Ca2+ channel levels in resting cells or following stimulation. Importantly, CSP over-
expression enhanced secretion in permeabilised cells independently of any Ca2+ 
channel requirement. Thus, this work demonstrated that CSP directly functions in 
regulated exocytosis. Over-expression of CSP in INS-1 pancreatic beta cells also 
impacted insulin secretion; in this case over-expression of CSP inhibited release (see 
Table 1.1) (Brown et al., 1998). Moreover, it was examined whether CSP over-
expression had any effect on voltage-dependent Ca2+-channels in these cells, by 
using the whole cell configuration of the patch-clamp technique. No difference was 
detected in Ca2+-channel activity in control cells and cells over-expressing CSP. This 
work suggested that CSP is not a modulator or a subunit of Ca2+-channels and must 
play an alternative role in regulated secretion (Morales et al., 1999). 
The role of CSP in exocytosis was more accurately analysed by examining the effect 
of CSP over-expression of dense-core granules exocytosis in single adrenal 
chromaffin cells using amperometric recordings to detect released catecholamines 
(see Table 1.1) (Graham and Burgoyne, 2000). CSP over-expression caused a 
reduction in amperometric spike number after stimulation, indicating a decrease in 
fusion events leading to a reduction in catecholamine release by ~ 82 %. The mean 
spike amplitude was unaffected by CSP over-expression, but closer examination of 
spike parameters revealed that the total charge per spike was significantly increased 
(half-width increased ~ 60 %), and there was a deceleration in the rate of the spike 
rise. These results indicated that CSP is important for fusion pore formation or even 
controls fusion pore opening.  
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The idea that CSP does not regulate activity of voltage-gated Ca2+-channels is in 
agreement with previous work of Pupier et al., 1997, where the interaction of CSP 
with presynaptic calcium channels was examined by assessing the ability of CSP 
antibodies to immunoprecipitate N-type Ca2+-channels solubilised from peptidergic 
terminals of the neurohypophysis or brain P2 membranes labelled with a specific 
radioligand [125I]-ωGVIA. The CSP antibody could not capture more Ca2+-channels 
than non-immuno IgG, which concluded that CSP does not form a complex with 
these Ca2+-channels (Pupier et al., 1997). However, subsequent work suggested that 
CSP does interact with the N-type calcium channel (Magga et al., 2000). In this work 
it was examined whether the protein-protein interaction between CSP and the Gβγ 
subunit of the G protein complex influences calcium channel activity. CSP was co-
expressed with the N-type (α1B, β1b and α2-δ) Ca2+-channels in tsa-201 cells and its 
function was assessed via whole cell patch clamping. Compared to the typically N-
type Ca2+-channel current waveform, the channels co-expressed with CSP exhibited 
a slowed current waveform and the densities appeared reduced by ~2-fold. This led 
to the assumption that CSP has a strong inhibitory effect on these channels. It was 
proposed if the inhibitory effect of G protein on N-type Ca2+-channel activity is 
dependent on the physical interaction between CSP and the channel, then a reduction 
of CSP binding should be simultaneous with a reduction in the G protein effect. Thus 
CSP, N-type Ca2+-channel and the α1BII-III linker synprint region of N-type Ca2+-
channel were co-expressed in tsa-201 cells. Whole cell patch clamping revealed a 
dramatic reduction in prepulse facilitation induced by CSP, which indicates Gβγ 
modulation of voltage-gated Ca2+-channels. Compendious the results showed that 
interactions between CSP and N-type calcium channels result in a robust inhibition 
of channel activity by G protein βγ subunits.  
It was investigated whether huntingtin mutants, which have expanded polyglutamine 
repeats, alter the association of G proteins with CSP (Miller et al., 2003). The 
huntingtin protein is an essential protein of unknown function. Mutations in its gene 
cause Huntington’s disease. The initial pathological target in Huntington’s disease is 
the degeneration of the striatal medium spiny GABAergic neuron. The huntingtin 
protein mutant contains 36-250 polyglutamine repeats in exon1, compared to the 
wild type protein with 6 to 39 repeats. It has been observed that proteins with 
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expanded polyglutamine repeats interfere with the chaperone balance of the cell. In 
vitro binding assays were used to analyse the effect of the normal huntingtin protein 
exon1 (HDQ20) and the protein with the expanded polyglutamine repeats in exon1 
(HDQ53). HDQ53 reduced the interaction between CSP and G proteins and it was 
also shown that HDQ53 directly bound to CSP. HDQ53 tended to aggregate after 
some time. CSP chaperone function on HDQ53 could be excluded. Despite that, 
further experiments revealed that the Huntington’s disease protein (HDQ53) blocked 
the CSP modulation of G protein inhibition of calcium channel activity. 
 
 
1.5.4 Protein interactions of CSP 
 
1.5.4.1 Heat-shock proteins and co-chaperones 
One defining domain of CSP is the J-domain, a 70 amino acid region, which is a 
conserved motif of the DnaJ family of co-chaperones identified in Escherichia coli. 
DnaJ proteins function in conjunction with HSC70 (Heat-Shock Cognate protein of 
70 kDa, homolog to DnaK in bacteria) to regulate many cellular processes.  
HSC70 is a ubiquitously expressed molecular chaperone that regulates substrate 
proteins by several mechanisms, including the stabilisation of unfolded proteins, 
promotion of correct protein folding and assembly/disassembly of multimeric protein 
complexes (Beckmann et al., 1990; Langer et al., 1992). The binding and release 
kinetics of HSC70 proteins are controlled by an ATPase activity, which is subject to 
regulation by cofactors including DnaJ proteins. It was shown that CSP binds to both 
HSC70 and HSP70 (heat-shock inducible isoform) and stimulates their ATPase 
activity by ~ 13-fold (Braun et al., 1996; Chamberlain and Burgoyne, 1997a, b). In 
contrast, synaptotagmin (vesicle protein) and α-SNAP (NSF activator) were not able 
to activate HSC70 (Braun et al., 1996).  
The conserved tripeptide, histidine-proline-aspartate (HPD), is present in all J 
domains and has been shown to play an important role in the interaction between 
DnaJ proteins and HSC70/DnaK (Wall et al., 1994; Tsai and Douglas, 1996). 
Mutations in the HPD motif of CSP (H43Q or D45A) completely inhibited activation 
of HSC70 ATPase activity (Chamberlain and Burgoyne, 1997a). Furthermore, 
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competition-binding assays with these two mutants and wild type CSP suggested that 
the mutants were unable to bind to HSC70. In agreement, tryptic digestion confirmed 
that unlike wild type CSP, the CSP(H43Q) and CSP(D45A) mutants were unable to 
promote conformational changes in HSC70 (Chamberlain and Burgoyne, 1997a). 
As other HSC70/DnaJ protein pairs have been shown to regulate protein 
folding/aggregation, it was examined if CSP/HSC70 could prevent aggregation of 
heat-denatured firefly luciferase (Chamberlain and Burgoyne, 1997a). Prevention of 
protein aggregation by binding to exposed hydrophobic regions of denatured proteins 
is a classical assay for chaperone activity. Wild type CSP as well as the HPD mutants 
(CSP(H43Q) and CSP(D45A)) were able to act as molecular chaperones by blocking 
luciferase aggregation. In contrast, HSC70 was ineffective at preventing aggregation, 
whereas CSP and HSC70 together functioned synergistically to prevent luciferase 
aggregation, suggesting that they form a chaperone ‘machine’. 
Subsequent work built upon these earlier studies by showing that CSP/HSC70 form a 
complex with a third chaperone protein, αSGT (Small glutamine-rich 
tetratricopeptide repeat-containing protein alpha) (Tobaben et al., 2001). The 
trimeric complex formed in the presence of ADP and was disassembled by Mg2+-
ATP. αSGT has a tetratricopeptide repeat (TPR) motif, which is known to be a 
protein-protein interaction module. Furthermore, most TPR-containing proteins are 
associated with multiprotein complexes, and there is evidence indicating that TPR 
motifs are important to the functioning of chaperones, cell-cycle, transcription, and 
protein transport complexes (Blatch and Lassle, 1999). αSGT has also been shown, 
together with HSP70/HSP90, to promote cytoplasmic retention of the androgen 
receptor and to be a determinant of the sensitivity and specificity of androgen 
receptor activation (Buchanan et al., 2007; Goodarzi et al., 2008). 
It was shown that αSGT and CSP intensely activate the HSC70 ATPase (~19-fold), 
compared to CSP (~12-fold) or SGT (~3-fold) alone, thus it was assessed whether 
this trimeric complex behaves as a chaperone-complex; to approach this, denatured 
firefly luciferase was used as a substrate. The results demonstrated that CSP, αSGT 
or HSC70 alone were not able to re-fold denatured luciferase, and that CSP/HSC70 
only achieved a low level of luciferase reactivation, however all three proteins 
together renatured ~60 % of denatured luciferase in the presence of ATP, indicating 
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that SGT increases the efficiency of CSP/HSC70 chaperone activity. The 
CSP/HSC70/αSGT-complex is also likely to be important in vivo as the proteins 
interact in cells as revealed by co-precipitation of αSGT from purified vesicles with 
CSP and HSC70. Indeed CSP regulates αSGT association with synaptic vesicles, as 
SGT was decreased in this fraction from CSP knockout mice (Fernandez-Chacon et 
al., 2004). 
β-small glutamine-rich TPR protein (βSGT) is an isoform of αSGT expressed 
exclusively in brain, which shares approximately 60 % amino acid sequence identity 
with the αSGT isoform (Tobaben et al., 2003). Both α- and βSGT incorporate the 
defining tetratricopeptide repeats (TPRs) motif, which is known to bind to the C-
terminus of HSC70 (Liu et al., 1999; Scheufler et al., 2000; Tobaben et al., 2001). 
The TRPs of βSGT were shown to bind to the cysteine string domain of CSP 
(Tobaben et al., 2003), as truncation of 6 of the 14 cysteine residues in CSP blocked 
this interaction. The interaction of βSGT with the cysteine-string domain may be via 
hydrophobic interactions, as mutations of all cysteines to hydrophilic serines 
abolished binding, whereas mutation of the cysteines to alanine had less of an effect 
on binding.  
Chemical cross-linking experiments revealed that CSP/HSC70 also bind to a 
complex containing αGDP-dissociation inhibitor (αGDI) and HSP90 (heat-shock 
protein of 90 kDa) (Sakisaka et al., 2002). αGDI regulates membrane release and 
recycling of Rab GTPases and HSP90 is a specialised chaperone that is known for its 
role in stabilising intermediates of molecules in signalling pathways. This suggested 
that a major component of a membrane-associated complex containing αGDI is 
likely to include HSP90 tethered to synaptic vesicles through CSP/HSC70 and 
possibly other factors. As Rab proteins play key roles in membrane fusion pathways, 
this interaction of CSP may be relevant to its function in exocytosis, however, no 
further work on this area has been forthcoming. 
The J-domain is clearly important for the function of CSP in exocytosis as point 
mutations in the HPD motif (CSP(H43Q) and CSP(D45N)) reduced the inhibitory 
effect of CSP over-expression on secretion of human insulin C-peptide from HIT-
T15 cells (Zhang et al., 1999). Furthermore the J-domain is also important for the 
function of Drosophila CSP at neuromuscular junctions (Bronk et al., 2005). Two 
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defined mutants, ΔJ-CSP (deletion of the J-domain) and CSP(H45Q) (point mutation 
in the conserved HPD tripeptide motif) were unable to reverse the lethal phenotype 
of Drosophila CSP null mutants. Indeed, expression of both J-domain mutants even 
enhanced the temperature sensitive lethality of CSP null Drosophila. However, the J-
domain is not required for every function of CSP. For example, the number of 
synaptic boutons is reduced in CSP null mutants and this was reversed by expression 
of either wild type CSP, ΔJ-CSP or CSP(H45Q). Wild type CSP increased the 
number of boutons to 186 % of wild-type controls, whereas the mutants reversed the 
decrease of synaptic boutons in csp null flies to 74 % - 80 % of wild type controls. In 
addition it was observed that expression of ΔJ-CSP in motor neurons increased the 
excitatory junction potential (EJP) amplitudes at 22°C in the mutant, however normal 
transmission functions were not restored (Bronk et al., 2005; Weng et al., 2009). 
Thus, the J-domain seems to be essential for only a subset of the synaptic functions 
of CSP. Finally, although some functions of CSP might proceed in the absence of 
HSC70 interaction, it is important to note that mutation of HSC70 in Drosophila 
caused a ~50 % reduction of nerve-evoked neurotransmitter release at 23°C and was 
abolished at 30°C (Bronk et al., 2001). The loss of nerve-evoked neurotransmitter 
secretion was caused by reduced Ca2+-sensitivity of exocytosis downstream of Ca2+ 
entry, which could be rescued by increasing internal and external calcium. The 
results indicated that HSC70 and CSP might act in mutual pathways, as CSP mutant 
Drosophila displayed similar temperature sensitive effects (Zinsmaier et al., 1994), 
homozygous HSC70-CSP double mutants showed a similar loss of evoked release, 
and CSP and HSC70 have been shown to interact with each other in vitro and in vivo 
(Chamberlain and Burgoyne, 1997b, a; Bronk et al., 2001; Tobaben et al., 2001). 
These results suggested that CSP and HSC70 cooperatively enhance release by 
increasing the calcium sensitivity of vesicle fusion (Bronk et al., 2001). 
 
 
1.5.4.2 Ca2+ channels 
CSP was identified in one study as a subunit or modulator of Ca2+-channel subunits 
in Torpedo (Gundersen and Umbach, 1992) and it has been repeatedly suggested that 
CSP might regulate Ca2+-channel activity (Umbach and Gundersen, 1997). 
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Neurotransmitter release in the central and peripheral nervous system is regulated by 
Ca2+ entry through voltage-gated Ca2+ channels (VGCCs). VGCCs also regulate 
secretion from chromaffin and pancreatic beta cells. Different VGCCs are important 
for regulated exocytosis in different cell types. For example L-type VGCCs regulate 
secretion from pancreatic beta cells, whereas N-type and P/Q-type VGCCs are 
localised at presynaptic terminals and are important for neurotransmitter release. 
To assess if CSP interacts with P/Q-type calcium channels, in vitro binding assays 
were performed (Leveque et al., 1998). P/Q-type calcium channels consists of 
several subunits, α1, α2δ, β1-4, and γ. The α1 subunit has 24 transmembrane domains 
and forms the ion conducting pore and consists of the characteristic four homologous 
I-IV domains containing six transmembrane α-helices each (Dolphin, 2006). The 
domains II and III are linked through an intracellular loop in the α1A subunit of the 
P/Q calcium channel (Sheng et al., 1998). A GST-tagged form of this II-III linker 
region of the P/Q calcium channel α1A subunit (GST-II-IIIA) immobilised on 
glutathione-sepharose beads was shown to interact with in vitro translated 35S-
labelled CSP (Leveque et al., 1998). Furthermore, endogenous (and hence 
palmitoylated) CSP was also able to associate with the GST-II-IIIA fusion protein. 
This direct association of CSP with P/Q-type channel α1A subunits suggested that 
CSP might indeed regulate calcium channel activity by binding to and modulating 
the II-III linker region of the α1A subunit (Leveque et al., 1998).  
The activity of VGCCs can also be regulated by heterotrimeric G proteins. It has 
been demonstrated that syntaxin 1A physically binds to both the N-type calcium 
channel domain II–III linker and to the Gβγ subunit (Jarvis et al., 2000; Lu et al., 
2001). The protein complex facilitates G protein interactions with the channel 
leading to channel inhibition. Cleavage of syntaxin 1A with botulinum toxin C 
(BoNT C) removes the syntaxin 1A-mediated enhancement of G protein modulation 
and reduces the probability of interactions between the channel and Gβγ. In a separate 
study, Magga et al. (2000) examined the possibility that CSP might also regulate 
VGCC function indirectly via interaction with regulatory pathways. This hypothesis 
was initially tested by examining the interaction of CSP with heterotrimeric G 
protein subunits. GST-tagged CSP or a mutant truncated after the J-domain (CSP(1-
82)) were coupled to glutathione agarose beads and incubated with a rat hippocampal 
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homogenate. Western Blot analysis revealed that the Gβγ subunits of the G protein 
complex associated with recombinant full-length CSP in vitro, but not with the 
CSP(1-82) construct. This indicated that Gβγ complex interacts with the linker region, 
cysteine-string domain or C-terminus of CSP or that the complete structure of CSP is 
required for binding. Further analysis of interactions between these proteins revealed 
co-precipitation of CSP with anti-syntaxin and anti-Ca2+ channel β1 subunit 
antibodies. Hence, direct binding of Gβγ to CSP and/or syntaxin may be linked with 
regulation of VGCCs. Interestingly, analysis of the Gα subunit of the trimeric GTP 
binding proteins via western blotting revealed that this subunit bound to CSP(1-82) 
in an ATP dependent manner. This finding may suggest the intriguing possibility that 
CSP chaperones the Gα/Gβγ interaction in addition to Gβγ/VGCC (Magga et al., 
2000).  
Further analysis of the CSP/Gα interaction demonstrated that the J-domain and linker 
region of CSP also associate with the inactive GDP-bound conformation of 
Gα (Natochin et al., 2005). The CSP(1-112) mutant increased the initial rate of 
GTPγS binding to Gαs but not Gαi. Moreover, transiently expressed CSP enhanced 
Gαs-mediated signalling and therefore increased intracellular cAMP levels. These 
data suggested that CSP modulates G protein function by targeting the inactive GDP-
bound form of Gαs and promoting GDP/GTP exchange. It was suggested that upon 
activation by HSC70/SGT, CSP is a direct guanine nucleotide exchange factor 
(GEF), however there is no experimental evidence to support this statement. Thus, 
biochemical studies are consistent with the notion that CSP might regulate Ca2+ 
channel function directly or indirectly via effects on heterotrimeric G proteins. 
However, there is a lack of strong evidence that CSP regulates VGCC in vivo and 





The SNARE protein VAMP (synaptobrevin) is a key component of the exocytosis 
machinery. Pairing between VAMP on secretory vesicles and syntaxin/SNAP25 on 
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the plasma membrane forces the vesicle membrane and the plasma membrane into 
close contact and promotes membrane fusion (Weber et al., 1998; Wang and Tang, 
2006). The first report of an interaction between CSP and VAMP by Leveque et al. 
(1998) indicated coimmunoprecipitation of CSP and VAMP from solubilised 
synaptosomes. However Leveque and colleagues were unable to show an interaction 
between the recombinant forms of VAMP and CSP, suggesting that the interaction 
might be indirect. A subsequent study reported that CSP1, but not CSP2, 
coimmunopreciptated with both VAMP2 and VAMP7 under stimulating conditions 
(high Ca2+-levels) from HIT-T15 cell extracts. Importantly, these interactions were 
verified using recombinant proteins, showing that the interaction is direct. As CSP1 
and CSP2 are identical except that CSP2 has a truncated C-terminal domain, this 
work showed the importance of the C-terminus of CSP for VAMP2 interaction (Boal 
et al., 2004). In contrast, analysis of binding to CSP truncation mutants suggested 
that VAMP8 binds to the linker domain and/or cysteine-string region (Weng et al., 
2009).  
There is currently no data available that indicates that a CSP-VAMP interaction 
regulates exocytosis. In pancreatic beta cells, the inhibitory effect of CSP2 over-
expression in exocytosis was less than that of CSP1, indicating some function of the 
extreme C-terminus of CSP in exocytosis; subsequent work should examine whether 
this difference reflects an important role for CSP-VAMP2 binding. By analysing 
more CSP truncation mutants/point mutants it should be possible to map the minimal 
region of CSP required for VAMP binding. This will allow the effects of more 
defined CSP mutants on exocytosis to be examined, and more directly correlate 




It was suggested that CSP might facilitate VGCC activation by promoting the 
dissociation of the plasma membrane associated SNARE protein syntaxin (Seagar et 
al., 1999). To investigate if there was an association between the functions of CSP 
and syntaxin, it was examined whether co-expression of syntaxin 1A suppresses the 
 
 - 37 -
phenotype associated with CSP over-expression in Drosophila (Nie et al., 1999). The 
results revealed that co-expression of syntaxin 1A partially suppressed the CSP over-
expression phenotype (crumpled wings and rough eyes; see Table 1.1). Moreover 
syntaxin immunopurified with CSP from Drosophila protein extracts, indicating that 
the two proteins interact. It was subsequently shown that His6-CSP1 interacts with 
GST-syntaxin 1A in vitro, demonstrating a direct interaction (Chamberlain et al., 
2001). The fusion of GLUT4 vesicles with the plasma membrane in adipocytes is 
regulated by syntaxin 4. Interestingly immobilised His6-CSP pulled down syntaxin 4 
from a lysate of 3T3-LI adipocytes. This observation was important as adipocytes do 
not express VGCCs, suggesting that the CSP-syntaxin 4 interaction is not related to 
Ca2+ channel regulation. Subsequent in vitro binding assays examining interactions 
between CSP1/CSP2 and syntaxin 1/4 reported that both CSP1 and CSP2 bound to 
syntaxin 1A whereas syntaxin 4 only interacted with CSP1. These results are 
reminiscent of analysis of VAMP2/VAMP7 binding to CSP, and suggest that 




Deletion of CSP in mice resulted in a decrease in the expression level of the SNARE 
protein SNAP25 (Chandra et al., 2005), suggesting a possible chaperone role for 
CSP (see 1.5.9).  
To map protein interaction of CSP in hormone secretion of pancreatic β cells, pull-
down experiments were carried out with immobilised CSP1 and extracts of clonal β 
cells (Boal et al., 2011). Immunoblot analysis identified proteins which are known to 
bind to CSP, such as VAMP2 and HSC70; however, SNAP25 was also identified as 
a possible binding partner of CSP1 reciprocal. Pull down assays with immobilised 
SNAP25 confirmed that CSP, as well as HSC70 and VAMP2 bind to SNAP25. 
Truncation mutants of CSP (CSP(1-82), CSP(1-110), CSP(1-167), CSP(110-198) 
and CSP(138-198)) and CSP(SSP), which incorporates 12 serines instead of 
cysteines, were generated to address which domain(s) is/are implicated for binding to 
SNAP25. The linker domain was found to be crucial for the interaction between 
SNAP25 and CSP, as CSP(1-82) failed to interact with SNAP25, whereas CSP(1-
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110) bound efficiently. Nevertheless, direct binding of CSP1 to SNAP25 (i.e. with 




To identify additional interacting partners of CSP, pull-down assays from solubilised 
rat brain were performed using immobilised recombinant His6-CSP (Evans and 
Morgan, 2002). This approach identified synaptotagmin as a CSP binding partner. 
Synaptotagmin is a vesicle associated protein and acts as a Ca2+ sensor in 
synchronous neurotransmitter release. It mediates calcium-dependent interactions 
with SNAREs, such as SNAP-25 (Schiavo et al., 1997; Gerona et al., 2000) and 
syntaxin 1A (Bennett et al., 1992; de Wit et al., 2009). 
It has been recently shown that CSP interacts with the SNARE protein SNAP25 
(Boal et al., 2011; Sharma et al., 2011). As Boal and colleagues (2011) showed that 
CSP/SNAP25 interaction was indirect (see 1.5.4.5), it was examined if CSP might 
bind indirectly to SNAP25 via a further protein expressed in pancreatic beta cells. 
Since SNAP25 has shown to bind directly to synaptotagmin 1 in neurons (Schiavo et 
al., 1997; Gerona et al., 2000), an interaction with synaptotagmin 9 (which regulates 
secretion in beta cells) was examined. Pull down assays with recombinant 
synaptotagmin 9 and immobilised CSP or SNAP25, showed that synaptotagmin 9 
was able to bind to either of the immobilised proteins. Immunoprecipitation using an 
anti-CSP antibody, demonstrated that CSP bound with a higher affinity to 
synaptotagmin 9 than to synaptotagmin1 (Evans et al., 2001) and synaptotagmin 5-7. 
A point mutation in the linker domain (CSP(E93V)) abolished the binding between 
CSP1 and synaptotagmin 9, in addition in silico analysis hypothesised that CSP(E93) 
generated a hydrophilic area, which might support the interaction to synaptotagmin 9 
via positively charged ions, such as calcium (Boal et al., 2011). To further 
investigate which domain of synaptotagmin 9 is important for CSP binding, 
FRET/FLIM in clonal MIN6 β cells analysis was undertaken, revealing that the 
calcium binding C2A domain of synaptotagmin 9 is required and sufficient to 
mediate binding to CSP. Since the calcium binding C2A domain of synaptotagmin 9 
was involved in the interaction with CSP, it was investigated whether this interaction 
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could be modulated by calcium. Binding efficiency of His6-CSPα(1-110) to GST-
synaptotagmin 9(C2A domain) was raised 10-fold in the presence of 1 µM – 10 µM 
calcium, which was interesting since these values are consistent with the Ca2+-
concentration range that is required for insulin exocytosis from pancreatic β cells. 
 
 
1.5.4.7 Homomeric interactions of CSP 
It has long been recognised that CSP forms dimers and higher molecular weight 
aggregates on SDS-PAGE gels. Analysis of CSP truncation mutants suggested that 
the linker and cysteine string domain are involved in homomeric interactions of CSP 
and that chaperone function at the synapse may involve CSP self-association 
(Swayne et al., 2003). Further work using chemical cross-linking showed that CSP1 
and CSP2 differed in homodimerisation, suggesting that the C-terminus influences 
oligomerisation of CSP (Boal et al., 2004). However, to date it has not been 
demonstrated that oligomerisation of CSP is physiologically relevant, although Boal 
et al (2004) reported that CSP dimer formation was increased during stimulation of 
exocytosis in HIT-T15 pancreatic beta cells. 
 
 
1.5.5 Phospho-regulation of CSP  
Protein kinase A (PKA) and protein kinase C (PKC) modulate calcium-triggered 
exocytosis in many cell types (Morgan and Burgoyne, 1992; Morgan et al., 1993; 
McFerran and Guild, 1996; Scott et al., 1998; Murphy et al., 1999). CSP was 
identified as a novel PKA and PKC substrate in vitro and in vivo, together with 
proteins such as α-SNAP and Rab3a (Evans et al., 2001). Identification of the PKA 
phosphorylation site of CSP was determined by analysis of preparative quantities of 
recombinant CSP phosphorylated in vitro by PKA. Phosphorylated CSP proteins 
were digested with trypsin and tryptic fragments separated by reversed phase high-
performance liquid chromatography (RP-HPLC). The results demonstrated that CSP 
was phosphorylated by PKA on serine at amino acid position 10 (Ser10) in the N-
terminal domain.  
 
 - 40 -
PKA phosphorylation of Ser10 of CSP has been demonstrated to affect exocytosis in 
adrenal chromaffin cells. Wild type CSP and a CSP(S10A) mutant were transfected 
into chromaffin cells, which were then permeabilised with digitonin and Ca2+ 
stimulated exocytosis measured through amperometric recordings. Over-expression 
of wild type CSP resulted in a reduction of evoked exocytotic spikes (Graham and 
Burgoyne, 2000). This reduction in spike number was also observed with the serine 
10 mutant CSP(S10A). However, analysis of spike kinetics found that the expression 
of CSP(S10A) had no effect on the rise time and half-width of spikes relative to 
control, whereas  spike kinetics were altered in cells over-expressing wild type CSP 
(Evans et al., 2001). These observations provide clear evidence that Ser10 is 
important for the effect of CSP on amperometric spike parameters and highlight a 
likely role for PKA/PKC in modulating CSP regulation of exocytosis. 
Phosphorylation of CSP is likely to affect exocytosis by modulating protein-protein 
interactions. Interestingly phosphorylated CSP (P-Ser10) bound less efficiently to 
synaptotagmin in vitro via pull down assays, suggesting that synaptotagmin binding 
is refractive to CSP phosphorylation. CSP-synaptotagmin binding likely requires 
Ser10 as serine to alanine mutation disrupted this interaction (Evans and Morgan, 
2002). Furthermore it was also revealed that mutation at the phosphorylation site of 
CSP (CSP(S10D)) significantly reduced binding to synaptotagmin 9 in pancreatic 
beta cells, indicating the importance of phosphorylated CSP for binding topology. 
CSP-syntaxin 1A binding was also decreased when CSP was phosphorylated by 
PKA (Evans et al., 2001), suggesting that PKA might modulate CSP function by 
disrupting several interactions important for exocytosis. 
 
 
1.5.6 CSP domains important for regulated exocytosis 
As discussed earlier, there is strong in vivo evidence that interaction with HSC70 
plays an important role in CSP functions. The rescue of CSP over-expression 
phenotypes in Drosophila by syntaxin over-expression also provides evidence that 
the CSP-syntaxin interaction is important in vivo. However, at present there is a lack 
of compelling evidence that CSP interactions with VAMP and synaptotagmin are 
important in vivo. Domains outside the J-domain are important for CSP function 
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although the effects of mutations in these regions of CSP have not been linked to a 
loss of interaction with a specific protein(s). The role of the highly conserved linker 
domain of CSP was analysed at nerve terminals of CSP null Drosophila 
neuromuscular junctions (Bronk et al., 2005), by generating a ΔL-CSP (deletion of 
the linker domain) mutant. ΔL-CSP did not rescue the temperature sensitive lethality 
of CSP null Drosophila, although it did reverse the loss of synaptic boutons in NMJs 
from CSP null mutants. Indeed, the number of synaptic boutons in cells expressing 
ΔL-CSP was even higher than control. Rescue experiments with ΔL-CSP also 
demonstrated that the L-domain of CSP is not required for maintaining normal 
evoked release, which is in agreement with the findings of Arnold et al. (2004), who 
observed that deletion of the linker domain of CSP rescued the temperature-sensitive 
paralysis of Drosophila CSP null mutants (Arnold et al., 2004). 
Studies in Drosophila and pancreatic beta cell lines by the Lang group have 
examined the importance of distinct domains of CSP for regulated exocytosis in 
mammalian cells. This group have employed over-expression of point and truncated 
mutants of CSP1 and CSP2. These studies are complicated somewhat by the fact that 
over-expression of wild type CSP1 or CSP2 promotes a large inhibition of regulated 
exocytosis, and functional importance is placed on residues or domains that lessen 
this inhibitory effect when mutated. Exocytosis was measured from HIT-T15 cells 
co-transfected with human preproinsulin (phINS) and CSP (Zhang et al., 1999; Boal 
et al., 2004). A point mutation, CSP1(E93V), in the highly conserved linker region 
(amino acids 83-112) of CSP inhibited insulin secretion to the same extent as seen 
with over-expression of wild type CSP (Zhang et al., 1999). Point mutations in the 
linker (E93V) and J-domain (H43Q) in CSP2 (CSP2(H43Q/E93V)), which has a 
shorter C-terminus than CSP1 (Chamberlain and Burgoyne, 1996), abolished the 
inhibitory effect on secretion compared to full-length CSP2 over-expression. As the 
corresponding mutations in CSP1 did not prevent the inhibitory effect of exocytosis, 
this suggested that there might be a functional interaction between the C-terminus 
and J-domain in the regulation of exocytosis. These results suggested that the C-
terminal domain of CSP has an important function in regulated exocytosis (Zhang et 
al., 1999). The effect of CSP mutations on exocytosis is summarised in Table 1.2. 
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Table 1.2: Effects of CSP mutations on exocytosis in relation to over-expression of 
wild type CSP, which has an inhibitory effect on exocytosis. 
Organism/Cell 
Type 
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1.5.7 Additional functions of CSP 
As CSP has been functionally implicated in regulated exocytosis (discussed in 1.5.3), 
it was assessed whether CSP might function in other membrane trafficking steps, 
including plasma membrane delivery of cystic fibrosis transmembrane conductance 
regulator (CFTR) (Zhang et al., 2002a). CFTR is responsible for the cAMP-activated 
chloride conductance of epithelial cell membranes and mutations of CFTR, such as 
CFTRΔF508 (Kerem et al., 1990), cause cystic fibrosis. To examine subcellular 
distribution of CSP in airway epithelial cells, immunofluorescent staining was 
performed and analysed by confocal imaging. CSP showed a punctate and vesicular 
distribution pattern and colocalised partially with the endoplasmic reticulum and also 
with CFTR at the apical plasma membrane. Coimmunoprecipitation experiments 
using CSP antibody revealed that CSP associates with the immature (core-
glycosylated) form of CFTR present at the ER and with the mature (fully-
glycosylated) CFTR, which resides at the apical membrane domain. The effect of 
CSP on CFTR-dependent membrane current (ΔIm) and membrane capacitance (ΔCm) 
changes during cAMP stimulation were also studied. Co-expression of CSP with 
CFTR decreased the ΔIm and ΔCm responses that resulted from CFTR stimulation. 
Immunoblotting analysis revealed that CSP co-expression eliminated the mature 
glycosylated form of CFTR and led to an accumulation of immature CFTR, 
suggesting that CSP might be a CFTR co-chaperone that stabilises intermediate 
forms of CFTR to promote its folding and maturation. Furthermore it was suggested 
that CSP is implicated in the production of immature CFTR and subsequently assists 
the progression of CFTR to the Golgi (Zhang et al., 2006). CSP knock down 
experiments augmented the expression of mature CFTR, whereas increased levels of 
CSP led to a block in progression of CFTR to the mature form. The J-domain of CSP 
was central to the effects on CFTR maturation, because another J protein (Hdj-2) 
also increased the levels of immature CFTR, and the CSP(H43Q) mutant rescued 
CFTR maturation. CSP might regulate the trafficking of CFTR from the endoplasmic 
reticulum, and co-expression of CSP resulted in CFTR accumulation in a perinuclear 
compartment that colocalised with the ER protein calnexin. CSP over-expression 
also increased the amount of HSC70 which co-immunoprecipitated with CFTR (see 
Table 1.1) (Schmidt et al., 2009). Furthermore, the increased association of HSC70 
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with CFTR was mirrored by an increase in CHIP co-precipitation (C terminus of 
HSC70 interacting protein) with CFTR. CHIP has been shown to target CFTR for 
proteasomal degradation and it was therefore suggested that CSP might promote 
proteasome-mediated degradation of CFTR by increasing the interaction of CFTR 
with CHIP. 
CSP may also function in constitutive fusion events at the plasma membrane. Indeed 
CSP is expressed in IM-2 mammary epithelial cells at approximately 10-fold lower 
levels than in brain (Gleave et al., 2001). Sucrose gradient fraction of KIM-2 cells, 
together with immunoisolations from post-nuclear supernatants and 
immunofluorescence analyses illustrated that CSP is localised on vesicles in this cell 
type. The role of CSP in constitutive exocytosis was detected via the secretion of 
growth hormone, which was transiently transfected into KIM-2 cells. The results 
revealed that CSP over-expression had no effect on constitutive exocytosis in KIM-2 
cells (see Table 1.1).  
 
 
1.5.8 Palmitoylation and membrane-association of CSP 
The defining motif of CSP, the cysteine string domain, is extensively palmitoylated 
(Gundersen et al., 1994; Mastrogiacomo et al., 1994a). Palmitoylation is a common 
post-translational modification most often involving the attachment of palmitate 
groups onto cysteine residues via thioester linkage. Many cellular proteins undergo 
rapid dynamic cycles of palmitoylation and depalmitoylation, which can have a 
major effect on protein function (Salaun et al., 2010). Palmitoylation is now known 
to regulate modified proteins in many ways, including regulating protein sorting, 
membrane microlocalisation, protein-protein interactions and protein function. Other 
than mediating membrane binding, there has been interest in the dynamics of CSP 
palmitoylation, and how this modification might affect CSP function.  
It was examined if synaptic vesicle cycling correlated with changes in the 
palmitoylation status of Drosophila CSP (van de Goor et al., 1995). These 
experiments were performed in temperature sensitive Drosophila dynamin mutants 
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(shibirets1)(Poodry and Edgar, 1979). At restrictive temperatures synaptic vesicle 
recycling in shibirets1 flies is blocked at an early stage of endocytotic retrieval of 
vesicles from the plasma membrane, and synaptic vesicle proteins become localised 
to the plasma mebrane. No obvious difference in CSP palmitoylation, judged by 
migration on SDS-PAGE, was observed in fractionated post-nuclear supernatants of 
shibirets1 flies incubated at permissive and restrictive temperatures. This suggested 
that CSP does not undergo marked changes in palmitoylation during vesicle cycling 
in Drosophila. The question of whether CSP undergoes cycles of palmitoylation and 
depalmitoylation and whether dynamic palmitoylation has any role in 
neurotransmitter release, was also addressed by Gundersen’s group (Gundersen et 
al., 1996). Here, a larval neuromuscular preparation of Drosophila was treated with 
tunicamycin to block palmitoylation. Electrophysiological recordings of nerve-
evoked responses showed no obvious change in tunicamycin treated cells, even at 
sustained high level transmitter release, and no depalmitoylation of CSP was 
observed. Thus, it was suggested that CSP does not undergo cycles of 
palmitoylation/depalmitoylation. However, it should be mentioned that this work 
showed no control to demonstrate that tunicamycin actually blocks palmitoylation 
and indeed tunicamycin is not commonly used as a palmitoylation inhibitor (Resh, 
2006). 
More recent studies have investigated the enzymes that palmitoylate CSP. A family 
of ‘DHHC’ proteins that catalyse cellular palmitoylation reactions was recently 
characterised (Fukata et al., 2004); about 20 of these proteins are expressed in 
Drosophila (Bannan et al., 2008). The Huntingtin-interacting protein 14 (Hip14), 
which is a homologue to mammalian DHHC17, was found to be a candidate 
palmitoyl-tranferase for CSP in Drosophila (Ohyama et al., 2007). A genetic screen 
was used to identify mutations that affect neurotransmitter release; hereby Hip14 was 
identified. Hip14 was shown to be expressed throughout the nervous system, but was 
also present in other tissues. Interestingly, Hip14 mutants exhibited mislocalisation 
of both CSP and SNAP25 in larval ventral cord neurons (VCN). Furthermore, the 
level of CSP at neuromuscular junctions (NMJ) was reduced, and the molecular mass 
of the protein was 6-7 kDa lower than in control flies. Moreover Hip14 mutants 
exhibited temperature sensitive exocytotic defects, similar to those observed in CSP 
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null mutant Drosophila (Zinsmaier et al., 1994). These results led to the suggestion 
that Hip14 palmitoylates CSP and that the defects in evoked release observed in 
Hip14 mutants are caused by a failure of palmitoylation and therefore mislocalisation 
of CSP. This idea was confirmed by an elegant experiment in which the defect in 
evoked release in Hip14 mutants was overcome by expressing a chimeric form of 
CSP fused to the transmembrane domain (TMD) of VAMP. The VAMP TMD 
facilitated the targeting of CSP to synapses in the absence of palmitoylation. The fact 
that the unpalmitoylated CSP-VAMP TMD chimera rescued exocytosis suggests that 
palmitoylation of the cysteine-string domain might only be required as a membrane 
binding and targeting module, and does not have other important functions for CSP, 
although this clearly merits further investigation. 
24 DHHC proteins have been identified in mammalian cells and many of these 
proteins have been shown to palmitoylate specific substrates (Fukata et al., 2004). 
Greaves et al., 2008 showed that DHHC3, DHHC7, DHHC15 and DHHC17 were 
able to palmitoylate CSP in co-expression studies in HEK293 cells; it was also 
shown that these DHHC proteins are localised to the Golgi. By analysing membrane 
binding and palmitoylation of a large panel of CSP mutants (Greaves and 
Chamberlain, 2006; Greaves et al., 2008) it was proposed that CSP has a weak 
membrane affinity that mediates membrane interaction and proximity to Golgi-
localised DHHC proteins. Subsequent palmitoylation mediates tight membrane 
association, facilitating targeting of CSP to secretory vesicles and plasma membrane. 
 
 
1.5.9 Phenotype of CSP null mice 
Analysis of null mutants clearly highlighted an important role for CSP in evoked 
neurotransmitter release in Drosophila (Zinsmaier et al., 1994). Subsequent work 
from several groups also provided strong evidence that CSP functions in regulated 
exocytosis pathways in mammalian cells (see 1.5.3).  
CSPα knock out mice were generated by isolating genomic CSPα clones and 
constructing a targeting vector that deleted the first exon encoding residues 1-36 of 
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mouse CSPα. Thereafter a targeting vector was electroporated into embryonic stem 
cells and homologous recombinants were selected and used to breed CSPα KO mice. 
Genotyping and immunoblotting indicated if the mice were hetero- or homozygote, 
and clearly showed that CSPα was not detectable in the homozygote KO mice. 
Immunoblotting of brain samples also demonstrated that expression of proteins 
including VAMP2, SCAMP1 and complexins were not affected by the ablation of 
CSPα. At birth CSPα-/-, CSPα+/- and CSPα+/+ mice were similar, based on weight 
and survival. Interestingly however, around two to three weeks after birth CSPα−/− 
mice suffered from progressive weakness and stopped gaining weight. Furthermore 
the CSPα−/− mice lost spontaneous physical activity, which could also be observed to 
a lesser extent in CSPα+/− mice. At this time, the CSPα−/− mice also showed muscle 
weakness, revealed by their tendency to clasp hindlimbs when suspended by the tail 
and the lack of gripping strength on fore- and hindlimbs. By P30, CSPα−/− mice were 
only able to eat when stimulated to do so. CSPα-/- mice died from P21 onwards and 
none survived beyond three months of age. Internal examination revealed no major 
abnormalities, except bilateral intraabdominal cryptorchidism, a failure of testicular 
descent. When P15 KO mice were placed on their left or right side, they had 
difficulties in getting up. CSPα−/− mice also displayed a poor acoustic startle 
response. These conditions became more severe at P25 and indicated that synaptic 
transmission at the neuromuscular junction (NMJ) may be perturbed.  
Electromyography is a technique for evaluating and recording the electrical activity 
produced by skeletal muscles. This technique was used to study skeletal muscle 
responses in wild type and CSPα−/− mice at P15, P23 and P45. Wild type mice had a 
small mean amplitude of compound muscle action potentials (CMAPs) at P15, but 
this increased ~2 fold at P23 and P45. The CSPα−/− mice exhibited reduced (relative 
to wild type) CMAPs at P15 and this was more profound at P23 and P45. These 
findings indicate that older CSPα−/− mice exhibit a limited functional impairment of 
the NMJ. Further analysis using light- and electron microscopy revealed that wild 
type mice showed ramified NMJs by ~P21 and each receptor rich branch of the 
postsynaptic apparatus was directly apposed by a presynaptic nerve terminal. In 
contrast the postsynaptic apparatus of CSPα−/− mice was less mature and had a 
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perforated appearance with some branches appearing thinner than in wild type 
animals. Since the pre- and postsynaptic apparatus develop in parallel, these 
observations suggest that nerve terminals initially formed normally, but then began 
to degenerate. Further electromicroscopic analyses of the synaptic ultrastructure of 
sternocleidomastoid muscles revealed a normal appearance in mutants, related to the 
number of presynaptic active zones. However, 42 % of the terminals contained 
vacuoles and/or multilamellar bodies, which is symptomatic of a degenerative 
process, and 45 % of nerve terminals were invaginated at the surface.  
Previous work had hypothesised that CSPα functions as a molecular chaperone, is 
involved in calcium channel activity or plays a role in Ca2+-triggered exocytosis (see 
1.5.5). These models for CSPα function were tested through further analysis of 
CSPα−/− mice. Thus, synaptic transmission and calcium channel function were 
examined at the Calyx of Held synapse. The analysis suggested that calcium channel 
function was normal in CSPα−/− mice, as similar activation time course and voltage 
dependence of Ca2+ currents was observed. Aga-IVa toxin, which inhibits Ca2+ 
current at the Calyx synapse mediated by Aga-IV-sensitive P/Q-type VGCCs, 
inhibited the majority of Ca2+ currents in both wild type and CSPα−/− synapses. This 
demonstrated that there was not a loss of P/Q-channel function in the mutants which 
was being masked by compensation by other channel subtypes. Presynaptic N-type 
calcium currents were analysed after adding the specific antagonist ω-conotoxin and 
applying voltage steps every 15 seconds; no significant difference between wild type 
and CSPα−/− mice was evident. Together, this data provides good evidence that 
CSPα is not essential for presynaptic Ca2+ channel function. The coupling of G 
protein-coupled receptors to voltage-gated calcium channels was also analysed in 
CSPα−/− mice. The G protein-mediated coupling of GABAB receptors to P/Q-type 
channels was also unchanged in CSPα−/− mice.  
To examine the importance of CSP for synaptic exocytosis, synaptic transmission 
was studied at the Calyx of Held synapse from P9-P11 mice using afferent fiber 
stimulation in brainstem slices and recording AMPA receptor-mediated excitatory 
postsynaptic currents (EPSCs). Shapes and amplitudes, as well as rise and decay 
times of EPSCs were indistinguishable between wild type and CSPα−/− mutants. 
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Furthermore CSPα deletion did not alter synaptic responses during stimulus trains or 
spontaneously occurring miniature EPSCs in the recording intervals between evoked 
EPSCs. Nevertheless synaptic responses were more heterogeneous in the CSPα 
mutants than in wild type mice. To study exocytosis more accurately, the kinetics of 
the slow and fast components of transmitter release were recorded using pre- and 
postsynaptic voltage-clamp recordings, and the kinetics of these were analysed, 
however no differences were detected. This led to the suggestion that coupling of 
Ca2+ channels to vesicle fusion and the Ca2+ sensitivity of vesicle fusion were not 
significantly altered in CSPα−/− mice (Fernandez-Chacon et al., 2004).  
It is possible that CSPα inactivation leads to more pronounced defects at the Calyx 
of Held at later stages of development, as seen in NMJs (see above). Therefore 
synaptic transmission in Calyx synapses was also tested in P20-P23 mice using 
afferent fiber stimulation. At this developmental stage significant changes were 
detected for the CSPα−/− mice. The average initial EPSC amplitude was smaller at 
P20-P23 than at P9-P11 in the CSPα−/− mice and ~2 fold lower than in wild type 
animals of similar age. In addition transmitter release was more asynchronous in the 
CSPα−/− mice than in wild type animals, as shown by the decreased ESPC rise time 
and decay. Morphological examination of Calyx terminals in CSPα mutants at P25 
revealed severe synapse structural changes. Neurons were surrounded by distinct 
wide electron-lucent areas, containing black, electron dense particles, which were 
identified as degenerated mitochondria. Some electron-lucent areas also contained 
aggregates of agglutinated presynaptic vesicles. The postsynaptic cells of the 
CSPα−/− mice were smaller than wild type, but overall had a normal appearance. 
As a whole, the work of Fernandez-Chacon et al., 2004 showed that deletion of 
CSPα caused progressive dysfunction of synapses that eventually killed the mice. 
This lethality seemed to be caused by the loss of nerve terminal integrity, instead of 
changes in transmission as hypothesised previously.  
Later work which focused more on photoreceptor synapses of the retina in CSPα−/− 
mice indicated that these mutants initially have some visual function but suffer from 
complete blindness after 4 weeks (Schmitz et al., 2006). Changes were detected in 
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the ultrastructual appearance of the photoreceptor ribbon synapses in mutant mice 
and photoreceptor terminals tended to be smaller than in wild type and terminals 
showed an increase in synaptic vesicle density. 
It is known that over-expression of α-synuclein causes late onset neurodegeneration 
(Fernagut and Chesselet, 2004). The relationship between transgenic α-synuclein 
effects and the CSPα function was studied by generating mice homozygous for 
CSPα deletion and hemizygous for transgenic α-synuclein over-expression. 
Intriguingly the transgenic expression of human and mouse α-synuclein prevented 
the weight loss, neuronal cell death and completely abolished the lethality associated 
with the CSPα−/− genotype.  
A quantitative assessment of motor behaviour of wild type, CSPα−/− and CSPα−/− 
mice over-expressing transgenic α-synuclein (CSP-/- Synhtg) was undertaken 
(Chandra et al., 2005). This analysis revealed that CSPα−/− mice had restricted 
exploratory behaviour and showed ‘jagged and jerky’ movements and sudden falls, 
reflecting ataxic behaviour. The co-expression of α-synuclein in CSPα−/− mice 
reversed this ataxic behaviour. As over-expression of α-synuclein rescues the 
CSPα−/− phenotype, it was examined whether endogenous α-synuclein dampens the 
progression of the CSPα−/− phenotype. For this, CSPα−/− mice were crossed with α/ 
β-synuclein double knock out mice, which do not exhibit a major phenotype. The 
‘triple’ knock out mice weighed less at P8 than control and at P20 they were half the 
size compared to wild type mice. They eventually died a few days after weaning 
(generally no survival after P30). In contrast, the CSPα−/− mice stopped gaining 
weight after ~ P21 and survived as far as three months. These results showed that the 
loss of endogenous synuclein accelerated the CSPα−/− phenotype, highlighting that 
endogenous synuclein dampens the effect of CSPα−/− phenotype, as suspected. 
The observed rescue of the CSPα−/− phenotype by synuclein over-expression 
suggested that α-synuclein might act as a co-chaperone with CSPα or function 
downstream of CSPα. To address this idea, it was examined whether α-synuclein 
interacts with CSPα, HSC70 and SGT, and if α-synuclein can replace CSPα in 
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stimulating HSC70 ATPase activity. This analysis found that α-synuclein did not 
show binding to any of these proteins and did not activate the HSC70 ATPase 
activity. The possibility of α-synuclein acting as a general chaperone was explored 
by crossing the transgenic α-synuclein mice with transgenic mice, which expressed 
mutant superoxide dismutase (SOD), causing spinal cord neurodegeneration. 
Transgenic α-synuclein did not improve neurodegeneration which was caused by 
SOD over-expression, suggesting that α-synuclein does not act as a general 
chaperone, and therefore that its effects are more specific for CSPα (Chandra et al., 
2005).  
Interestingly it was found that the levels of the SNARE-protein SNAP25 were 
decreased by 30 %- 40 % at all ages (P5, P10 and P40) in CSPα−/− mice and smaller 
decreases (~ 20 %) in HSC/HSP70 and α-synuclein levels were also detected. Other 
synaptic proteins, such as VAMP2, syntaxin and complexin did not exhibit altered 
expression levels in CSPα−/− mice. Reduced SNAP25 levels were specifically related 
to the loss of CSPα, since over-expression of α-synuclein did not rescue SNAP25 
expression throughout development, whereas it did rescue the decrease of 
HSC/HSP70 levels. This suggested that α-synuclein and CSPα might both alter 
SNARE function but possibly via different mechanisms. Immunoprecipitation of 
assembled ternary SNARE complexes from CSPα−/− mice revealed that SNARE 
complex levels were also significantly decreased in the knock out mice, which was 
reversed by transgenic wild type α-synuclein.  
Another group looked at synaptic function of CSPα using the CSPα−/− mice 
generated by Fernandez-Chacon (Fernandez-Chacon et al., 2004; Ruiz et al., 2008). 
Here it was suggested that CSPα is essential for normal Ca2+ sensitivity of regulated 
exocytosis in mature synapses, as calcium sensitivity was decreased in CSPα-/- 
terminals, but the amplitudes of the postsynaptic responses were rescued with high 
Ca2+ concentrations. 
The function of CSPα at small central synapses was explored in CSPα−/− mice, by 
studying long-term hippocampal cultures (Garcia-Junco-Clemente et al., 2010). 
Neurons that lacked CSPα failed to maintain a high number of synapses compared to 
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control, observed after 30 days of culturing the neurons. Interestingly, further 
analyses demonstrated that the loss of synapses was restricted to GABAergic 
synapses in culture. However, it should be noted that such a difference was not 
readily apparent in brain slices. In contrast, the number of glutmatergic terminals was 
similar between mutant and wild type cultures. It was also found that GABAergic 
terminals expressing synaptotagmin-2 were more imperilled, since KO cultures did 
not show any expression of synaptotagmin-2 after 30 divisions, whereas wild type 
cultures exhibited colocalisation of synaptotagmin-2 and the GABA transporter 
VGAT. Synaptotagmin-2 is a member of hippocampal basket cell terminals, which 
are a subpopulation of GABAergic cells, and electron microscopy analyses indicated 
degeneration of these basket cell terminals. Further analysis revealed that 
spontaneous release, measured by the miniature inhibitory postsynaptic current 
(mIPSC), was also impaired in mutant cultures. Generally CSPα appears to be an 
important component of an unknown physiological mechanism that maintains 
presynaptic function, especially of synaptotagmin-2 expressing GABAergic 
synapses, which fire action potentials at high frequencies.  
As discussed previously, transgenic α-synuclein expression, which was able to 
rescue the CSPα KO phenotype and SNARE complex levels, did not reverse the 
decrease of SNAP25 levels present in CSPα−/− mice. Recent work has revealed that 
SNAP25 mRNA levels are normal in CSPα−/− mice (Sharma et al., 2011) and 
SNAP25 degradation is a temperature-sensitive phenotype in CSPα−/− neuronal 
cultures. No temperature-sensitive changes were observed with the closely related 
SNAP23 protein or with SGT and syntaxin. In addition CSPα depletion resulted in a 
40 % increase in ubiquitination of SNAP25, as well as HSC70. In order to examine if 
SNAP25 degradation is dependent on synaptic activity in mutants, cycles of 
assembly and disassembly of SNARE-complexes were analysed. Synaptic activity 
was silenced using tetrodotoxin (TTX) or enhanced with increased K+ or Ca2+ 
concentrations. Examination of steady-state levels in CSPα−/− cultures revealed that 
synaptic silencing induced a 70 % increase in SNAP25 levels, whereas synaptic 
activation caused a 30 % decrease, compared to syntaxin 1 and VAMP2 levels, 
which were unchanged. This revealed that SNAP25 levels were controlled by 
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synaptic activity in the absence of CSPα. Interestingly, HSC70 and SGT levels were 
significantly increased upon enhancement of synaptic activity in both genotypes 
(wild type and CSPα−/−), suggesting that their increase during high activity may 
serve to protect SNAP25 from activity-dependent degradation.  
 
 
1.5.10 Mammalian CSP isoforms 
Two distinct CSP cDNA species were identified through PCR amplification of 
bovine chromaffin cell cDNA and termed CSP1 and CSP2 (Chamberlain and 
Burgoyne, 1996). The primers used to amplify these cDNAs corresponded to the 5’ 
and 3’ ends of the previously identified rat CSP coding sequence. Both DNA bands 
were detected in every rat tissue examined (e.g. kidney, liver, pancreas, spleen, lung 
and adrenal), except in brain, where only one DNA band (CSP1) was detected. 
Sequencing of the DNA bands revealed that CSP1 had 88 % nucleotide identity and 
95 % amino acid identity with rat CSP. CSP2 was shown to be a novel splice variant 
of CSP1; CSP2 is identical to CSP1, but has a 72-base pair insert, which incorporates 
two stop codons into the C-terminus of the encoded protein, resulting in a truncated 
isoform. Subsequent work confirmed that CSP2 mRNA is also expressed in humans 
(Coppola and Gundersen, 1996). Expression of CSP2 protein has not been reliably 
established to date. 
Two additional novel mammalian CSP isoforms were identified in human testis, and 
called CSPβ and CSPγ (Tobaben and Stahl, 2001; sequences to be found in 
GenBank, CSPβ: AF368276, CSPγ: AF368277; unpublished; Figure 1.3 and Figure 
1.4). Both of these isoforms were also identified in mouse testis (Fernandez-Chacon 
et al., 2004). CSPα, CSPβ and CSPγ are present on separate chromosomes (Evans et 
al., 2003); the overall amino acid homology between CSPα and CSPβ is 69 %, 
CSPα and CSPγ 55 %, and CSPβ and CSPγ 52 %. Comparing the defining motifs of 
the CSP isoforms, reveals that the cysteine-string domain of CSPα and CSPβ share a 
76 % similarity, whereas CSPα and CSPγ, as well as CSPβ and CSPγ, share 56 % 
congruency. The J-domain of CSPβ is 83 % identical to CSPα, the CSPγ J-domain 
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Figure 1.3: Alignment of rat CSP isoforms. Alignment of the sequences of rat CSPα, -β 
and -γ. Conserved amino acids present in all 3 isoforms are coloured green, conserved 
residues present within 2 isoforms are coloured yellow. The blue box highlights the highly 
conserved J-domain and the red box the highly conserved cysteine string domain. 
 
shares 74 % identity with the J-domain with CSPα and the J-domains of CSPβ and 
CSPγ are 69 % identical.  
Although CSPβ and CSPγ were reported to be largely testis-specific, quantitative 
PCR revealed that CSPβ is expressed in inner hair cells (Schmitz et al., 2006).  
Pull down experiments with homogenates from insulin-secreting MIN6 cells on 
immobilised recombinant CSPβ or CSPα showed that recombinant CSPβ bound to 
HSC70/SGT complex to a similar extent as CSPα (Boal et al., 2007). To further 
characterise the biochemical properties of CSPβ, this isoform was over-expressed in 
HIT-T15 pancreatic beta cells, which were then fractionated into cytosol and 
membrane fractions. CSPβ was mainly present in the membrane fraction and this 
association was only disrupted after Triton X-100 treatment, demonstrating that 
membrane attachment is tight. Immunoblot analysis showed that over-expressed 
myc-tagged CSPβ was detected in three different sizes, with the major band at 30 
kDa, a minor band and at 33 kDa and a band observed at 65 kDa, which probably 
corresponded to a dimeric form of myc-CSPβ. The myc-CSPβ bands detected at 30 
kDa and 33 kDa indicate a non-palmitoylated (30 kDa) and palmitoylated form of 
CSPβ. As the major CSPβ band (30 kDa) was refractive to hydroxylamine treatment 
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Figure 1.4: Alignment and phylogenetic tree of CSPβ in a section of vertebrates. A. 
Amino acid sequences of CSPβ (beta) from several species (as noted in the figure) were 
aligned. Conserved amino acids present in all species are highlighted green, conserved 
residues present in 80 % of the species are coloured blue and conserved residues present in 
60 % of the species are coloured yellow. B. Amino acid sequences of CSPα (alpha) from 
Danio rerio and Homo sapiens, CSPβ (beta) from several species (as noted in the figure) 
and CSPγ (gamma) from Homo sapiens were used to construct a phylogenetic tree. The tree 
depicts the branching history of the CSP isoforms, in particular the relationship of CSPβ in 
vertebrates. CSPβ from Xenopus tropicalis to Homo sapiens show close evolutionary 
relation, compared to Homo sapiens and Danio rerio CSPα and Homo sapiens CSPγ, which 
are more distantly related on the tree. However, the tree indicates that Danio rerio CSPβ is 
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and did not incorporate [3H]-palmitic acid, this suggests that CSPβ is predominantly 
non-palmitoylated. The subcellular distribution of CSPβ in HIT-T15 cells was 
examined by immunofluorescence in cells expressing HA-tagged CSPβ. This tagged-
CSPβ did not colocalise with insulin containing granules like CSPα, but instead was 
detected on the trans Golgi network (TGN), colocalising with the TGN marker 
Vti1b. 
Mutations in the cysteine string domain of CSPβ, to make it more similar to CSPα 
did not result in colocalisation of CSPβ with insulin granules, suggesting that the 
cysteine-string domain is not the predominant factor determined for the different 
localisation of CSPα and CSPβ. Recently a CSPβ antibody was generated against the 
C-terminal amino acid sequence QPTNTNEKTQLIREGSRSY (Gundersen et al., 
2010). This antibody was specific for recombinant CSPβ; however it only detected a 
protein band at 100 kDa in testis. The authors suggested that this band represents a 
homotetramer of CSPβ or a complex consisting of other proteins. Interestingly this 
‘CSPβ’ band was also detected at 100 kDa in mouse brain, contrasting to the work of 
Fernandez-Chacon et al., 2004, who claimed that CSPβ was testis specific, revealed 
through northern blot analysis. In the work of Gundersen et al., 2010 it was 
demonstrated that CSPβ RNA could only be detected in brain samples by northern 
blotting when more than 10 µg of RNA was used. The ‘CSPβ’ protein band was 
detected throughout the CNS and subcellular fractionation also revealed that CSPβ is 
mainly found within synaptosomes and synaptic vesicle fractions. Over-expression 
of CSPβ in frog oocytes led to a block of cortical granule exocytosis, suggesting that 
CSPβ might be involved in regulated exocytosis similar to CSPα (see Table 1.1). 




1.6 Aims and hypothesis 
Depletion of CSPα in Drosophila is embryonic lethal and in embryos synaptic 
vesicle exocytosis was decreased by approximately 50 % at 22°C and abolished at 
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higher temperatures. These results provided strong evidence that CSPα has an 
important role in presynaptic neurotransmission. However, more recent work on 
CSPα null mice uncovered an important neuroprotective function for CSPα in brain, 
but also challenged the proposed function of CSPα in neuronal exocytosis, as no 
defect in this pathway was evident, at least in young animals. The only reported 
developmental abnormality of CSPα null mice was bilateral cryptorchidism, a failure 
of testicular descent during development. Interestingly, two additional CSP isoforms 
were recently identified in mouse and human testis, CSPβ and CSPγ. One 
consequence of the identification of CSPβ and CSPγ is that they may complicate 
analysis of CSPα knockout mice. 
Our hypothesis is that CSPα performs an important function in exocytosis pathways 
throughout the body. With this in mind, the aims of this thesis are: (i) to deplete 
CSPα expression using siRNA and examine the effect of this on regulated and 
constitutive exocytosis; (ii) to examine how the expression of CSPα and interacting 
partners changes in defined neurological disorders; (iii) to define the localisation and 
function of CSPα in testis and investigate possible co-distribution with INSL3, since 
depletion of INSL3 also leads to cryptorchidism; (iv) to delineate the expression 
profiles of the CSP isoforms CSPβ and CSPγ, by generating and using CSPβ and 
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2.1 Material and suppliers 
 
2.1.1 Chemicals 
If not stated otherwise, all chemicals used were supplied by Sigma-Aldrich Company 




2.1.2 Molecular biology reagents 
XL10-Gold® Ultracompetent bacterial cells (genotype TetrD(mcrA)183 D(mcrCB-
hsdSMR-mrr)173 endA1 supE44 thi-1 recA1 gyrA96 relA1 lac Hte [F´ proAB 
lacIqZDM15 Tn10 (Tetr) Amy Camr]) were purchased from Stratagene (La Jolla, 
U.S.A). TOP 10 Chemically Competent Cells (strain F- mcrA Δ(mrr-hsdRMS-
mcrBC) Φ80lacZΔM15 ΔlacΧ74 recA1 araD139 Δ(araleu) 7697 galU galK rpsL 
(StrR) endA1 nupG), PureLink™ Quick Plasmid Miniprep Kit, PureLink™ HiPure 
Plasmid Filter Purification Kit, SYBR® Safe DNA gel stain and DNA ladder (1 kb) 
were obtained from Invitrogen Ltd. (Paisley, U.K.). RNeasy® Mini Kit and E. coli 
M15 [pREP4] cells were purchased from Qiagen (Crawley, U.K.); the M15 cells are 
derived from E. coli K12 and harbour the lacIq mutation. GoTaq®DNA polymerase, 
pfu polymerase, Oligo (dT)15 Primer, M-MLV Reverse Transcriptase, Recombinant 
RNasin® Ribonuclease Inhibitor, dNTPs (dATP, dCTP, dGTP, dTTP) and T4 DNA 
Ligase were purchased from Promega (Southampton, U.K.). Oligonucleotide Primers 
were synthesised by Sigma-Proligo (Sigma-Aldrich®, Dorset, U.K.). Dharmafect 
transfection reagent and small interference RNA (siRNA) were obtained from 
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2.1.3 Small interference RNA 
 
Table 2.1: Small interference RNA oligonucleotides (5’>3’) for rat CSPα in rat  
siRNA Name Target Sequences 
CSP #1 AGACAGAAUUCUACGUAUCUU 
CSP #2 AGACACACCGAUCGUCAUAUU 
CSP #3 UUAACAACGCCCACGCAAUUU 
CSP #4 CUUGAUACAUGAAGUGCGUUU 
 
Table 2.2: Small interference RNA oligonucleotides (5’>3’) for human CSPα 
siRNA Name Target Sequences 
hCSP #1 GGGUUGGACAAGAACGCAA 
hCSP #2 GGAUACAUCUGGACGUGCU 





2.1.4.1 PCR primers 
 
Table 2.3: Oligonucleotide primers (5’>3’) for DNA amplification of CSP isoforms from 
mammalian tissues 
Primer Name Forward Sequences Reverse Sequences 
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Table 2.4: Oligonucleotide primers (5’>3’) for CSPβ and CSPγ. having HindIII (AAGCTT) 
and BamHI (GGATCC), and INSL3 having HindIII (AAGCTT) and Sal1 (GTCGAC) 
restriction sites incorporated, which allowed the amplified DNA to be inserted into 
pQE30 and/or pEGFP-C2 vectors 
























Table 2.5: Oligonucleotide primers (5’>3’) used to generate CSPα N-terminal 
truncation mutants incorporating HindIII (AAGCTT) and BamHI (GGATCC) restriction 
sites, which allowed the amplified DNA to be inserted into the pEGFP-C2 vector 
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Table 2.6: Oligonucleotide primers (5’>3’) to generate CSPα− and CSPβ−chimeras 
incorporating or deleting EcoRI (GAATTC) restriction sites through  site-directed 
mutagenesis 































Table 2.7: Oligonucleotide primers (5’>3’) used for quantitative real-time PCR in rat 
testicular cells samples 
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Table 2.8: Oligonucleotide primers (5’>3’) used for quantitative real-time PCR in 
mouse testicular cells 
















The plasmid vector pEGFP-C2 was purchased from Clontech Laboratories Inc. 
(Mountain View, California, U.S.A), which encodes a red-shifted variant of wild-
type GFP (excitation maximum: 488 nm, emission maximum: 507 nm) and expresses 
kanamycin resistance in E.coli. The pQE-30 plasmid vector was obtained by Qiagen 
(Crawley, U.K.). mCherry plasmid, which has an maximum excitation at 587 nm and 
maximum emission at 610 nm, was synthesised by Colin Rickman (Rickman et al., 
2010) and contains mCherry in the pEGFP-C2 backbone and expresses kanamycin 
resistance in E.coli. pGH-CSPalpha-beta and pGH-CSPbeta-alpha plasmid vectors 
were designed to include flanking HindIII and BamHI restriction site, and were 
synthesised by Biomatik (Wilmington, U.S.A). Both plasmids expressed an ampicilin 
resistance in E.coli. pEGFP-C2-CSPα was constructed by Dr Luke Chamberlain 
(Greaves and Chamberlain, 2006). 
 
 
2.1.6 Cell culture plastics and media 
All cell culture plasticware was obtained from Greiner Bio-One (Kremsmünster, 
Austria). 30 mm coverslips were purchased from VWR International (Lutterwoth, 
Leicestershire, U.K.). 12 mm pre-coated poly-D-lysine coverslips were obtained 
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from BD Biosciences (Oxford, U.K.). The 30 mm coverslips were coated with 1.5 ml 
Poly-D Lysine (100 ng/ml, in sterile distilled H2O; Sigma-Aldrich) for at least 1 hour 
at room temperature, washed, dried and sterilised under ultra violet (UV) light. Each 
75 cm² flask for growth of PC12 cells was coated with 200 µl collagen (extracted 
from rat tail, see 2.2.2), dried and sterilised under UV-light for at least 16 hours and 
stored at 4°C until required. Advanced RPMI 1640 Media, Dulbecco’s Modifies 
Eagle Media (D-MEM; with and without Pyruvate), D-MEM/F-12 (1:1) Media, F-12 
Media (Nutrient Mixture), Hanks’ Balanced Salt Solution (HBSS) (without CaCl2 
and MgCl2), GlutaMAXT-I, Versene, Foetal Calf Serum, Lipofectamine™ 2000, and 
Trypsin-EDTA were all purchased from Invitrogen Corporation (Paisley, U.K.). 
Equine Serum Defined Donor Hyclone and Defined Foetal Bovine Serum Hyclone 





2.1.7.1 Primary antibodies 
A polyclonal CSPα antibody and an Hsc70 polyclonal antibody were obtained from 
Stressgen® Biotechnologies Corporation (Victoria, British Columbia, Canada). The 
immunoaffinity purified CSPα antibody, which was raised in rabbit, was derived 
from a synthetic peptide sequence from the carboxy-terminus of rat CSPα. Hsc70 
was protein A affinity purified, and was derived from rabbits inoculated with a 
synthetic peptide from the sequence of human Hsc70. This sequence is identical to 
cow, hamster, mouse and rat. For immunoblotting, the antibodies were used at a 
dilution of 1:1,000. The CSPα antibody was further used at a dilution of 1:50 for 
immunofluorescence or 1:100 for immunohistochemistry. 
 
SNAP25 (SMI 81) monoclonal antibody raised in mice immunized with full-length 
SNAP25, was purchased from Covance Inc. (Princeton, New Jersey, U.S.A). The 
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specific epitope lies at the N-terminus of the SNAP25 protein (Connell et al., 2009). 
The dilution factor for use in immunoblotting was 1:10,000. 
 
The anti-HA monoclonal antibody raised in rat was purchased from Roche 
Diagnostics Ltd. (Burgess Hill, U.K.). This antibody recognises the HA peptide 
sequence YPYDVPDY derived from the human influenza virus hemagglutinin 
protein (amino acids 98-106) and its dilution factor for immunoblotting was 1:1,000. 
 
Living Colors® A.v. Monoclonal GFP Antibody (JL-8) was obtained from Clontech 
Laboratories Inc. (Mountain View, California, U.S.A). The affinity purified 
monoclonal antibody was produced by hybridoma cells against full-length Aequorea 
victoria green fluorescent protein (GFP). The antibody was used at a dilution ratio of 
1:3,000 for immunoblotting. 
 
Synaptic Systems GmbH (Göttingen, Germany) provided the monoclonal 
synaptobrevin 2/VAMP2 antibody, Synaptotagmin I and polyclonal SNAP23. 
VAMP2 antibody was produced in mice against the synthetic peptide 
SATAATVPPAAPAGEG (amino acids 2-17 in rat synaptobrevin 2). The SNAP23 
antibody was derived in rabbit against the synthetic peptide DRIDIANARAKKLIDS 
(amino acids 196-211 in human). The Synaptotagmin I antibody was derived from 
mouse against amino acids 80 - 421. The dilution ratio of VAMP2 antibody for 
immunoblotting was 1:10,000, whereas SNAP23 and Synaptotagmin I antibodies 
were used at 1:1,000. 
 
Monoclonal antibodies recognising Syntaxin 1 (HPC-1), HSP70 and α-Tubulin 
(DM1A) all produced in mice, were purchased from Sigma-Aldrich Company Ltd. 
(Dorset, U.K.). Syntaxin antibody was derived from a synaptosomal plasma 
membrane fraction from adult rat hippocampus. The immunogen for the HSP70 
antibody was full-length HSP70 isolated from bovine brain. The α-Tubulin antibody 
was derived from rat brain. Syntaxin 1 and HSP70 antibodies were used at a dilution 
of 1:5,000 for immunoblotting. The α-tubulin antibody was used for 
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immunofluorescence or immunohistochemistry at a dilution of 1:50 or 1:100 
respectively. 
 
Abcam plc (Cambridge, U.K.) supplied the primary monoclonal actin antibody, 
which was raised in mouse and protein G purified. The affinity purified rabbit 
polyclonal Cyclophilin B antibody was raised against a C-terminal peptide of human 
Cyclophilin B. α-Synuclein antibody, which was an affinity purified polyclonal 
antibody, and was derived from a peptide from human α-Synuclein around the 
phosphorylation site of tyrosine 133 and raised in rabbit. The protein A purified 
GAPDH antibody was raised in rabbits against the human protein. The dilution factor 
used in immunoblotting for the actin antibody was 1:5,000, 1:2000 for GAPDH and 
1:1,000 for both Cyclophilin B and α-Synuclein. 
 
Monoclonal antibodies recognising Trans Golgi network 38 (TGN38) and GM130 
were raised against the rat proteins and purified from tissue culture supernatant or 
ascites by affinity chromatography. Both antibodies were used for 
immunofluorescence at a dilution of 1:50. The GM130 antibody was also used for 
immunohistochemistry at a dilution of 1:100. 
 
Cell Signaling Technology® (Hitchin, Hertfordshire, U.K.) provided the polyclonal 
antibodies against Heat Shock Protein 60 (HSP60) and Heat Shock Protein 90 
(HSP90). Both antibodies were produced by immunising rabbits with synthetic 
peptides corresponding to human HSP60 and human HSP90 respectively. The 
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2.1.7.2 Secondary antibodies 
Amersham ECL (Little Chalfont, Buckinghamshire, U.K.) provided sheep anti-
mouse IgG, donkey anti-rabbit IgG and goat anti-rat IgG, which were all HRP-
conjugated and used at a dilution ratio of 1:2,000 for immunoblotting. 
The AlexaFluor® 647 goat anti-mouse, AlexaFluor® 546 donkey anti-mouse and 
AlexaFluor® 488 goat anti-rabbit, which are labelled with a tandem dye construct and 
are prepared from affinity-purified antibodies, were purchased from Invitrogen Ltd. 
 
 
2.1.8 Radioactive materials 




2.1.9 Animal tissues 
The Sprague Dawley albino laboratory rat breed (species rattus norvegicus) was 
sacrificed to collect various organs for analysis (University of Edinburgh, Hugh 
Robson Building, U.K.). 
 
 
2.1.10 Mammalian cell lines 
HeLa-C1 cells were kindly provided Dr Andrew Peden (Department of Clinical 
Biochemistry, University of Cambridge, Cambridge Institute for Medical Research). 
William Walker provided the Sertoli cells 15P-1 (derived from rat) and MSC-1 
(derived from mouse) (Department of Cell Biology and Physiology, Magee Women's 
Research Institute, University of Pittsburgh, 204 Craft Avenue, Room B305, 
Pittsburgh, PA 15261, USA). The Leydig cells (R2C) were obtained from Douglas 
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Stocco (Department of Cell Biology and Biochemistry, Texas Tech University 
Health Sciences Centre). 
 
 
2.2 Animal dissection 
Sprague Dawley rats (see 2.1.9), which were sacrificed, were dissected to collect 
organs for research analysis.  
 
2.2.1 Sperm isolation 
For sperm isolation mature male rats (> 3 months old) were used (see 2.1.9). The 
male rat was disinfected with 70 % ethanol to avoid any contamination and the testis 
with the attached vas deferens was dissected out of the animal and kept in PBS [137 
mM NaCl, 25.36 mM Na2HPO4, 4.41 mM KH2PO4, 2.7 mM KCl, pH 7.4]. Under a 
light microscope the testis was carefully detached from the vas deferens and the fat. 
Thereafter the vas deferens with the epididymis was unfolded in a small sterile petri 
dish. Finally the spermatozoa were squeezed out of the vas deferens and epididymis 
into 500 µl homogenisation buffer [20 mM HEPES, 1 mM MgCl2, 250 mM sucrose, 
2 mM EDTA, 1 % (v/v) nonyl phenoxylpolyethoxylethanol (NP-40), 1 mM DTT, 
protease inhibitor cocktail (Roche), pH 8.0] and collected in a fresh and sterile 1.5 ml 
tube. For further procedures see 2.6.5.  
 
 
2.2.2 Collection of rat-tail collagen 
Collagen, collected from mature rat tails, was used to coat flasks to facilitate PC12 
cells adherence (see 2.1.6). Rat tails were immediately frozen down after collection 
from the donor. When required, the tails were removed from the freezer and placed 
in a sterile 50 ml tube filled with 70 % alcohol and allowed to thaw (approximately 
15-20 minutes). The tip of the tails was then pinched with a pair of sterile pliers and 
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the skin pulled back until the tendons were visible. The tendons were gently 
dissected from the tail and placed in a sterile petri dish containing 10 ml of dH2O for 
20 minutes to hydrate them. A sterile conical flask was filled with 500 ml of sterile 
dH20 and filled with tendons (1 g/100 ml). Glacial acetic acid was added to a final 
concentration of 1 % (v/v). The tendons were left to soak for 48 hours at 4°C with 
gentle mixing at 50 rpm. Thereafter the soaked tendons were centrifuged at 35,000 x 
g for 1 hour and the supernatant was collected and aliquoted in 5 ml volumes. The 
collagen was made and provided by Colin Rickman. 
 
 
2.3 Molecular biology 
 
2.3.1 Standard molecular biology protocols 
All overnight cultures were grown in Luria-Bertani broth (LB) media [10 g/L NaCl, 
10 g/L tryptone (Merck), 5 g/L yeast extract (Bacto™ Yeast Extract, BD)], which was 
autoclaved prior to use. The LB agar solutions contained LB media and 20 g/L agar 
(Invitrogen). LB media was supplemented with the appropriate antibiotics (100 
µg/ml ampicillin, 30 µg/ml kanamycin). 
Diethylpyrocarbonate (DEPC)-water was made by adding 0.1 % DEPC to ultra pure 
water, incubating over night and autoclaving to inactivate traces of DEPC. 
 
 
2.3.2 DNA amplification by polymerase chain reaction (PCR) 
Polymerase chain reaction (PCR) is used to amplify specific DNA sequences and is 
also a method to introduce mutations into DNA.  
PCR reaction mixes contained 50 ng of DNA template (either cDNA or plasmid 
DNA) and 125 ng each of sense and antisense oligonucleotide primers, which were 
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synthesised by Sigma-Proligo. The sequences of all primers used in this thesis are 
shown in section 2.1.4. Also added to the PCR-mix was 5 µl 10 x Pfu reaction buffer 
(Promega), 1 µl of 40 mM dNTP (10mM of each dATP, dTTP, dGTP and dCTP), 1 
µl Pfu DNA polymerase (Promega) and DEPC-treated dH2O to a final volume of 50 
µl. The PCR reaction consisted of an initial denaturation step for 1 minute at 94°C to 
melt the DNA. Following this, 30 cycles were performed consisting of a denaturing 
step at 94°C for 30 seconds, an annealing step at 50°C for 30 seconds and an 
extension step at 72°C for 3 minutes. PCR products were stored at 4 °C until 
required. This protocol was used for amplification of coding regions and specific 
truncation mutants for cloning purposes, and also for analysis of CSP expression 
patterns in rat tissues. 
 
 
2.3.3 Amplification of CSPβ and CSPγ and INSL3 from rat testis 
 
2.3.3.1 RNA purification 
Total RNA was purified from ~ 30 mg of tissue using an RNeasy Mini Kit (Qiagen 
Ltd.) according to the manufacturer’s protocol. The tissue was homogenized, until it 
was uniformly homogenous, with a rotor-stator homogenizer in 600 µl RLT buffer 
(composition proprietary), containing 10 % (v/v) β-Mercaptoethanol (β-ME). 
Following this, 600 µl of 70 % ethanol was added to the homogenised lysate and 
mixed through pipetting and then applied to an RNeasy mini column contained 
within a 2 ml collection tube. The solution was passed through the column by 
centrifugation for 15 seconds at 10,000 rpm and the column was then washed by 
adding 700 µl of RW1 (composition proprietary) and centrifuging at 10,000 rpm for 
15 seconds. Thereafter 500 µl of RPE buffer (composition proprietary) was added 
and the column centrifuged at 10,000 rpm for 15 seconds. To dry the spin column 
membrane, which avoids ethanol carry over during RNA elution, the column was 
centrifuged at 10,000 rpm for 2 minutes. After centrifugation the column was placed 
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in a fresh collection tube and 40 µl of RNase-free water (DEPC treated dH2O) added 
directly to the column and centrifuged at 10,000 rpm for 1 minute to eluate RNA.  
 
 
2.3.3.2 Reverse transcription (RT) PCR of CSPβ,CSP γ and INSL3 
Purified RNA was translated into cDNA by RT-PCR (Transcriptor High Fidelity 
cDNA Synthesis Sample Kit (Roche)) according to the manufacturer’s protocol.  
For RT-PCR, 0.5 µg of purified RNA was added to 0.5 µg oligo (dT)18 primer. 
DEPC water was added to a final volume of 11.4 µl. To ensure denaturation of RNA 
secondary structure the template–primer mixture was heated in a thermal block for 
10 minutes at 65°C. Thereafter 4 µl of 5 x reaction buffer, 0.5 µl protector RNase 
inhibitor (40 U/µl), 2µl deoxynucleotide mix (10 mM each dATP, dTTP, dGTP, 
dCTP), 1µl dithiothreitol (DTT) and 1.1 µl reverse transcriptase (20 U/µl) was added 
to the denatured template-primer mix and carefully mixed by pipetting. The reaction 
was then incubated at 50°C for 30 minutes, following which the sample was heated 
to 85°C for 5 minutes, to inactivate the RT enzyme. The cDNA was either directly 
used for PCR amplification or stored at -20°C for later use.  
 
 
2.3.3.3 Cloning of CSPβ, CSPγ and INSL3 into pQE30 and eGFP-C2 
vectors 
Cloning CSPβ and CSPγ into pQE30 and eGFP-C2 produces the CSP isoform 
proteins with an N-terminal His6-tag or GFP-tag, however, INSL3 is only cloned into 
the eGFP-C2 vector. The His6-tag is important for protein purification (see 2.5), 
whereas the GFP-tag allows proteins to be visualised by confocal imaging (see 2.9). 
The CSP isoforms and INSL3 were amplified through PCR using primers with the 
required restriction sites (BamHI and HindIII, see table 2.3). To clone the CSP 
isoforms into pQE30 vector the BamHI restriction site is on the N-terminus and 
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HindIII on the C-terminal site, in contrast to cloning into eGFP-C2 vector, where the 
restriction sites are on the opposite sites. To create “sticky ends” the amplified CSP 
isoforms and INSL3 as well as the vectors underwent an approximately one hour 
digest procedure (see 2.3.9) and were subsequently run on 1 % agarose gel (see 
2.3.7). The target DNA samples were purified from the agarose gel (see 2.3.8), and 
were cloned using ligation and subsequent transformation (see 2.3.11). 
 
 
2.3.4 RT-PCR analysis of CSP isoforms mRNA expression in 
mammalian tissues 
Note that the RT-PCR protocol used to analyse mRNA expression was different to 
that used in the previous section for cloning of CSPβ and CSPγ.  
After RNA purification as described in section 2.3.3.1, 2 µg of the extracted RNA 
was combined with 0.5 µg of Oligo (dT)15 Primer (Promega) and made to a final 
volume of 15 µl, by adding RNase free dH2O (DEPC-dH2O). The mix was then 
incubated at 70°C for 5 minutes prior to the addition 5 µl dNTPs, 0.625 µl 
Recombinant RNasin® Ribonuclease Inhibitor, 1 µl murine retroviral reverse 
transcriptase (M-MLV RT), 10 µl of 5 x reaction buffer and nuclease-free water 
(DEPC-treated H2O) to a final volume of 50 µl. This reaction-mix is incubated for 60 
minutes at 42°C. 
To probe for CSP isoform expression, specific primers for each of the three isoforms 
were designed. The sequence of these primers is shown in table 2.3 of section 2.1.4. 
250 ng of forward and reverse primers were added to 5 µl of the RT-PCR reaction 
mix (see above) in a sterile 0.2 ml PCR-grade tube, followed by 10 µl of 5 x Green 
GoTaq® Reaction Buffer, 1 µl of 10 mM dNTPs, 0.25 µl GoTaq® DNA Polymerase 
and DEPC-treated dH2O to 50 µl. The PCR amplification was performed as 
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2.3.5 Site-directed mutagenesis 
Site-directed mutagenesis allows specific mutations to be created at defined sites in a 
cloned DNA molecule.  
Primers encoding for the desired mutations were designed for plasmid amplification. 
The mutagenesis mixture consisted of 50 ng of plasmid DNA, 125 ng of each 
forward and reverse primer, 5 µl of 10 x Pfu buffer, 1 µl of 10 mM dNTPs and 1 µl 
Pfu polymerase. The mixture was made to a final volume of 50 µl by adding DEPC-
treated dH2O. The mutagenesis-mix was heated to 95°C for 1 minute to denature the 
DNA-template. This was followed by 18 cycles consisting of a DNA denaturation 
step at 95°C for 30 seconds, an annealing step for 1 minute at 50°C and a DNA 
extension step at 68°C for 13 minutes (2 minute per kb, plasmid is approximately 
6kb). 
Following PCR amplification the template DNA was removed by enzymatic 
digestion with Dpn I for 2 hours at 37°C. An aliquot of the PCR mixture was 
visualised on a 1 % (w/v) agarose gel (see 2.3.7) against the DNA-template to 
confirm that PCR was successful. If successful, 2 µl of the Dpn I treated PCR 
mixture was used for transformation (see 2.3.11) of XL10® gold supercompetent 
cells (Stratagene). Colonies that formed on antibiotic selection plates were grown 
overnight in 5 ml Luria-Bertani broth (LB) medium (see 2.3.1) and the plasmid was 
isolated using a small-scale plasmid preparation (see 2.3.12), followed by DNA 
sequencing to ensure that the DNA contained the desired mutation. Sequencing was 
performed by the University of Dundee DNA sequencing service (see 2.3.16). 
 
 
2.3.6 Quantitative real-time PCR 
Primers designed for DNA amplification were obtained from MWG-Biotech 
(Ebersberg, Germany). The mutagenesis mixture consisted of 50 ng of testis DNA, 
100 pmol of each forward and reverse primer and 125 µl of Brilliant® Sybr Green 
QPCR Master Mix (Stratagene). The qRT-PCR-mix was heated to 95°C for 7.5 
minutes to denature the DNA template. This was followed by 45 cycles consisting of 
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a DNA denaturation step at 95°C for 25 seconds, an annealing step for 25 seconds at 
63°C and a DNA extension step at 72°C for 25 seconds. Finally the dissociation 
stage, where the double-stranded DNA product is melted into single-stranded DNA, 
was initiated by 1 cycle consisting of 1 minute at 95°C, 30 seconds at 63°C and 95°C 
for 30 seconds. The dissociation curve is used to ensure that only a specific PCR 
product was generated with the specific set of primers. The external control 
luciferase and internal control succinate dehydrogenase (SDH) were amplified under 
the same conditions. 
 
 
2.3.7 Agarose gel electrophoresis 
For visualisation or purification of DNA fragments amplified by PCR or following 
restriction endonuclease digestion (see 2.3.9), the sample was electrophoretically 
separated in a 1 % (w/v) agarose gel in TBE buffer [44.5 mM Tris Base, 44.5 mM 
boric acid, 1.59 mM EDTA, pH 8.3] supplemented with Sybr Safe® (1: 10,000, 
Invitrogen). DNA was visualised after electrophoresis under an ultraviolet lamp.  
 
 
2.3.8 DNA purification from agarose gels 
DNA bands were excised from agarose gels in a minimal volume of agarose and 
transferred to a 1.5 ml tube. DNA purification was performed with a QIAquick® Gel 
Extraction Kit (Qiagen Ltd) according to the manufacturer’s protocol. First the 
weight of the DNA gel slice was determined. Thereafter 3 volumes of QG Buffer 
was added to the gel slice (i.e. 100 mg gel slice = 300 µl QG buffer) and 
subsequently heated at 50°C for 10 minutes with occasional vortexing to melt the gel 
slice containing the DNA. When the DNA gel slice was completely solubilised, 1 gel 
volume of isopropanol was added to the mixture and gently mixed by pipetting. The 
mixture was then transferred to a QIAquick® Spin Column and centrifuged for 1 
minute at 13,000 rpm and the flow-through was discarded. The column was then 
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washed with 500µl QG Buffer to remove any residual agarose and subsequently 
washed with 750 µl PE Buffer by centrifuging the column for 1 minute at 13,000 
rpm. The flow-through was again discarded and the column was centrifuged for a 
further 1 minute to remove any residual buffer. The column was then transferred to a 
fresh 1.5 ml collection tube, and the DNA eluted by adding 30 µl of DEPC-treated 
dH2O to the column, followed by centrifuging for 1 minute at 13,000 rpm. One tenth 
(v/v) of the eluted DNA was resolved on a 1 % (w/v) agarose gel against a 100 bp or 




2.3.9 Restriction endonuclease digestion of DNA 
DNA restriction digestion reactions contained 1-2 µg vector DNA, 1µl of each 
FastDigest® restriction enzymes (Fermentas Life Sciences), 2µl of 10 x FastDigest® 
Buffer and DEPC-treated water added to a volume of 20 µl. The mixture was 
incubated for 1 hour at 37°C. Agarose gel electrophoresis was performed to 
determine if the digestion was successful (see 2.3.7). 
 
 
2.3.10 Ligation of insert DNA with plasmid vector 
To ensure high ligation efficiency it is important to use a higher concentration of the 
insert than the plasmid vector following restriction digestion. An estimate of vector 
and insert concentration was achieved by comparison of the band intensities with 
molecular standards of known concentration on an agarose gel (see 2.3.7). The molar 
mass ratio for DNA molecules was estimated using the following formula:  
 
[(ng vector * insert size (kb)) / vector size (kb)] x molar ratio of insert = ng of insert 
required. 
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The ligation reaction mixes consisted of the calculated vector:insert ratio, 1 µl T4 
DNA ligase (Promega) and 10 µl 2 x LigaFast™ DNA ligation buffer (Promega). The 
final volume of the ligation mix was made to 20 µl with DEPC-treated dH2O. The 
ligation reaction was allowed to proceed at room temperature for at least 5 minutes. 
 
 
2.3.11 Transformation of competent bacterial cells 
To amplify recombinant plasmid DNA, transformations were performed into 
ultracompetent XL10 gold (Stratagene) (or supercompetent TOP10 cells 
(Invitrogen)). The competent cells, stored at -80°C, were defrosted on ice and 30 µl 
transferred into a fresh 15 ml tube per transformation. Subsequently 1 µl of ligation 
mix or 10 ng of purified plasmid DNA was added to the cells and incubated on ice 
for 20 minutes. The cells were then heat shocked for exactly 30 seconds at 42°C and 
immediately put back on ice for 5 minutes to allow the cells to recover. Thereafter 
200µl of LB medium was added to the cells and incubated at 37°C for 30-60 minutes 
on an orbital shaker at 200 rpm. The entire transformation mixture was then plated 
on prewarmed agar plates (see 2.3.1) which contained the appropriate antibiotic (100 




2.3.12 Small-scale (miniprep) plasmid purification 
Miniprep plasmid preparations were used to screen bacterial colonies for the 
presence of the appropriate plasmid DNA. Subsequent restriction digestion (see 
2.3.9) and agarose gel electrophoresis (see 2.3.7) then confirmed if the ligation of the 
insert and vector was successful (see 2.3.10). This Miniprep purification typically 
yields ~ 5 µg of plasmid DNA. A colony was picked from the agar plate and grown 
in 5 ml of LB media, containing the appropriate antibiotic at 37°C and 200 rpm for 
approximately 16 hours. After growing the bacteria overnight, 1.5 ml of the culture 
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was transferred to a fresh 1.5 ml tube and centrifuged at 12,000 x g to pellet the 
bacteria. The remaining 3.5 ml were kept at 4°C until required. The rapid small-scale 
plasmid preparation, also known as “miniprep”, is based on the alkaline lysis method 
(Birnboim and Doly, 1979). Here, the PureLink™ Quick Plasmid Miniprep Kit from 
Invitrogen was used to isolate the recombinant plasmid DNA. The bacteria pellet was 
completely resuspended by thoroughly pipetting in 250 µl Resuspension Buffer [50 
mM Tris-HCl, pH 8.0; 10 mM EDTA], followed by the addition of 250 µl of Lysis 
Buffer [200 mM NaOH, 1 % (w/v) SDS]. The suspension was gently mixed by 
inverting the tube several times and the mixture was incubated for 5 minutes at room 
temperature. Subsequently, 350 µl of Precipitation Buffer [3.1 M potassium acetate, 
pH 5.5] was added and mixed by inverting the tube several times until the mixture 
was homogenous. To separate the plasmid lysate from cell debris, the mixture was 
centrifuged at 12,000 x g for 10 minutes. The recovered lysate was then loaded onto 
a spin column contained within a 2 ml collection tube. Thereafter, the spin column 
was centrifuged at 12,000 x g for 1 minute and the flow-through was discarded. 
Afterwards 500 µl of Wash Buffer was added to the column, incubated for 1 minute 
at room temperature, then centrifuged at 12,000 x g for 1 minute and the flow-
through discarded. This wash step was repeated once. To remove any residual 
solution remaining on the column, a final centrifugation step (12,000 x g for 1 
minute) was performed. The spin column was then placed into a fresh 1.5 ml tube 
and the recombinant DNA was eluted by adding 50 µl of DEPC-treated dH2O to the 
spin column and centrifuging at 12,000 x g for 2 minutes. The eluate contained 
purified plasmid DNA which was then analysed by endonuclease digestion (see 
2.3.9) for 1-2 hours and agarose gel electrophoresis beside 100 bp or 1 kb DNA 
ladder standards to determine the size of the DNA. 
 
 
2.3.13 Large-scale (maxiprep) plasmid purification 
Maxiprep plasmid preparations were used to obtain high yields and purity of DNA (~ 
200-500 µg) for sequence analysis and transfection of mammalian cell lines. As with 
the Miniprep purifications, the principle is based on the alkaline lysis method. 
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PureLink™ HiPure Plasmid Filter Purification Kits (Invitrogen) were used for 
maxiprep purification of plasmid DNA. When analysis of miniprep DNA had shown 
that cloning was successful, the remaining 3.5 ml of the miniprep overnight culture 
(see 2.3.12) was added to 100 ml LB media containing the appropriate antibiotic. 
The culture was grown for approximately 16 hours at 37°C on a shaker (200 rpm). 
Following this growth phase, the culture was centrifuged at 4,000 x g for 20 minutes 
to pellet bacteria. The bacteria pellet was then completely resuspended by pipetting 
in 10 ml Resuspension Buffer [50 mM Tris-HCl, pH 8.0; 10 mM EDTA, 20 mg/ml 
RNase]. Thereafter 10 ml of Lysis Buffer [0.2 M NaOH, 1 % (w/v) SDS] was added, 
mixed by inverting the capped 50 ml tube until homogenous and then incubated at 
room temperature for 5 minutes. Following this, 10 ml Precipitation Buffer [3.1 M 
potassium acetate, pH 5.5] was added and immediately mixed by inverting the tube 
several times until the solution was homogenous. The precipitated lysate was 
transferred to a HiPure Filter Maxi Column, which was pre-equilibrated with 25 ml 
Equilibration Buffer [0.1 M sodium acetate, pH 5.5; 0.6 M NaCl, 0.15 % (v/v) 
Triton® X-100], and the lysate run through the filter via gravity flow. The filter maxi 
column contains a filter insert inside the DNA-binding column; the filter insert 
removes cells debris, allowing the purified lysate onto the DNA-binding matrix. To 
increase the final DNA yield, the filter column was washed with 10 ml Wash Buffer 
[0.1 M sodium acetate, pH 5.0; 825 mM NaCl] before discarding. The Maxi DNA-
binding column was then washed with 50 ml of wash buffer, followed by elution of 
the DNA with 15 ml Elution Buffer [100 mM Tris-HCl, pH 8.5; 1.25 M NaCl] into a 
fresh 50 ml tube. Isopropanol (10.5 ml) was added to the eluted DNA, mixed by 
inversion, and the DNA-propanol mixture centrifuged at 15,000 x g for 30 minutes at 
4°C. The supernatant was discarded and 5 ml of 70 % ethanol was added onto the 
remaining pellet without resuspension. Following centrifugation for 5 minutes at 
15,000 x g, the supernatant was carefully removed and the remaining DNA pellet air-
dried for 2-4 hours at room temperature. The dry DNA pellet was resuspended in 100 
µl DEPC-treated dH2O and the concentration was quantified via spectrophotometery 
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2.3.14 Glycerol stocks 
For prolonged storage of bacteria transformed with recombinant plasmid DNA, 500 
µl bacteria suspension was added to 500 µl sterile glycerol. The suspension was 
mixed by vortexing and stored in a -80°C freezer. When fresh plasmid DNA was 
required, a scraping from the frozen glycerol stock was placed into 50-250 ml LB 
media. The DNA was purified as described in section 2.3.13. 
 
 
2.3.15 Spectrophotometric quantification of DNA and RNA  
Analysis of UV absorption by purified RNA or DNA was used to determine 
concentration. Purines and pyrmidines in nucleic acid show absorption maxima 
around 260 nm (e.g., dATP: 259 nm; dCTP: 272 nm; dTTP: 247 nm) if the DNA 
sample is pure without significant contamination from proteins or organic solvents 
(proteins have a peak absorption at approximately 280 nm). The ratio of OD260/OD280 
was therefore determined to assess the purity of the sample. A ratio of 1.8-2.0 
showed that the absorption in the UV range was due to nucleic acid. The amount of 
DNA/RNA was quantified using the following formula: 
 
Absorbance (OD) * dilution factor * 50 = DNA concentration (µg/ml) 
 
Absorbance (OD) * dilution factor * 40 = RNA concentration (µg/ml) 
      
 
2.3.16 DNA sequencing 
The DNA which was generated by standard or mutagenesis PCR was sequenced on 
both strands by The University of Dundee DNA Sequencing Service™ (Dundee, 
U.K.). 
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2.4 Mammalian cell culture 
 
2.4.1 Storage and reuse of mammalian cells 
For long-term storage of mammalian cells 1 ml of growth media containing 
approximately 106 cells, was made to 10 % (v/v) dimethyl sulfoxide (DMSO) in 1.5 
ml cyrotubes (Nunc™). The cell suspension was then frozen down in a controlled 
manner by using isopropanol on dried ice, followed by storage at -80°C.  
For use, frozen cells were thawed quickly at 37°C and added to a 25 cm² flask which 
contained 10 ml pre-warmed (37°C) cell specific media. The cells were incubated at 
37°C and 5/7.5 % CO2 overnight. Thereafter the media was taken off, to remove 
DMSO supplement, and replaced with fresh and pre-warmed media. 
 
2.4.2 Culturing mammalian cells 
Rat pheochromocytoma-12 (PC12) cells were grown in collagen-coated 75 cm² 
flasks under controlled conditions, in Complete Media [Advanced RPMI-1640 
containing 10 % (v/v) horse serum, 5 % (v/v) foetal bovine serum, 1 % (v/v) 
glutamax and 0.1 % (v/v) gentamycin, (Invitrogen Ltd.)]. The cells were maintained 
at an appropriate temperature and gas mixture of 37°C and 7.5 % CO2 in a cell 
incubator. 
PC12 cells were subcultured at least once a week, depending on their density. For 
this the complete media was removed and 2 ml of Versene gently added to the cells 
to remove dead cells and residual media. Afterwards, 5 ml Versene was added and 
the cells were detached from the surface of the flask by pipetting. The cells were then 
collected in a 50 ml tube containing 45 ml of antibiotic-free media [Advanced RPMI-
1640 containing 10 % (v/v) horse serum, 5 % (v/v) foetal bovine serum and 1 % 
(v/v) glutamax, (Invitrogen Ltd.)]. The cell suspension was then centrifuged at 500 x 
g for 5 min, the supernatant discarded and the cell pellet resupended in 10 ml media 
by pipetting. Cells were then reseeded at a dilution ratio of 1:3 in 75 cm² flasks or 
6/24-well plates as appropriate for microscopy and assay purposes.  
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Human Embryonic Kidney (HEK)-293 cells and Henrietta Lacks (HeLa) cells were 
cultured in 75 cm² flasks in D-MEM containing 5 % FBS (Invitrogen Ltd) at 37°C 
and 5 % CO2. HeLa-C1 cells were cultured in D-MEM containing 10% (v/v) FBS, 
50 IU/ml penicillin, 50 μg/ml streptomycin (Sigma-Aldrich). Sertoli cells (15P-1 
(rat) and MSC-1 (mouse)) were cultured in 75 cm² flasks in DMEM (containing 
pyruvate) supplemented with 5 % (v/v) FBS (Invitrogen Ltd), 50 IU/mL penicillin 
and 50 μg/mL streptomycin at 32°C and 5 % CO2. Leydig (R2C) cells were cultured 
in F-12 solution containing 15 % (v/v) HS, 2.5 % (v/v) FBS and 0.4 % (v/v) 
gentamycin (Invitrogen Ltd). To subculture the cells, they were washed briefly in 5 
ml of Trypsin-EDTA [0.05 % trypsin, 0.53 mM EDTA*4Na; (Invitrogen Ltd)] and 
then incubated at 37°C or 32°C for 2 minutes in 3 ml Trypsin-EDTA. The cells were 
then detached from the surface of the flask by gentle tapping. Cells were subcultured 
at a dilution ratio of 1:3 (Leydig cells (R2C) and Sertoli cells (MSC-1)), 1:10 
(HEK293 and HeLa cells), 1:20 (Sertoli cells (15P-1)) and (HeLa-C1 cells).To 
subculture the cells onto 6/24-well plates or coverslips for further analysis, the cells 
were diluted with their appropriate media without antibiotics. 
 
 
2.4.3 Small interference RNA transfection into mammalian cells 
RNA interference (RNAi) is a specific gene-silencing technique, where a double-
stranded (ds) RNA binds to a specific target mRNA sequence and brings about its 
cleavage. Small interference RNAs (siRNA) can also be introduced exogenously into 
cells. Double stranded siRNAs are designed that have sequences which are 
complementary to a specific target mRNA. siRNAs assemble into an RNA-induced 
silencing complex (RISC) to form an RNA-protein complex (known as siRISC); 
siRISC binds to the target mRNA and silences gene expression. 
To introduce siRNA into cells the lipid transfection reagents DharmaFECT® 1 (for 
animal cell lines) and DharmaFECT® 2 (for human cell lines) (Dharmacon; Thermo 
Scientific) were used, which are functionally verified to produce at least 75 % 
transfection efficiency. 0.25 x 106/ml cells were seeded on a 24-well plate to achieve 
a successful knock down efficiency and grown for 24 hours. siRNA (600 nM) was 
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made in 35 µl serum free media [Advanced RPMI-1640 supplemented with 1 % 
(v/v) glutamax]. In a separate tube 1 µl DharmaFECT® siRNA transfection reagent 
was added to 49 µl serum free media. After 5 minutes incubation time at room 
temperature, the siRNA solution and the Dharmafect solution were combined and 
incubated for 20 minutes at room temperature. Following this, 200 µl antibiotic-free 
media was added the siRNA-Dharmafect solution. The media from the cells was then 
removed and the entire 300 µl reaction mix was added to the cells (final siRNA 
concentration of 100 nM). The 24 well-plate was then returned to the 37°C incubator 
for 72 hours. 
 
 
2.4.4 Plasmid DNA transfection into mammalian cells 
Plasmid DNA was introduced into PC12, HEK 293, HeLa, HeLa-C1, Sertoli (15P-1 
and MSC-1) and R2C Leydig cells using Lipofectamine™ 2000 reagent (Invitrogen 
Ltd).  
The required quantity of plasmid DNA was added to 50 µl of serum free media in a 
sterile 1.5 ml tube and mixed by pipetting. Lipofectamine™ 2000 was was added 
into 50 µl of serum free media; Lipofectamine™ 2000 was used at a ratio of 2 µl/µg 
DNA. The plasmid and lipofectamine were incubated for 5 minutes at room 
temperature, then combined and incubated for a further 20 minutes. Subsequently, 
the plasmid-lipofectamine mixture was added to the cells, which were then returned 
to the incubator for 24 hours for all cell lines except PC12 cells, which were 
transfected for 48 hours. 
 
 
2.5 Purification of recombinant CSP proteins 
CSPβ and CSPγ were cloned into pQE30 as described in section 2.3.3.3. CSPα 
inserted between BamHI and HindIII sites in pQE30 was previously described 
(Chamberlain and Burgoyne, 1996). The pQE-30 vector encodes 6 histidine residues 
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(His6 tag) upstream of the cloned DNA, which has an affinity to metal ions like 
nickel (Ni2+). PQE30-CSPα, pQE30-CSPβ and pQE30-CSPγ were  transformed into 
competent E. coli M15 [pREP4] cells and transformed bacteria selected by growth on 
kanamycin and ampicilin agar plates (pREP4 encodes Kanr, pQE30 encodes Ampr) 
(see 2.3.11). Bacterial colonies were picked and grown in 5 ml LB media with the 
appropriate antibiotics for approximately 5 hours and then transferred into 500 ml 
supermedia [150mM NaCl, 1.5 % (w/v) tryptone, 2.5 % (w/v) yeast extract] with the 
appropriate antibiotics (see 2.3.1) and grown overnight on an orbital shaker at 250 
rpm and 37°C. The following day another 500 ml of supermedia was added to the 
overnight culture, which was also supplemented with Isopropyl β-D-1-
thiogalactopyranoside (IPTG; Calbiochem) to a final concentration of 1 mM, and 
incubated for a further 5 hours at 37°C and 250 rpm. The culture was then 
centrifuged at 4000 x g for 20 minutes and the cell pellet was resuspended in 200 ml 
breaking buffer [100 mM Hepes, 2 mM MgCl2, 500 mM KCl, 2 mM 2-
mercaptoethanol, pH 7.0]. The bacterial cells were then centrifuged again at 4,000 x 
g for 20 minutes and the pellet resuspended in 20 ml breaking buffer containing a 
protease inhibitor cocktail (Roche). The suspension was then subjected to a freeze-
thaw cycle at – 80°C, lysozyme added to 1 mg/ml and incubated on ice for 30 
minutes. Subsequently the suspension was subjected to four sonication cycles (Sanyo 
Soniprep 150) at an amplitude of 10 µm for 15 seconds. Finally the suspension was 
centrifuged at 50,000 x g for 30 minutes and the supernatant (containing soluble 
proteins) collected.  
The purification resin used for His6-tagged proteins is Ni2+-Nitrilo Triacetic Acid 
(NTA)-coupled agarose beads (Qiagen). The purified bacterial supernatant was 
incubated with 3 ml of Ni2+-NTA beads in a 50 ml tube for 1 hour at 4°C with end 
over-end rotation. The beads were then collected by centrifugation at 2,000 x g for 5 
minutes, followed by 3 washes in 40 ml imidazole buffer [50 mM imidazole, 20 mM 
HEPES, 200 mM KCl, 2 mM β-Mercaptoethanol, 2 mM MgCl2, 10 % (v/v) glycerol, 
pH 7.5] for 30 minutes each, imidazole competes with histidine for binding to Ni2+. 
Imidazole at 50 mM is not sufficient to elute His6-tagged proteins but removes 
proteins that are weakly bound to the resin. Elution of His6-tagged CSPs was 
achieved by adding successively 1 ml imidazole buffer containing 100, 150, 200, 250 
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or 500 mM imidazole. All elution steps were performed on ice with an incubation 
time of 5 minutes and subsequent centrifugation at 2,000 x g for 5 minutes. Each 
fraction was collected and an aliquot run on an SDS-PAGE gel (see 2.6.1 and 2.6.2) 
which was stained with Coomassie Blue to identify the peak fractions that contained 
the target protein. The fractions which containing the highest concentration of 
protein were combined and dialysed (Slide-A-Lyzer G2 Dialysis Cassettes, 10 K 
molecular weight cut off (MWCO), Thermo Fisher Scientific Inc.) against 5 litres of 
PBS at 4°C for 2 hours and then a fresh 5 litres of PBS overnight. The following day 
the protein solution was centrifuged at 14,000 x g for 10 minutes to remove any 
aggregated protein and the concentration measured through a BCA assay (see 2.6.6) 
 
 
2.6 Protein biochemistry 
 
2.6.1 Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
(SDS-PAGE) 
SDS-PAGE is a technique used to fractionate proteins according to their weight 
(Laemmli, 1970). 
The gel was made by pouring polyacrylamide solutions between glass plates 
assembled in a casting stand (BIO RAD Mini–PROTEAN Tetra Electrophoresis 
System). The final gel consists of two different gels. The main gel is the so-called 
resolving gel, which is responsible for protein seperation. The pore size can be varied 
according to the size of the target protein of interest, and is determined by the final 
concentration of acrylamide/bis-acrylamide. Unless specifically mentioned, all gels 
used were 12 %, made by mixing 5 ml of 2 x resolving buffer (0.2 % (w/v) SDS, 4 
mM EDTA, 750 mM Tris Base, pH 8.9), 4 ml 30 % acrylamide/bis-acrylamide, 1 ml 
dH2O, 8 µl N,N,N',N'-tetramethyl-ethane-1,2-diamine (TEMED), and 20 mg of 
ammonium persulfate (APS). TEMED is used for the chemical polymerisation of the 
polyacrylamide gel and the reaction is started by the addition of APS. The stacking 
gel is polymerised above the resolving gel and has a large pore size and a low 
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concentration of acrylamide. This stacking gel was prepared by mixing 4 ml stacking 
buffer (0.2 % (w/v) SDS, 4 mM EDTA, 250 mM Tris Base, pH 6.8), 1.2 ml 
acrylamide/bis-acrylamide, 2.8 ml dH2O, 10 µl TEMED, and 10 mg of APS. The 
purpose of the stacking gel is to concentrate proteins into a thin layer at the top of the 
resolving gel, thus improving resolution. A comb is placed into the unpolymerised 
stacking gel to create wells to load the protein samples.  
Prior to loading, the protein samples were made up in SDS sample buffer [50 mM 
Tris Base (pH 6.8), 0.1 % (w/v) bromophenol blue, 10 % (v/v) glycerol, 2 % (w/v) 
SDS, 25 mM Dithuothreitol (DTT)] and denatured at 100°C for 5 minutes. 
Protein samples were then loaded into the gel wells in a gel tank filled with running 
buffer [25 mM Tris Base, 250 mM glycine, 1 % (w/v) SDS]. The denatured proteins 




2.6.2 Coomassie blue staining 
Polyacrylamide gels were incubated in Coomassie staining solution [0.3 % (w/v) 
Coomassie Brilliant Blue R250 (Merck), 54.2 % (v/v) methanol, 9 % (v/v) glacial 
acetic acid] for 30 minutes at room temperature on an orbital shaker. Subsequently, 




After SDS-PAGE (see 2.6.1), proteins in the gel were transferred onto a 
nitrocellulose membrane (Protran® nitrocellulose membrane, 0.45 um pore size; 
Whatman plc, Brentford, Middlesex, U.K.). For this the nitrocellulose membrane 
was placed on top of the gel and between two pieces of Whatman paper (Thermo 
Fischer). All items were previously soaked in transfer buffer [48 mM Tris Base, 39 
mM glycine, 1.3 mM SDS, 20 % methanol] and great care was taken to remove any 
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air pockets. The gel and membrane sandwich was held within a gel holder cassette 
and submerged entirely in transfer buffer in the BIO RAD Trans-Blot cell (16 x 20 
cm blotting area) tank transfer system. The gel was positioned towards the cathode, 
allowing proteins to move from the gel to the membrane when a constant current of 
70 mA is applied for 16 hours. 
To confirm protein transfer, the nitrocellulose membrane was stained with Ponceau S 
dye (Invitrogen Ltd.) for approximately 60 seconds.  
The nitrocellulose membrane was then washed in PBS-T [137 mM NaCl, 10 mM 
Phosphate, 2.7 mM KCl, 0.02 % (v/v) Tween® 20, pH 7.4] and incubated in 5 % 
(w/v) non-fat milk (Marvel) in PBS-T for approximately 45 minutes at room 
temperature to block non-specific binding of the antibodies. The membrane was then 
probed with primary antibody (diluted in PBS-T) against the protein of interest. The 
dilution factors for specific antibodies are given in section 2.1.7. The primary 
antibody solution was left on the blot for 45 minutes at room temperature or over 
night at 4°C with gentle shaking. The membrane was then washed five times in PBS-
T (10 minutes per wash). The secondary antibody (Amersham ECL™; GE 
Healthcare) is species-specific to the primary antibody and is linked to horseradish 
peroxidase (HRP); the appropriate secondary antibody was diluted (1:2,000) in 1 % 
(w/v) non-fat milk and added to the nitrocellulose membrane for 45 minutes at room 
temperature with shaking. This was followed by washing the membrane 5 x 10 
minutes in PBS-T. Binding of HRP-coupled antibodies was visualised by enhanced 
chemiluminescence (ECL). For this a working solution of ECL was prepared by 
mixing equal volumes of ECL Solution 1 (100 mM Tris Base (pH 8.5), 2.45 µM 
Luminol, 0.9 µM Coumaric acid) and ECL Solution 2 (100 mM TrisBase (pH 8.5), 
0.061 % (v/v) H2O2). The ECL solution was added to the nitrocellulose membrane 
for 1 minute and the reaction product (luminescence) detected on light sensitive 
photographic film (Kodak) using an X-OMAT developer (Konica SRX-101A, 
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2.6.4 Protein cross-linking 
Amine specific chemical cross-linkers with different length spacer arms were 
employed to investigate protein interactions of CSPα. PC12 cells (106 cells/well of a 
24-well plate) were plated 24 hours prior to the experiment. The cells were washed 
twice with 300 µl Ca2+-Krebs buffer [154 mM NaCl, 5 mM KCl, 1.3 mM MgCl2, 1.2 
mM NaH2PO4, 10 mM Glucose, 20 mM HEPES, 3 mM CaCl2, pH 7.4], and then 
incubated with Ca2+-Krebs buffer either with or without 4 µM ionomycin at 37°C. 
After 5 minutes of incubation, the various cross-linkers (Thermo Scientific; dissolved 
in dry DMSO) were added to a final concentration of 2 mM for 10 minutes at 37°C. 
The cells were then put on ice for 30 minutes, followed by quenching of the cross-
linkers for 15 minutes with 50 mM Tris, pH 7.5. Finally the cells were lysed with 
200 µl sample buffer, boiled and resolved by SDS-PAGE and transferred to 
nitrocellulose for immunoblotting analysis (see 2.6.1 and 2.6.3).  
 
 
2.6.5 Lysis of mammalian tissues 
Mammalian tissues were homogenized in a dounce homogenizer in 500 µl of ice-
cold lysis buffer [20 mM HEPES, 1 mM MgCl2, 250 mM sucrose, 2 mM EDTA, 1 % 
(v/v) NP-40, 1 ml protease inhibitor cocktail (Roche), pH 7.4]. The lysate was then 
centrifuged at 14,000 x g for 3 minutes to remove insoluble material. The supernatant 
was collected in a fresh 1.5 ml tube and the pellet re-homogenised in a further 500 µl 
of lysis buffer, which was then centrifuged at 14,000 x g for 3 minutes. The two 
collected lysate samples were then pooled and protein concentration determined by a 
BCA assay (see 2.6.6). 
 
 
2.6.6 Bicinchoninic acid (BCA) assay 
The Bicinchoninic Acid (BCA) assay is a technique to detect the total protein 
concentration in a solution. The assay is based on the reduction of Cu2+ to Cu+ by the 
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presence of protein in the solution. Bicinchoninic acid reacts with Cu+ to form a 
purple colour end product, with a peak absorbance at 562 nm which is measured in a 
spectrophotometer. A BCA Protein Assay Kit (Thermo Scientific) was used to 
determine protein concentrations. Standards were prepared with bovine serum 
albumin (BSA) of known concentrations in a range between 0 µg and 20 µg in 50 µl. 
The samples were diluted 1:50 in dH2O. The samples and standards were then 
supplemented with the BCA working reagent, which consists of reagents A and B in 
a ratio of 50:1 according to the manufacturer’s protocol. Finally the samples were 
incubated for 30 minutes at 37°C, followed by reading the absorbance at 560 nm on a 
spectrophotometer. 
The protein concentration of the samples was determined by comparing the 
absorbance with the absorbance of the BSA standards. 
 
 
2.6.7 Fractionation  
Mammalian tissues and cell lines were routinely fractionated into cytosol and 
membrane fractions for analysis of protein localisation. All steps were carried out at 
4°C. 
Detection of the proteins in purified cytosol and membrane fractions was performed 
by resolving cell equivalents of the purified fractions by SDS-PAGE (see 2.6.1), 
followed by transferring the proteins onto nitrocellulose membranes (see 2.6.3). 
 
2.6.7.1 Fractionation of mammalian tissues 
A small amount of rat tissue (~ 100 mg) was homogenised in 1 ml fractionation 
buffer using a dounce homogenizer [20 mM TrisBase, 100 mM KCl, 250 mM 
sucrose, 2 mM MgCl2, 1 mM DTT, protease inhibitor cocktail, pH 8.0]. 800 µl of the 
homogenised tissue was then centrifuged at 55,000 rpm for 30 minutes at 4°C. The 
supernatant, which contained the cytosol fraction, was mixed with 280 µl 4 x SDS 
sample buffer. The membrane pellet was resuspended in 800 µl fractionation buffer 
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supplemented with 1 % (v/v) Triton-X 100, followed by homogenisation. The 
homogenised pellet was incubated on ice for 20 minutes and subsequently 
centrifuged at 55,000 rpm for another 30 minutes. The supernatant containing 
solubilised membrane proteins was mixed with 280 µl 4 x SDS sample buffer. Equal 
volumes of the cytosol and membrane fractions were then resolved by SDS-PAGE 
for immunoblotting and analysis. 
 
2.6.7.2 Fractionation of mammalian cell lines 
PC12 and HEK 293 cells were fractionated using a ProteoExtract® Subcellular 
Proteome Extraction Kit (Calbiochem). This Kit has 4 different buffers for isolation 
of specific cell fractions. Only Buffer I was used for cell fractionation. Buffer I 
contains digitonin and EDTA and permeabilises the membrane to release cytosolic 
proteins. 
Approximately 106 cells were plated per well of a 24-well plate and transfected with 
a specific amount of plasmid DNA for 24 hours (HEK cells) or 48 hours (PC12 
cells). The cells were then washed twice with 300 µl PBS, followed by adding 150 µl 
Buffer I supplemented with the Protease Inhibitor Cocktail (Roche) and incubated on 
ice for 10 minutes. Afterwards, the buffer containing released cytosolic proteins was 
removed from the cells, collected in a fresh 1.5 ml tube, centrifuged for 10 minutes at 
3,000 x g to remove any detached cells and mixed with 50 µl 4 x SDS sample buffer. 
The cells remaining on the 24-well plate were then washed once with 300 µl PBS 
and lysed with 200 µl SDS sample buffer. 
 
 
2.6.8 Isolation of Leydig, germ and Sertoli cells from rat testis 
To examine the testicular cells in which CSPα and CSPβ are expressed in vivo, the 
cells had to be isolated from rat testes.  
Two testes were removed from an adult male rat (> 3 months), gently decapsulated 
and placed in a 50 ml tube. The decapsulated testes were then washed twice in 40 ml 
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1 x HBSS media (adjusted with 7.5 % sodium bicarbonate to pH 7.4; Invitrogen 
Ltd.). Disintegration of the seminiferous tubules was achieved by incubating the 
tubules in a 25 ml collagenase solution (Sigma-Aldrich; 0.5 mg/ml in 1 x HBSS 
media) at 34°C and 80 oscillations/minute for 15 minutes and left to settle for a few 
minutes. To avoid poor yields and purity it was important that the seminiferous 
tubules were not fragmented during the collagenase incubation. The supernatant 
contained the Leydig cells, which were centrifuged at 1000 x g for 5 minutes 
followed by resuspending the cells in 2 ml D-MEM/F-12 (Invitrogen Ltd.). The 
remaining cells in the seminiferous tubules were washed three times with 40 ml 1 x 
HBSS media and then incubated for 10 min at 37°C in a trypsin solution (Sigma 
Aldrich; 0.5 mg/ml in 25 ml 1 x HBSS). Afterwards the tubules were washed three 
times, whereat the third wash contained a trypsin inhibitor (Sigma-Aldrich; 0.3 
mg/ml in 20 ml HBSS media), and allowed to settle for 2 minutes. To separate sertoli 
cells from germ cells, the tubules were incubated for 40 minutes at 34°C at 80 
oscillations/minute in a solution (25 ml) containing 0.1 % collagenase, 0.2 % 
hyaluronidase, 0.04 % Dnase I and 0.03 % trypsin inhibitor (Sigma-Aldrich). 
Thereafter the tubules were centrifuged at 1000 x g for 4 minutes to pellet the sertoli 
cells and subsequently washed three times. The supernatant, which contained germ 
cells, was collected and centrifuged at 1000 x g for 5 minutes to pellet the cells, 
which were then resupended gently in 2 ml D-MEM/F-12. At this stage the Sertoli 
cells were 40 % pure and the majority were single cells; any cell clumps would be 
lost in the steps that followed. In the next step the pelleted sertoli cells underwent a 
hypotonic shock to increase their purity. This was achieved by resuspending the 
pellet in 10 ml of HBSS media and then adding 25 ml of HBSS media which had 
been diluted 1:10 with deionised water. The tube was gently inverted for at least 
three times to disperse the cells. Thereafter the Sertoli cells were centrifuged at 500 x 
g for 4 minutes and the supernatant decanted. The Sertoli cells were then gently 
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2.6.9 Chemical depalmitoylation of palmitoylated proteins 
Neutral hydroxylamine is commonly used to depalmitoylate proteins in vitro. 200 µl 
of 1 M HA (pH 7) or 1 M Tris (pH 7, control) were added to 200 µl of a purified 
membrane fraction (see 2.6.7.1), and incubated overnight at room temperature in the 
presence of protease inhibitors. The treated membrane fractions were then mixed 
with 140 µl 4 x SDS sample buffer containing 100 mM DTT. Tris and HA-treated 
membrane samples were loaded on SDS gels alongside untreated membranes and 




2.6.10 Constitutive exocytosis assay 
The HeLa-C1 cell line stabley expresse the pQCXIP-S1-eGFP-FM4-FCS-hGH 
construct. This construct was virally transfected into HeLa-M cells and then 
autocloned using a MoFlow Flow cytometer based on GFP fluorescence. The clonal 
cell lines were then screened for their ability to efficiently secrete the reporter 
construct (Gordon et al., 2010). The construct (pQCXIP-S1-eGFP-FM4-FCS-hGH) 
forms ligand reversible aggregates that get trapped during trafficking in the 
endoplasmic reticulum (ER). When the cells are incubated with rapamycin the 
aggregates are solubilised and efficiently secreted from the cells. 
HeLa-C1 cells were seeded onto 24-well plates 24 hours prior to siRNA or plasmid 
transfection (see 2.4.3 and 2.4.4). The transfection media was removed from the cells 
and 200 µl of pre-warmed D-MEM supplemented with or without 1 µM rapamycin 
was added to the cells followed by returning the 24-well plates back into the 
incubator at 37°C and 5 % CO2 for 1 or 2 hours. To stop secretion, the cells were 
immediately placed on ice. The cell media was then added into 1.5 ml tube 
containing 70 µl 4 x SDS sample buffer and the remaining cells on the 24-well plates 
were lysed with 270 µl 1 x SDS sample buffer. The media samples (containing 
secreted proteins) were loaded beside cell lysates on SDS gels and the amount of 
secretion was characterised by quantification of GFP signal on immunoblots. 
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Secretion was expressed as a percentage of the total cell content of the GFP-labelled 
construct. 
For live cell imaging, the cells were seeded onto 30 mm coverlips (see 2.4.2) 24 
hours prior to imaging. The cells were imaged for 1 minute, followed by adding 1 
µM rapamycin and continuing imaging for another 2 hours. 
 
 
2.6.11 Exocytosis assay 
PC12 cells were seeded onto 24-well plates 24 hours prior to siRNA or plasmid 
transfection (see 2.4.3 and 2.4.4). The cells were then washed twice with 300 µl 
Ca2+-Krebs buffer, followed by adding 300 µl of Ca2+-Krebs buffer with or without 
300 µM ATP to stimulate regulated exocytosis. After 15 minutes stimulation, 
supernatants were added to fresh 1.5 ml tubes containing 10 µl protease inhibitor 
cocktail. The cells on the 24-well plate were then lysed with 200 µl lysis buffer 
[PBS, 0.5 % (v/v) Triton-X 100, protease inhibitor cocktail (Roche)] for 20 minutes. 
A small fraction of the solubilised cells can be supplemented with 4 x SDS sample 
buffer for detection of protein expression by SDS-PAGE and immunoblotting (see 
2.6.1 and 2.6.3).  
 
 
2.6.12 [3H]-dopamine assay 
PC12 cells (0.25 x 106) were seeded onto a 24-well plate 24 hours prior to siRNA 
transfection. Following addition of siRNA, cells were incubated for a further 72 
hours. Each well of cells was incubated in 300 µl RPMI 1640 media with 0.0088 
mg/ml ascorbic acid and 0.0185 MBq/ml [7, 8, 3H] dopamine at 37°C for 90 minutes. 
Thereafter the exocytosis assay is performed on the cells (see 2.6.11). Stimulation 
was performed for 15 minutes at room temperature, following which the supernatant 
was removed and added to ice-cold 1.5 ml tubes and centrifuged at 15, 000 x g for 2 
minutes to pellet any detached cells (see 2.6.11). The supernatant from this spin was 
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transferred into fresh tubes. The cells on the 24-well plate were lysed in 300 µl 0.5 % 
(v/v) Triton-X 100 in H2O with protease inhibitors for 20 minutes at room 
temperature, and mixed with detached cells (see 2.6.11). 
100 µl of supernatant and 100 µl of cell lysate were added to 4 ml scintillation fluid 
and [3H]-dopamine detected by scintillation counting (Tri-Carb 2500 TR Liquid 
Scintillation Analyzer, Packard Biocsciences, U.S.A). Secretion of [3H]-Dopamine 
was expressed as a percentage of total cell content (i.e. ([3H]-supernatant/([3H]-
supernatant + [3H]-cells) * 100). 
 
 
2.6.13 Human growth hormone (hGH) assay 
Plasmid transfection of PC12 cells has a low efficiency (~ 20 %). Therefore the [3H]-
dopamine assay which monitors release from the whole cell population is not useful 
to determine the effects of transient plasmid transfection on exocytosis efficiency (as 
only ~ 20 % of the signal would be from transfected cells). Therefore a co-
transfection with a plasmid of interest and a plasmid encoding human growth 
hormone (hGH) is performed. Co-transfection efficiency of PC12 cells is ~ 90-95 % 
(Graham et al., 1997). Human growth hormone release is monitored by an enzyme-
linked immunosorbent assay (ELISA) (Roche). 106 PC12 cells were seeded per well 
of a 24-well plate, transfected (1 µg DNA plasmid or 100 nM siRNA) and 0.5 µg 
hGH plasmid. The assay was performed 48 hours after transfection, starting with the 
exocytosis assay as described in section 2.6.11.  
In the ELISA assay, hGH antibody is bound to the surface of a microtiter plate. 
Human growth hormone standards are set up with hGH concentration between 0 and 
400 pg/ml. 200 µl of each standard were added in duplicate to the microtiter plate. 
The supernatant and cell lysate samples from the exocytosis assay were initially 
centrifuged at 14,000 x g for 3 minutes, before adding 200 µl of the supernatant and 
15 µl of cell lysate solutions (added up to 200 µl with sample buffer; provided in the 
kit) to the plate. The microtiter plate was then covered with a foil and incubated for 1 
hour at 37°C. Afterwards the solution was removed from the plate and the plate 
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washed 5 x with 250 µl washing buffer (supplied in the kit). Anti-hGH-digoxigenin 
(anti-hGH-DIG); 200 µl of 1 µg/ml was then added to the microtiter plate which was 
incubated at 37°C for an hour. Thereafter the solution was discarded and washed 5 x 
with washing buffer to remove unbound anti-hGH-DIG. Subsequently, 200 µl of 200 
mU/ml anti-DIG-peroxidase (anti-DIG-POD) was added to each well of the 
microtiter plate and incubated for an hour at 37°C. After the incubation time, the 
anti-DIG-POD solution on the plate was discarded and each well washed again with 
5 x washing buffer. Finally 200 µl of POD substrate was added to the wells and 
incubated at room temperature until a colour change occurred. The optical density 
(OD) of the samples was measured at 405 nm with a reference wavelength at 490 
nm, using a microtiter plate reader. Remaining cell lysate sample from the exocytosis 
assay was diluted in SDS sample buffer, resolved by SDS-PAGE and transferred 
onto a nitrocellulose membrane, to analyse either protein over-expression or knock-
down as appropriate. 
The data from the hGH assays was analysed in Excel (Microsoft® Office Package). 
The hGH concentration of experimental samples was determined by comparison with 
the value of the known standards.  
 
 
2.7 Indirect immunofluorescence 
Approximately 106 PC12 cells were added per well of a 6-well plate containing 
sterile poly-D-lysine coated coverslips (VWR). The following day, the cells were 
transfected for 48 hours. The amount of transfected DNA varied and is indicated in 
the figure legends of result chapters. The cells were washed twice with 2 ml of ice-
cold PBS, followed by fixation in 1 ml of 4 % (v/v) formaldehyde for 30 minutes at 
room temperature. Afterwards, the fixed cells were washed twice with 2 ml PBS and 
permeabilised in PBS containing 0.3 % (w/v) BSA and 0.1 % (v/v) Triton® X-100 
for 6 minutes at room temperature. After removing the permebilisation solution the 
coverslips were washed three times with 2 ml PBS containing 0.3 % (w/v) BSA. The 
permebialised cells were incubated in 30 µl primary antibody at its appropriate 
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dilution (see 2.1.7.1) by inverting the coverslips upside down in the antibody solution 
placed on parafilm for 60 minutes. The coverslsips were then returned to the 6-well 
plate with the cells facing up and washed three times with 2 ml of PBS containing 
0.3 % (w/v) BSA to remove unbound primary antibody. The coverslips were 
subsequently incubated (cell slide down) with secondary antibody at its appropriate 
dilution (see 2.1.7.2) on a strip of parafilm for 60 minutes, covered in a box 
impervious to light. The secondary antibodies used were specific to the host IgG in 
which the primary antibody was raised and were conjugated to an appropriate Alexa 
Fluor dye (488, 543 or 647, Invitrogen Ltd.). To remove excess secondary antibody 
the coverslips were washed three times with 2 ml of PBS (0.3 % (w/v) BSA, rapidly 
submerged in dH2O and allowed to air dry at room temperature. The coverslips were 
then mounted cell side down on slides using mowiol (10.5 % (w/v) Mowiol 4-88 
(Calbiochem), 21 % (v/v) Glycerol, 2.5 % (w/v) 1,4-diazabicyclo[2.2.2]octane 
(DABCO, Sigma-Aldrich), 0.2 M Tris pH 8.5), left to dry over night and stored in a 




Immunohistochemistry is a technique to localize proteins in tissue sections by the use 
of antibodies. The antigen-antibody interaction are here visualised through 
fluorescence. 
 
2.8.1 Fixation, paraffin embedding and sectioning of testis 
The fixation of tissues is essential to ensure the preservation of the cell morphology 
and tissue architecture. Testis, of adult male rats, were directly fixed in 4 % (v/v) 
formaldehyde for 24 hours. Afterwards the tissues were kept in 70 % (v/v) ethanol 
until required. 
Testis was embedded in paraffin through an overnight programme. Firstly the testis 
was incubated in 70 % (v/v) ethanol for 45 minutes, followed by 90 minutes in 80 % 
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(v/v) ethanol and a 2 hour incubation in 95 % (v/v) ethanol. Thereafter the tissues 
were incubated for 6 hours in 99 % ethanol and finally in 100 % ethanol to ensure 
that no water was left in the tissue. To clear the tissue, it was incubated in xylene for 
5 hours and 30 minutes. The final step was the actual paraffin wax embedding; the 
tissue was incubated in paraffin wax for 8 hours at 60 °C. Afterwards the paraffin 
embedded testis was set in a block of paraffin wax for sectioning. 
To section testis in 10 µm thick slices, a rotary microtome (Jung RM 2035, Leica 
Microsystems (U.K.) Ltd, Milton Keynes, U.K.) was used. The sections were then 
placed in 30°C warm water to ensure that the sections flatten out fully, and then 
carefully placed on special adhesion slides (SuperFrost® Plus Microscope Slides, 
VWR International), which are permanent positive charged to bind the sections. The 
slides were dried for 24 hours in a 37 °C incubator and kept in a slide box until 
required. 
 
2.8.2 Immunolabelling of testis sections 
The testis sections were initially dewaxed for approximately 30 minutes in xylene, 
followed by 5 minutes washes in 100 %, 95 %, 90 % and 70 % ethanol respectively. 
Afterwards the slices were rehydrated in distilled water for at least 5 minutes, 
followed by equilibration in 10 mM Citrate buffer (10 mM Citric acid, 0.05 % 
Tween 20, pH 6) for 10 minutes to facilitate optimal binding of primary antibodies. 
The sections were then microwaved four times for 5 minutes; to keep the slices 
covered in solution they were replenished with dH2O after each 5 minutes and left to 
cool off for at least 20 minutes. To reduce background fluorescence, the slices were 
covered in methanol supplemented with 3 % H2O2 (Sigma-Aldrich) and incubated 
for 30 minutes. Thereafter the testis sections were washed three times for 5 minutes 
with PBS. The slides were then dried around the sections, the edges of the slide were 
sealed with a Dako Pen (Dako Denmark A/S, Glostrup, Denmark), and blocked with 
300 µl goat serum [20 % goat serum (Sigma-Aldrich), 5 % BSA in PBS] for 30 
minutes. Afterwards the sections were incubated overnight at 4 °C with 300 µl 
primary antibody (see 2.1.7.1) diluted in goat serum. 
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The following day the slides were washed three times in PBS for 5 minutes per wash. 
Thereafter the sections were incubated for 60 minutes at room temperature with the 
appropriate AlexaFluor® secondary antibody (see 2.1.7.2), followed by three 5 
minutes washes with PBS. The sections were then dried and a coverslip (22*64 mm, 
VWR International) was mounted on the sections with ProLong® Gold antifade 
reagent with DAPI (Invitrogen Ltd.), which stains double stranded DNA. The slides 
were dried overnight and stored in a box impervious to light. 
 
 
2.9 Optical microscopy 
 
2.9.1 Widefield microscopy 
For live cell imaging, the fluorescence-based wide-field microscopy was used 
because it illuminates full samples. Here the Olympus IX-81 microscope equipped 
with Olympus Cell^R acquisition software (Olympus, Essex, U.K.) and an Image 
EM EM-CCD 512x512 camera (Hamamatsu UK) were used. The images were taken 
with 63 x oil Plain Apochromat objective, and were acquired every 10 seconds. 
EGFP fluorescence was visualised by using 488nm laser excitation and monitoring 
fluorescence at 500-555nm. 
 
2.9.2 Confocal microscopy 
In this work, confocal microscopy was used to analyse fixed cells. The principal of a 
confocal microscopy is that it uses a point illumination and a pinhole in an optical 
plane in front of a detector to filter out of focus light information. This means that 
only the light from the fluorescence object is viewed.  
Here the Zeiss LSM510 confocal system (Carl Zeiss, Oberkochen, Germany) or the 
Leica SP5 C system (Leica Microsystems GmbH, Wetzlar, Germany) were used for 
confocal laser scanning microscopy (CLSM). Different fluorophores were detected 
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with a dichroic beam splitter, which seperates the excitation and the emission light. 
Sample excitation was achieved using the appropriate laser line (488, 543 or 633 
nm). Fluorescence emission was monitored using a 500-550 nm band-pass filter (488 
nm excitation), a 560 nm long-pass filter (543 nm excitation), or a 650 nm long-pass 
filter (633 nm excitation). To detect Dapi stain a Multiphoton laser was used and set 
770 nm. Image stacks were collected in 130 nm steps with pinhole set to 1 Airy unit. 
Afterwards, images stacks were deconvolved with Huygens Scientific Volume 




2.10 Data analysis 
Immunoblots were scanned and protein band intensity was quantified using ImageJ 
software (Image Processing and Analysis in Java). Great care was taken to ensure 
that band intensities were not saturated and likely to be in the linear range. Relative 
protein expression levels were calculated using Excel software (Microsoft® Office 
system). The values measured were presented as the standard error of the mean 
(SEM). The statistical significance was ascertained through the unpaired two samples 
Student’s t-test or one-way analysis of variance (ANOVA) test, useful for comparing 








CHAPTER THREE:  
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3.1 Introduction 
Exocytosis, the fusion of intracellular vesicles with the plasma membrane, is 
fundamental to intercellular communication in multicellular organisms. This pathway 
facilitates the release or secretion of molecules from the cell. In addition, exocytosis 
is essential for delivery of resident proteins to the plasma membrane. There are two 
different pathways of exocytosis, constitutive and regulated exocytosis. Constitutive 
exocytosis occurs without regulation, e.g. pathways regulating the delivery of lipids 
and ‘house-keeping’ proteins to the plasma membrane or the secretion of antibodies 
and extracellular matrix components from the cell. In contrast, regulated exocytosis 
facilitates the controlled release of extracellular molecules or insertion of membrane 
components in response to a physiological signal. The most common signal for 
regulated exocytosis is an increase in intracellular Ca2+ concentration (Burgoyne and 
Morgan, 2003). 
Regulated exocytosis occurs in specialized secretory cells, such as mast cells, 
chromaffin cells and pancreatic β cells, controlling the release of histamine, 
catecholamines and insulin, respectively (Burgoyne and Morgan, 2003). Several 
proteins function in exocytosis, and the membrane fusion step is widely believed to 
result from an interaction between SNARE (SNAP receptor) proteins on the vesicle 
membrane and plasma membrane. In neuroendocrine cells, these SNARE proteins 
are VAMP2, which is bound to vesicle membranes and syntaxin1A and SNAP25, 
which are associated with the plasma membrane (Hong, 2005). 
Several proteins have been implicated as SNARE regulators. NSF (N-
ethylmaleimide sensitive factor) and its cofactor α-SNAP (α-soluble NSF attachment 
protein), function to disassemble SNARE complexes following fusion (Hong, 2005). 
Munc18 is thought to function by regulating the formation of functional SNARE 
complexes (Shen et al., 2007). Synaptotagmin is a calcium-binding protein that is 
proposed to facilitate calcium-dependent SNARE-mediated membrane fusion via 
interactions with the SNARE proteins and negatively charged phospholipids 
(Chapman, 2008). Another possible SNARE regulator is cysteine string protein 
(CSP) (Evans et al., 2003). 
CSP was first identified in Drosophila melanogaster (Zinsmaier et al., 1990) and 
was later identified in Torpedo as a possible Ca2+-channel regulator (Gundersen and 
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Umbach, 1992). Inactivation of the CSP gene in Drosophila is lethal at an embryonic 
stage, with only 4% of the mutant flies surviving into adulthood (Zinsmaier et al., 
1994). Analysis of the surviving flies showed that they displayed uncoordinated, 
sluggish movements and exhibited intense shaking. Furthermore, the surviving adult 
mutant flies were temperature sensitive and died within 4-5 days at 22°C or within an 
hour if the temperature was raised to 30°C. It was subsequently shown that 
neurotransmitter exocytosis was decreased by ~50 % at 22°C in the mutant embryos 
and abolished at higher temperatures (Umbach et al., 1994). These results indicate 
that CSP has an important role in presynaptic neurotransmission (Chamberlain and 
Burgoyne, 1998, 2000). One of the important regulatory domains of CSP is the 
cysteine string domain (Chamberlain and Burgoyne, 2000; Evans et al., 2003). The 
cysteine string is a 24 amino acid motif, containing 14 cysteine residues, the majority 
of which are thought to be palmitoylated (Gundersen et al., 1994), and this domain is 
responsible for the localization of CSP to the membranes of organelles and secretory 
vesicles (Greaves et al., 2008). Another important domain is the J-domain, which is 
the defining motif of the DnaJ family of co-chaperones, and this region mediates 
CSP binding and activation of the chaperone Hsc70 (heat shock protein 70 kDa) 
(Braun et al., 1996; Chamberlain and Burgoyne, 1997a).  
The function of CSP in exocytosis is not clear, but may involve the regulation of 
protein folding. It has been suggested that a CSP-HSC70 chaperone complex, 
together with SGT (small glutamine rich tetratricopeptide repeat protein), regulates 
the folding of exocytotic proteins including SNAREs (Tobaben et al., 2001; Tobaben 
et al., 2003), indeed CSP has been shown to interact with both VAMP and syntaxin 
(Nie et al., 1999; Chamberlain and Burgoyne, 2000; Evans et al., 2003). 
In addition to the role of CSPα in neurotransmission in Drosophila, several 
subsequent studies suggested that this protein also functions in regulated exocytosis 
in a range of mammalian cell types including: adrenal medullary chromaffin cells 
(Graham and Burgoyne, 2000), pancreatic beta cells (Brown et al., 1998; Zhang et 
al., 1998) and PC12 cells (Chamberlain and Burgoyne, 1998). However, recent work 
found no obvious exocytosis defect in CSP null mice (Fernandez-Chacon et al., 
2004), raising a number of questions about the proposed role of CSP in exocytosis. 
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Since the function of CSP is not clear, the aim in this chapter is to bring more clarity 
to this topic. Most studies that have investigated CSP function in mammalian cells 
have used over-expression of wild-type or mutant CSPs. However, results from over-
expression can be complicated to interpret and therefore we aimed to examine effects 
of CSP depletion. By knocking down CSP expression using siRNA, the role of CSP 




3.2.1 Successful knock down of CSPα in PC12 cells 
Phaeochromocytoma-12 (PC12) cells, which are a tumour cell derivative of rat 
neuroendocrine adrenal medullary chromaffin cells, express endogenous CSPα and 
neuronal SNARE proteins and are specialised in regulated exocytosis (Greene and 
Rein, 1977; Schubert and Klier, 1977; Rebois et al., 1980). To date, CSPα 
knockdown had been successfully achieved in 3T3 cells (Zhang et al., 2006), but not 
in PC12 cells. Indeed there are only a few reports of successful knockdown of 
proteins in PC12 cells using siRNA (Thonberg et al., 2004; Noordman et al., 2006; 
Podszywalow-Bartnicka et al., 2010). Four different siRNAs were tested for their 
ability to deplete CSPα expression. Three siRNAs correspond to the open reading 
frame of CSPα and one to the non-coding region. Initially it was determined what 
cell density is optimal for successful knock down. PC12 cells were plated at different 
densities 24 hours prior to the transfection (2, 1, 0.5 and 0.25 x 106 cells/well) and 
transfected with 100 nM of either CSPα siRNA, cyclophilin b siRNA or no siRNA 
(as control) (see 2.4.3) for 72 hours. The cells were lysed, resolved by SDS-PAGE 
and transferred to nitrocellulose membrane for immunoblotting analysis using anti-
CSPα antibody. Figure 3.1A indicates that a cell density of 0.25 x 106 cells achieved 
an effective depletion of CSPα. 
To investigate the optimal transfection time to achieve the highest CSPα knock down 
efficiency at a cell density of 0.25 x 106 cells, cells were transfected for 3 days, 5 
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Figure 3.1: siRNA-mediated depletion of CSPα in PC12 cells. A. PC12 cells growing on 
24-well plates and seeded at the indicated densities were incubated with 100 nM of siRNA 
molecules directed against CSPα or with siRNA against cyclophilin B for 3 days. The cells 
were lysed, samples resolved by SDS-PAGE and protein levels examined by immunoblotting 
with a polyclonal CSPα antibody (Stressgen). B. CSPα siRNA transfection was carried out 
with four different siRNA for different time periods as indicated. Cells were plated at 0.25 x 
106/well. CSPα expression levels were detected by immunoblotting. Position of molecular 
weight standards are shown on the left of all panels. 
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days or 5 days with a re-transfection after 72 hours. The results (Figure 3.1B) 
demonstrate that CSPα depletion was not further enhanced by either a longer 
incubation period or a double transfection.  
Thus, all subsequent CSPα knock down experiments in PC12 cells were carried out 
at a cell density of 0.25 x 106 cells/well and an incubation time of 72 hours. This 
treatment protocol promoted a significant knock down of CSPα expression by ~80 % 
(Figure 3.2A and 3.2B). Furthermore all four siRNAs were effective at depleting 
CSPα expression levels.  
It has been suggested that a CSPα-HSC70 chaperone complex regulates the folding 
of exocytotic proteins including SNAREs. Indeed, CSPα has been shown to interact 
with both VAMP2 and syntaxin 1A (Nie et al., 1999; Chamberlain and Burgoyne, 
2000; Evans and Morgan, 2003) and SNAP25 levels are reduced in CSPα null mice 
(Chandra et al., 2005). To examine whether CSPα knock down has any effect on the 
expression levels of exocytotic SNARE proteins, levels of SNAP25, VAMP2 and 
syntaxin 1A were analysed by immunoblotting. Figure 3.3 shows that the CSPα 
knock down had no effect on the expression levels of these SNARE proteins. This 
result also demonstrates that CSPα siRNAs have a high specificity towards CSPα. 
Together these results show that CSPα can be successfully depleted in PC12 using 
siRNA and that this knockdown has no effect on expression of SNARE proteins. The 
siRNA approach was therefore used for further experiments to investigate if CSPα 
plays a role in regulated exocytosis in PC12 cells.  
 
3.2.2 CSPα depletion results in a decreased secretion of 3H-dopamine 
and human growth hormone from PC12 cells 
Previous studies have implicated CSPα in exocytosis by examining effects of over-
expression (Chamberlain and Burgoyne, 1998; Zhang et al., 1999; Graham and 
Burgoyne, 2000). However, recent work found no obvious exocytosis defect in 
neuronal cells of CSPα null mice (Fernandez-Chacon et al., 2004), raising a number 
of questions about the proposed role of CSPα in exocytosis. Thus, CSPα knockdown 
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Figure 3.2: CSPα depletion with siRNA and quantification of knock down efficiency. 
PC12 cells were transfected with 100 nM of 4 different CSPα siRNAs, a cyclophilin B siRNA 
or no siRNA (control), and incubated for 72 hours. The cells were subsequently lysed, 
resolved by SDS-PAGE and transferred to a nitrocellulose membrane. Protein levels were 
examined by immunoblotting with a polyclonal CSPα antibody (Stressgen). A. Shows a 
representative immunoblot. Position of molecular weight standard is shown on the left. B. 
CSPα levels were quantified in control and siRNA treated cells (n=4) by densitometry. 
Expression in control cells was arbitrary set to 100 and expression in siRNA-transfected cells 
are shown relative to this. *** indicates a significant decrease (p<0.0001) in CSPα 
expression compared to control cells using a one-way ANOVA test. 
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Figure 3.3: SNARE protein levels in CSPα-depleted cells. CSPα siRNAs, at a 
concentration of 100 nM, were transfected into PC12 cells for 3 days. Cells were then lysed, 
the samples resolved by SDS-PAGE and transferred to nitrocellulose membranes, which 
were then probed with specific SNAP25 (Synaptic Systems), VAMP (Synaptic Systems) and 
syntaxin (HPC-1, Sigma) antibodies; actin (monoclonal, Abcam) served as a control. Position 
of molecular weight standards are shown on the left of panels. 
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in a model system may provide further insight into CSPα function in regulated 
exocytosis. 
PC12 cells are specialised in regulated exocytosis releasing catecholamines, such as 
dopamine, and are therefore widely used as a secretory cell model (Schubert et al., 
1974). PC12 cells are known to synthesise, store and release dopamine (Greene and 
Tischler, 1976). 
To analyse CSPα function in regulated exocytosis in PC12 cells, a radio-labelled 
[3H]-dopamine assay was performed that reliably reports exocytotic responses 
(Chamberlain and Burgoyne, 1998). PC12 cells (0.25 x 106 cells/well) on 24-well 
plates were transfected with siRNA for 72 hours. CSPα siRNA#1 and #2 were 
selected for analysis, because they showed the highest CSPα knock down (Figure 
3.2B) and CSPα siRNA 4 was chosen, as it targets the non-reading frame. Following 
a 3 day incubation, cells were incubated with [3H]-Dopamine in RPMI 1640 media 
for 90 minutes at 37°C (see 2.6.12). Thereafter the cells were washed and incubated 
in Krebs buffer with or without 300 µM ATP. ATP activates regulated exocytosis by 
promoting Ca2+ entry through ligand-gated P2X receptors (Burnstock and Kennedy, 
1985; Surprenant et al., 1995). After 15 minutes the buffer was removed and the cells 
were lysed in 0.5 % Triton X-100. The 3H content in the buffer and the cell lysate 
was calculated by scintillation counting. The results in Figure 3.4A demonstrate that 
basal release of dopamine was unaffected by CSPα siRNAs. However, dopamine 
release from ATP-stimulated PC12 cells was significantly decreased by all three CSP 
siRNAs (Figure 3.4A and 3.4B). 
In these dopamine release assays ‘non-targeting’ siRNA was used as a control. It was 
important to ensure that the non-targeting siRNA had no effect on exocytosis. Thus, 
[3H]-Dopamine assays were performed comparing ‘non-targeting’ siRNA with no 
siRNA (transfection reagent alone). Figure 3.4C reveals that these two treatments 
show no significant difference in dopamine release and explicitly shows that the 
‘non-targeting’ siRNA has no effect on regulated exocytosis.  
Previous work has suggested that CSPα may regulate uptake of vesicle content (Jin 
et al., 2003).  
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Figure 3.4: Reduced CSPα expression levels correlates with a decreased level of Ca2+-
stimulated exocytosis in PC12 cells.  
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Figure 3.4: Reduced CSPα expression levels correlates with a decreased level of Ca2+-
stimulated exocytosis in PC12 cells.PC12 cells transfected with 100 nm of the indicated 
siRNA for 3 days were washed and loaded with [3H] dopamine for 90 minutes at 37°C. Cells 
were then incubated in the presence or absence of 300 µM ATP for 15 minutes at room 
temperature. Secreted and cell-associated [3H] dopamine was assayed by scintillation 
counting and secreted dopamine expressed as a percentage of the total cell content. A. 
Comparison of [3H] dopamine release from PC12 cells treated with CSPα siRNAs or a non-
targeting siRNA. The data presented show normalised mean values +/- SEM (n=18 from 6 
independent experiments). Statistical significance was determined using a one-way ANOVA 
test. ** denotes a p value of <0.001 and *** indicates a p value of <0.0001 for ATP-
stimulated secretion compared with cells treated with non-targeting siRNA. There were no 
significant differences between the values for basal secretion. B. The level of ATP-stimulated 
release (secretion in presence of ATP minus basal secretion) was calculated for each 
condition. All three CSP siRNAs caused a significant decrease in this component of 
dopamine release (*** indicates a p value <0.0001 for the ATP dependent component of 
dopamine secretion compared with cells treated with non-targeting siRNA). C. Comparison 
of dopamine release in cells that were mock-transfected or transfected with non-targeting 
siRNA. A Student’s t-test revealed no significant difference in dopamine secretion between 
the two sets of cells (p=0.385 for basal secretion and p=0.482 for ATP-stimulated release; 
n=6 from 2 separate experiments). 
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To investigate if CSPα has any role in dopamine uptake into vesicles, the total 3H-
dopamine content was quantified in cells transfected with non-targeting siRNA 
compared to cells treated with CSPα siRNA. The results (Figure 3.5) show that all 
CSPα siRNA reduced cellular dopamine levels although this was only significant for 
oligos #1 and #2. These findings indicate a potential role for CSPα in regulating 
dopamine uptake into vesicles and this may warrant further investigation in the 
future. Note however that as secretion of [3H]-Dopamine (Figure 3.4) is expressed as 
a % of total cell content, any reduction in dopamine uptake by CSPα depletion 
should not impact on secretion assay results. 
[3H]-Dopamine assays suggest that CSPα is required to ensure maximum efficiency 
of Ca2+-stimulated exocytosis in neuroendocrine PC12 cells. We next planned to 
perform “rescue” experiment with CSPα mutants for structure-function studies. 
Rescue experiments are achieved by transfecting siRNA-resistant CSPα-expression 
plasmids into PC12 cells treated with siRNA. However, as the dopamine release 
assay measures secretion from the entire cell population, and plasmid transfection 
efficiencies in PC12 cells are not higher than ~ 30 %, the dopamine release assay 
was not suited for such rescue experiments. 
The human growth hormone (hGH) assay however allows regulated secretion to be 
examined only in cells transfected by plasmid (Gleave et al., 2001). Thus, PC12 cells 
are transfected with hGH plasmid and hGH secretion used as a measure of exocytosis 
only from transfected cells. For these experiments, a single siRNA (siRNA#1) was 
used. Following transfection with hGH plasmid and siRNA#1 (see 2.4.3 and 2.4.4), 
hGH secretion was measured using an ELISA kit (see 2.6.13). The results (Figure 
3.6) show that the basal secretion levels were significantly lower in cells treated with 
CSPα siRNA compared to the control treated with no siRNA. Human growth 
hormone secretion in response to ATP stimulation also showed a significant 
reduction in the cells treated with CSPα siRNA. However, because the effects of 
CSP siRNA on hGH secretion were small, it was decided that the “window” to 
perform rescue experiments was not sufficient, and this was not pursued further. 
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Figure 3.5 Effect of CSPα siRNAs on dopamine accumulation in PC12 cells. Cells were 
transfected with 100 nM CSPα siRNA or non-targeting siRNA (control) for 72 hours. Cells 
were then loaded with [3H]-dopamine at 37°C for 90 minutes. The dopamine content of PC12 
cells was determined by liquid scintillation counting. Error bars show the standard error of 
the mean (n=3). ** indicates a significant decrease (p<0.001) in dopamine content compared 
to cells treated with non-targeting siRNA using a one-way ANOVA test. 
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Figure 3.6: Growth Hormone secretion from PC12 cells treated with CSPα siRNA. 
PC12 cells were incubated for 3 days with 100 nM CSPα siRNA 1. The control had 
transfection reagent only. After 72 hours, cells were incubated for 15 minutes in either Krebs 
buffer or buffer containing 300 μM ATP at room temperature. Thereafter the cells were lysed 
and released and cell-associated hGH was assayed using an ELISA kit. Normalised results 
are expressed as a percentage of hGH release relative to the total cell hGH content. Error 
bars show the standard error of the mean (n=3). ** and *** indicate a significant decrease 
(p<0.001 and p<0.0001, respectively) in growth hormone release compared to control cells 
using a Student’s t-test. 
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3.2.3 Chemical cross-linking experiments reveal that CSPα 
participates in distinct protein-protein interaction following elevation of 
[Ca2+]i 
As previously mentioned, it was suggested that CSPα interacts with HSC70 (Braun 
et al., 1996; Chamberlain and Burgoyne, 1997b), syntaxin (Nie et al., 1999; 
Chamberlain et al., 2001), VAMP (synaptobrevin) (Boal et al., 2004; Weng et al., 
2009) and voltage gated Ca2+ channels (Leveque et al., 1998; Magga et al., 2000). It 
is also known that CSPα dimerizes, although the relevance of these interactions is 
not clear (Swayne et al., 2003; Boal et al., 2004). To further investigate whether 
CSPα function is linked to exocytosis, it was examined whether CSPα participates in 
distinct protein-protein interaction upon cell stimulation. 
For this, chemical cross-linkers were used, which offer the potential to stabilise 
transient protein-protein interactions. To increase intracellular Ca2+ levels ionomycin 
was used, which causes a sustained Ca2+ influx, maximising chances of visualising 
protein-protein interactions. 
Five different cross-linkers where used, which differ in reactive groups and size of 
the spacer arm (Figure 3.7A). Control cells were treated under the same conditions, 
but with no cross-linkers added. After 5 minutes of ionomycin-stimulation the cross-
linkers were added, the cells were incubated for a further 10 minutes at 37°C and 
then incubated for 30 minutes on ice. Thereafter the cross-linkers were quenched for 
15 minutes using 50 mM Tris on ice (2.6.4).  
Cross-linked samples were resolved by SDS-PAGE and examined by 
immunoblotting. Figure 3.7B demonstrates that in addition to monomeric CSPα (~30 
kDa) present in all lanes, distinct bands can be seen with some cross-linkers, which 
represent protein-protein interactions of CSPα. DFDNB cross-links a protein-
complex at ~60 kDa (arrowhead in Figure 3.7B) in both basal and stimulated 
conditions. This appears to be a dimeric form of CSPα, which can also be detected in 
samples not exposed to cross-linker. In addition DSG and EGS treatment resulted in 
the appearance of a cross-linked species (asterisk) specifically in ionomycin-treated 
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Figure 3.7: Chemical cross-linking of CSPα in PC12 cells. A. Table of the 
different chemical crosslinkers and their spacer arm lengths. B. Cells were incubated with or 
without 4 μM ionomycin at 37°C for 5 minutes. Afterwards 2 mM of the various crosslinkers 
were added, incubated for 10 minutes at 37°C and the cells were then incubated on ice for 
30 minutes and quenched for 15 minutes with 50 mM Tris, pH 7.5. Cells were subsequently 
lysed, resolved by SDS-PAGE and transferred to a nitrocellulose membrane, which was 
probed for CSPα. Position of molecular weight standards are shown on the left of panel. This 
experiment was repeated 3 times with similar qualitative results. 
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cells. These protein complexes were detected in three separate experiments that were 
performed. 
These findings show that CSPα participates in protein-protein interactions following 
stimulation which results in Ca2+ influx, promoting regulated secretion. To date, I 
have been unable to determine the composition of the protein complex cross-linked 
by DSG and EGS, and blotting with antibodies against SNAP25, syntaxin, 




3.2.4 Expression of CSPα in cell types that do not have defined 
regulated exocytosis pathways 
CSPα was identified in Drosophila melanogaster (Zinsmaier et al., 1990) and 
surviving null mutants displayed impaired and sluggish movements (Umbach et al., 
1994; Zinsmaier et al., 1994). Furthermore neurotransmitter release was decreased by 
~50 % at 22°C in the mutant embryos and completely abolished at higher 
temperatures. These findings resulted in a more focused research on the role of CSPα 
in regulated exocytosis. 
CSPα is known to be expressed in PC12 cells and in brain, which are specialised in 
regulated exocytosis. To establish if CSPα might also have a cellular function 
unrelated to regulated exocytosis, it was firstly investigated if CSPα is expressed in 
HEK293T and HeLa cells, which have not been reported to have regulated secretory 
pathways. Surprisingly CSPα was found to be expressed at high levels in both 
HEK293T and HeLa cells. Indeed, although CSPα is clearly enriched in brain, 
expression levels were similar in PC12 cells, which are highly specialised for 
regulated exocytosis, and HEK293T cells (Figure 3.8A). In contrast SNAP25, which 
functions in regulated exocytosis in neuronal and neuroendocrine cells, was only 
detected in PC12 cells and brain (Figure 3.8A). The constitutive SNARE protein 
SNAP23 was expressed in the four samples, but was clearly enriched in HEK293T 
and HeLa cells. Expression of CSPα in HeLa cells was confirmed by 
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Figure 3.8: Expression of CSPα in mammalian cell lines. A. Equal amounts (7.5 µg) of 
lysate from PC12 cells, HEK 293T cells, HeLa cells and rat brain samples were resolved by 
SDS-PAGE. Thereafter the gels were either transferred to nitrocellulose membrane and 
probed with CSPα (Stressgen), SNAP25 (Synaptic Systems) or SNAP23 (Synaptic Systems) 
antibodies (top panel) or stained with coomassie blue (bottom panel). Position of molecular 
weight standards are shown on the left. B. HeLa cells and PC12 cells on glass coverslips 
were fixed with 4 % formaldehyde, and permeabilised in PBS containing 0.2 % Triton-X 100 
and 0.3 % BSA for 6 minutes. Cells were then incubated in PBS/0.3 % BSA containing 
polyclonal CSPα antibody (Stressgen) at 1:50 dilution. Cells were then washed and stained 
with anti-rabbit-488 (1:400, PBS/BSA) for 1 hour. Cells were mounted on slides and imaged 
on Zeiss LSM510 laser scanning confocal microscope. Scale bars represent 5 µm. 
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immunofluorescence analysis (Figure 3.8B). Similar to PC12 cells (Figure 3.8, 
bottom panel), CSPa displayed a punctate, vesicular distribution in HeLa cells 
(Figure 3.8, top panel) 
 
 
3.2.5 CSPα depletion in HeLa-C1 cells shows inconsistent results for 
constitutive exocytosis 
Based on the finding that expression of CSPα is not restricted to cells with defined 
regulated exocytosis pathways (see 3.2.4), it was investigated if CSPα also plays a 
role in constitutive exocytosis. In constitutive exocytosis, proteins traffic from the 
endoplasmic reticulum (ER), to the Golgi complex and are then packed into vesicles 
that fuse directly with the plasma membrane (Kelly, 1985). 
Constitutive exocytosis was examined in HeLa-C1 cells, which stably express a 
GFP-tagged ligand-reversible construct (pQCXIP-S1-eGFP-FM4-FCS-hGH), that is 
trapped in the ER, and upon incubation with rapamycin the aggregates solubilise and 
can get secreted through the secretory pathway (see 2.6.10) (Gordon et al., 2010). 
HeLa-C1 cells were imaged 24 hours after subculturing on 30 mm coverslips. Live 
cell imaging was carried out on a wide-field Olympus IX-81 microscope. 1 µM 
rapamycin was added to start the solubilisation of the construct. Figure 3.9 indicates 
that the HeLa-C1 cells were able to secrete the GFP-tagged construct after adding 
rapamycin (t=0). It could be seen that over time the construct moved from the ER 
(dispersed localisation) to the Golgi complex and almost disappeared after 120 
minutes, consistent with their secretion. A quantitative assay of GFP secretion was 
performed again over 240 minutes on 24-well plates to examine if the visual 
disappearance of the construct in Figure 3.9 was due to secretion. Constitutive 
secretion was detected via immunoblotting of cell lysates and the bathing buffer, 
which contained secreted molecules. Initial immunodetection of the GFP-tagged 
construct in the buffer could be visualised after 60 minute incubation with 1 µM 
rapamycin (Figure 3.10A). The control blot demonstrated no detection of the 
pQCXIP-S1-eGFP-FM4-FCS-hGH construct in all three supernatant fractions after 
240 minute incubation without rapamycin. The graph in Figure 3.10B demonstrates 
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Figure 3.9: Visualisation of Constitutive Secretion in HeLa-C1 cells. The HeLa-C1 cell 
line is stably transfected with GFP-tagged pQCXIP-S1-eGFP-FM4-FCS-hGH. The encoded 
protein forms ligand-reversible dimers and is trapped in the endoplasmatic reticulum. These 
dimers are disassembled by rapamycin, which was added (1 µM) at t=0. Following addition 
of rapamycin, cells were imaged on a Olympus IX-81 microscope, 60 x magnification, over a 
period of 120 minutes, with images obtained every 10 seconds, using indentical microscope 
settings at 488 nm excitation. Shown are the images taken every 15 minutes. Rapamycin 
leads to a progressive movement from endoplasmic reticulum to Golgi and a loss of 
fluorescence at later time points, indicating secretion into the cell media. 
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Figure 3.10: Quantitative measurement of constitutive secretion by immunoblotting. 
HeLa-C1 cells were incubated in the presence of 1 µM rapamycin for 15, 30, 60, 120 or 240 
minutes. Control cells were incubated in the absence of 1 µM rapamycin for 240 minutes. 
Intracellular trafficking was stopped at the indicated time points by placing cells on ice. 
Media, containing secreted protein, was transferred into fresh 1.5 ml tubes and the 
remaining cells were lysed. A. secreted and cell-associated proteins were resolved by SDS-
PAGE and transferred to nitrocellulose for immunoblotting analysis with a GFP antibody. B. 
Secreted GFP-tagged construct (supernatant) is expressed as a percentage of the total cell 
content (n=1 experiment in 3 replicates). 
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the quantified immunodetection of constitutive secretion, which is expressed as a 
percentage of the total cell content. Constitutive secretion increases for the first 2 
hours and then remains static between 120 minutes and 240 minutes. The control 
indicates that no release can be detected when no rapamycin is added. 
To examine the role of CSPα in constitutive secretion, an siRNA knockdown 
approach was used. Two different human CSPα siRNA’s (hCSP siRNA) were 
purchased and their ability to knock down CSPα was examined. To verify which 
siRNA concentration leads to optimal knock down, three different concentrations 
were tested (10 nM, 50 nM and 100 nM). Seventy-two hours post transfection the 
cells were lysed and samples resolved by SDS-PAGE, transferred to nitrocellulose 
membrane and protein levels determined by immunoblotting. Visual comparisons of 
the control knock down with non-targeting siRNA and hCSP siRNA showed that all 
concentrations of the two oligos were able to knock down CSPα (Figure 3.11A). The 
SNAP 23 blot served here as a loading control. Quantitative analyses of CSPα knock 
down demonstrated that both oligos at all concentrations tested were able to deplete 
CSPα significantly compared to the control (~ 70 %; Figure 3.11B). However, the 
best knock down results were achieved with 100 nM siRNA with both oligos, where 
80-85 % depletion could be achieved. Henceforward, all experiments involving 
knock down of CSPα in HeLa cells were done at a hCSP siRNA concentration of 
100 nM. 
The involvement of CSPα in constitutive exocytosis was examined in HeLa-C1 cells 
(see 2.6.10). Experiments were performed as described above, except that the 
rapamycin incubation was carried out for 60 and 120 minutes (120 minutes for the 
control (no rapamycin)). Initially, the effects of non-targeting siRNA on constitutive 
exocytosis were examined. The results showed (Figure 3.12A) that the non-targeting 
siRNA had no effect on the secretion compared to the mock-transfection. Figure 
3.12B indicated that constitutive secretion in cells in which CSPα was depleted with 
hCSP siRNA 1 was lower after 60 minutes rapamycin incubation compared to the 
mock-transfection. However, after 120 minutes, secretion in CSPα depleted cells 
was similar to mock-transfected cells.  
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Figure 3.11: siRNA-mediated depletion of CSPα in HeLa cells. HeLa cells were 
incubated with 10 nM, 50 nM and 100 nM of two siRNA molecules directed against distinct 
regions of human CSPα (see table 2.2) or with non-targeting siRNA as control. 72 hours post 
transfection, the cells were lysed, resolved by SDS-PAGE and transferred to nitrocellulose 
for immunoblotting analysis with a CSPα antibody (Stressgen) or SNAP23 (Synaptic 
Systems) antibody as loading control. A. CSPα and SNAP23 levels in siRNA treated cells 
from a single experiment. B. CSPα levels were quantified in control and siRNA treated cells 
(n=4 from 2 independent experiments). *** indicates a significant decrease (p<0.0001) in 
CSPα expression compared to control cells using a one-way ANOVA test. 
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Figure 3.12: Quantitation of constitutive exocytosis in HeLa-C1 cells treated with 
CSPα siRNA.  
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Figure 3.12: Quantification of constitutive exocytosis in HeLa-C1 cells treated with 
CSPα siRNA. siRNA treated (hCSP 1,2 or 3), non-targeting siRNA (NT si) or mock-
transfected (No si) cells were incubated without (control) or with 1 µM rapamycin for 60 or 
120 minutes. Intracellular trafficking was stopped by placing the cells on ice and media 
containing cell proteins was removed into fresh 1.5 ml tubes and the remaining cells were 
lysed. Secreted and cell-associated proteins were resolved by SDS-PAGE and transferred to 
nitrocellulose for immunoblotting with a monoclonal GFP (JL8, Living Colours) antibody (left 
panels). Position of molecular weight markers are shown on the left. The graphs (right 
panels) show secretion expressed as a percentage of the total cell content in cells treated 
with CSPα siRNA compared to the mock-transfected cells. ● (No siRNA; no rapamycin), ■ 
(NT or hCSP siRNA 1, 2 or 3; no rapamycin), ▲ (No siRNA; treated with rapamycin),  (NT 
or hCSP siRNA 1, 2 or 3; treated with rapamycin). Note ● (No siRNA; no rapamycin) cannot 
be seen as ■ (NT or hCSP siRNA 1, 2 or 3; no rapamycin) covers the symbol. 
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In cells were CSPα knock down occurred through hCSP siRNA 2 transfection, 
constitutive secretion was slightly greater than in the control cells after 60 minutes 
and 120 minutes (Figure 3.12C). As results obtained with oligos #1 and #2 were 
different, a third hCSP siRNA was obtained. Figure 3.12D shows that secretion in 
cells treated with hCSP siRNA 3 was initially lower than for the mock-transfected 
cells (60 minutes), but was slightly higher compared to the control cells at 120 
minutes. Overall, the results found no consistent effect of CSPα depletion on 




Here it was shown that CSPα expression levels could be depleted by ~80 % in PC12 
cells (Figure 3.2) and that all four commercial siRNAs were effective to a similar 
extent. Depletion of CSPα in this manner had no consistent effect on expression 
levels of the important SNARE proteins syntaxin, SNAP25 and synaptobrevin 
(VAMP). In the CSPα knock out mouse, no change in syntaxin and VAMP levels 
were noted but SNAP25 levels were reduced by ~50 % (Fernandez-Chacon et al., 
2004; Chandra et al., 2005). The lack of effect of CSPα depletion on SNAP25 levels 
in PC12 cells (Figure 3.3) may be due to the fact that CSPα expression in the knock 
out mouse is completely abolished (Chandra et al., 2005), whilst here there is still a 
residual amount of ~20 % of CSPα in PC12 cells; a complete abolishment of CSPα 
in PC12 cells might be needed to see any effect on SNAP25 expression. It is also 
possible that a longer time frame of CSPα reduction is required to see an effect on 
SNAP25 levels. 
The lack of effect on neuronal exocytosis in the CSPα null mice is inconsistent with 
previous over-expression studies in non-neuronal cells, including PC12 cells, 
chromaffin cells and pancreatic beta cells (Chamberlain and Burgoyne, 1998; Zhang 
et al., 1998; Graham and Burgoyne, 2000). Thus, we employed knockdown of CSPα 
to more directly examine the importance of this protein for regulated exocytosis in 
PC12 cells. CSPα depletion significantly reduced regulated secretion of 3H 
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dopamine by about ~15-20 %. This supports the notion that CSPα plays a regulatory 
role in regulated exocytosis in PC12 cells (Chamberlain and Burgoyne, 1998). 
Although effects on exocytosis were modest, a higher reduction in CSPα expression 
levels (> 80 %) might be predicted to further inhibit exocytosis. To reach a more 
complete depletion of CSPα in PC12 cells small hairpin RNA (shRNA) could be 
used to generate stable cell lines. With the prolonged expression of shRNA it may be 
possible to get a more pronounced reduction in CSPα levels, which might also lead 
to a reduction in SNAP25 levels, like that seen in the CSPα knock out mouse 
(Chandra et al., 2005). If a greater effect of CSPα knockdown on exocytosis could 
be achieved, it would be interesting to look at the fundamental role of domains of 
CSPα, such as the N- and C-termini, linker domain, J-domain and the cysteine string 
domain. By “rescuing” exocytosis with such mutants in cells depleted of endogenous 
CSPα, it will be possible to test the importance of these domains of CSPα in 
exocytosis and by inference which protein-protein interactions of CSPα might be 
functionally relevant (Bronk et al., 2005). 
It is possible that more pronounced effects of CSPα reduction on exocytosis may 
become apparent following repeated rounds of exocytosis/endocytosis. This may be 
particularly relevant if CSPα has a chaperone function in this pathway, regulating 
protein folding during vesicle dynamics. It may be possible to test this idea in future 
experiments by measuring exocytosis in CSP-depleted PC12 cells following multiple 
cell stimulation/recovery procedures.  
It has been reported that around 3 copies of CSPα are on each vesicle (Takamori et 
al., 2006), which suggest that the siRNA knock down, which achieved a depletion of 
~80 %, was not efficient enough for a rigorous effect in regulated exocytosis and that 
one copy of CSP might be sufficient to compensate for the loss of the other copies 
and still be a functional factor for successful regulated secretion.  
As a further way to assess whether CSPα might function in regulated exocytosis, it 
was examined if intracellular Ca2+ elevation (the trigger for regulated exocytosis) 
promoted interactions of CSPα with other cellular proteins. It was found that during 
ionomycin stimulation, CSPα was cross-linked to an unidentified protein by the 
cross-linkers DSG and EGS (Figure 3.7). Another cross-linker DFDNB, cross-linked 
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a band that was observed both before and after stimulation. In this case the band 
might be a CSPα-dimer. It is known that CSPα forms dimers in resting cells, but 
shows an increase in homodimerisation during stimulation (Boal et al., 2004). It 
would be interesting to further investigate which proteins are cross-linked to CSPα 
during stimulation. This could be achieved by screening several proteins by 
immunoblotting. Another approach would be to excise the band out from the SDS-
gel and identify the cross-linked proteins via mass spectroscopy.  
As already mentioned, CSPα might function in other pathways in addition to 
regulated exocytosis. Figure 3.8 shows that CSPα is expressed in HEK293T and 
HeLa cells, suggesting again that CSPα function might not be restricted to regulated 
secretion. HeLa and HEK293T cells are not thought to have well-defined regulated 
secretory pathways. This is supported in Figure 3.8 showing that SNAP25 is not 
detected in these cells, which is a specific indicator for regulated exocytosis in 
neurons (Oyler et al., 1989; Tao-Cheng et al., 2000; Washbourne et al., 2002). 
Moreover, SNAP23 is clearly enriched in HeLa and HEK293T cells, which regulates 
a wide variety of diverse membrane-membrane fusion events outside neuronal and 
neuroendocrine cells (Ravichandran et al., 1996). As CSPα is expressed in HeLa and 
HEK293T cells at comparable levels to that in PC12 cells, it was possible that CSPα 
has an important function that is universal. Therefore the possible role of CSPα in 
constitutive exocytosis (which occurs in all cell types) was examined in HeLa cells 
through siRNA-mediated depletion of CSPα in HeLa-C1 cells (3.6). However, the 
results obtained were inconsistent, and depletion of CSPα showed an increase in 
constitutive secretion (Figure 3.12C), a decrease (Figure 3.12B) or no obvious 
change (Figure 3.12D) using three different siRNAs. Thus, the outcome of this 
experiment revealed no clear involvement of CSPα in constitutive exocytosis. It may 
be that the depletion of CSPα was not sufficient to have a major effect on 
constitutive exocytosis. Indeed, oligo 1, which achieved the highest knock down, 
showed a reduction in constitutive secretion and might indicate a role for CSPα in 
constitutive exocytosis (Figure 3.12 B). Therefore, to achieve a more reliable result 
for CSPα function in constitutive exocytosis, a stable cell line of HeLa-C1 cells, 
which expresses small hairpin RNA, could be used to silence the CSPα gene 
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expression continuously and more effectively (Siolas et al., 2005). It is interesting to 
note that siRNA screens to identify R-SNARE proteins that regulate constitutive 
exocytosis in this cell type have also been unsuccessful (Gordon et al., 2010). This 
may indicate the requirement for a complete knockout of certain proteins to perturb 
this pathway. 
Although here we found no effect of CSPα in constitutive exocytosis in HeLa and 
HEK293T cells, future work could examine the effects of CSPα knock down in these 











ANALYSIS OF EXPRESSION LEVELS OF CSPα AND INTERACTING 
PARTNERS IN POST-MORTEM BRAIN SAMPLES FROM PATIENTS 
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4.1 Introduction 
Perturbations in neuronal pathways and chemical imbalances in the brain are thought 
to contribute to a wide range of mental illnesses and neuronal disorders. There is a 
major effort to identify genetic alterations associated with specific disorders to 
provide a molecular description of changes that lead to brain dysfunction. Mutations 
or single nucleotide polymorphisms in protein coding sequences of genes can lead to 
disruption of protein function. In addition, mutations occurring in non-coding regions 
can lead to changes in protein expression or gene splicing. On top of primary 
disease-associated genetic mutations, there are also likely to be numerous 
downstream compensatory changes that occur in the expression of other proteins. 
Thus, deciphering the precise changes that are associated with disease phenotype is a 
major challenge. 
Changes in neuronal communication are likely at the heart of several brain disorders, 
and therefore there is merit in analysing changes in the expression of the 
neurotransmitter release machinery in different disease states. It has been previously 
shown that mutation or deletion of certain proteins present at the active zone and 
involved in neurotransmitter release resulted in mental disorder phenotypes in mice. 
One of these proteins is RIM1α, which is required for presynaptic long-term 
potentiation (LTP) in hippocampus and cerebellum. RIMα-/- mice exhibit 
behavioural endophenotypes associated with schizophrenia and deficits in social 
behaviour (Powell et al., 2004; Blundell et al., 2010). In addition, recent studies have 
shown that alterations in the mRNA and protein expression levels of SNARE 
proteins and interacting partners are associated with mental disorders (Johnson et al., 
2008): single nucleotide polymorphisms of syntaxin, synaptotagmin and SNAP25 
(‘blind-drunk’ mutant mice) have been linked to schizophrenia. Furthermore it could 
be shown that a transgenic schizophrenia mouse model, which expresses a C-
terminal truncation of hDISC1 (human disrupted-in-schizophrenia 1), has 
significantly reduced SNAP25 expression levels (Jeans et al., 2007; Pletnikov et al., 
2008). Another protein that is associated with the SNARE proteins and implicated in 
mental disorders is complexin-2 (Sawada et al., 2002). Complexin-2 knock out mice 
display schizophrenia-like behavioral phenotypes, but only after an enviromental 
traumatic experience during puberty (e.g. mild parietal neurotrauma) (Radyushkin et 
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al., 2010). Interstingly a recent human genetic study has identified a single 
nucleotide polymorphism in complexin-2 of patients with schizophrenia (Begemann 
et al., 2010). Together, these phenotypic abnormalities in mouse mutants of SNARE 
proteins and interacting partners suggest that defects in exocytosis might be a 
prevalent underlying cause of specific mental disorders. 
Three brain disorders that are of particular interest are major depression, bipolar 
disorder and schizophrenia. In table 1 these neuropsychiatric disorders and their 
characteristics are summarised (Nikolaus et al., 2009; Brennaman and Maness, 
2010). Major depressive disorder is characterised by recurrent major depressive 
episodes, consisting of severely depressed mood persisting for at least for 2 weeks. 
These episodes may be isolated or recurrent and are categorised as mild, moderate, or 
severe (Kennedy, 2008). Various hypotheses have been put forward to account for 
the pathogenesis of major depressive disorder. One hypothesis suggests that interplay 
between genetics, psychological and social factors plays a role in the development of 
depression, but the precise causes may vary considerably dependent on individual 
circumstances. Other hypotheses propose that neuroendocrine function and/or 
neuroanatomy are changed (Manji et al., 2001; Sierksma et al., 2010). In general the 
prefrontal cortex, amygdala and medial thalamus are thought to be particularly 
important in the pathophysiology (Drevets and Raichle, 1992). Modulation of 
neuroendocrine function is thought to centre on changes in monoamines, in particular 
serotonin  
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Table 4.1: Summary of neuropsychiatric disorder characteristics. 
Disorder Age of onset Neurotransmitter(s) Affected Brain 
region(s) 









Schizophrenia Late adolescence, 
early adulthood 
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(5-hydroxytryptamine), norepinephrine (noradrenaline) and dopamine (Di Giovanni 
et al., 2006; Nutt, 2006). Indeed, monoamine oxidase inhibitors which prolong 
functional half-life, and selective serotonin reuptake inhibitors (SSRIs), which 
promote increased levels of serotonin at synapses (Burke et al., 1997; Amsterdam, 
1998), are frequently administered as antidepressants. 
Bipolar disorder (also referred to as bipolar depression or manic depression) is 
normally characterised by depressive phases alternating with periods of mania 
(persistent feelings of sadness, insomnia, euphoria and rage) (Kruger and Prager, 
2007). Again, interplay between environmental and genetic factors seems to be the 
underlying trigger for bipolar disorder. Interestingly, genetic studies have implicated 
a variety of genes that regulate metabolism of transmitters including serotonin, 
glutamate and dopamine (Kato, 2007). There are a variety of pharmacological 
treatments used for bipolar disorder including antidepressants and mood stabilisers, 
such as lithium. 
Schizophrenia is a chronic mental disorder with a global prevalence of 1-5 % (Young 
et al., 2010) and is characterised by a variety of symptoms, which lead to severe 
social dysfunctions. To date there are five major subtypes of schizophrenia that are 
distinguished by their symptoms, which includes delusions and hallucinations, 
thought disorder, immobilisation and agitated movement (McGlashan and Fenton, 
1991). In some cases there are also links to major depression, such as “post-
schizophrenic depression”, where patients have depressive episodes with low-level 
schizophrenic symptoms present after a phase of acute schizophrenia. Another 
condition is “schizoaffective disorder”, which is characterised by both symptoms 
displayed at the same time, schizophrenia and manic depressive episodes (Malhi et 
al., 2008). According to the present classification, symptoms in general must have 
been present for at least one month in a period of six months of disturbed 
functioning. To date, the pathogenesis of schizophrenia is not well understood. 
Evidence suggest that genetic, psychological and/or environmental factors may act 
together (Corcoran et al., 2003; Harrison and Owen, 2003). Similar to major 
depression and bipolar disorder, the neurotransmitter dopamine has been implicated 
in the pathophysiology of schizophrenia. This link is based on the positive effects of 
 
 - 134 -
drugs that block dopamine function, as well as effects of amphetamines (which 
trigger the release of dopamine), which can lead to schizophrenic symptoms (Seeman 
and Lee, 1975; Toda and Abi-Dargham, 2007). 
Given the link between neurotransmitter release and development of these mental 
disorders, several studies have investigated how components of the neurotransmitter 
release machinery are affected in these conditions, or how drug treatments affect 
protein expression. The mood stabiliser lithium, which has been used in the treatment 
of major depression and bipolar disorder (Schou, 1997), has been shown to promote 
a significant increase in regulated neurotransmitter release (e.g. dopamine and 
serotonin) (Hesketh et al., 1978; Maggi and Enna, 1980; Treiser et al., 1981; 
Staunton et al., 1982; Ebstein et al., 1983; Wang and Friedman, 1989). Indeed, 
lithium enhances CSPα gene expression in nerve growth factor (NGF) differentiated 
PC12 cells as well as in rat brain (Cordeiro et al., 2000), together with a coordinated 
up-regulation of secretory granule proteins (Codeiro, 2000b). 
Several reports have examined expression levels of secretory proteins in post-
mortem brain samples from patients suffering from mental disorders. However, 
CSPα has not been analysed. Here, we were able to gain access to human post-
mortem brain samples from patients suffering from major depression, bipolar 
disorder and schizophrenia. Following on from the work Cordeiro et al. (2000) it was 
analysed if there were any differences in CSPα expression in these patients compared 
with controls. In addition, expression of the CSPα-interacting partners α-synuclein, 
HSP70, syntaxin and synaptotagmin I were examined. As CSPα and HSP70 are 
important molecular chaperones, this analysis was extended to examine expression 
levels of the general heat shock chaperone proteins HSP60 and HSP90.  
 
4.2 Results 
4.2.1 Human post-mortem samples 
Human post-mortem samples were obtained from the Edinburgh Brain Bank. 
Anonymised details of the source of the brain material, including age, gender, post- 
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Table 4.2: Anonymised details of the human post-mortem control patients. PMI stands 
for post mortem interval (hours). 
Patients 
Category 
Gender Age PMI (h) Cause of Death Neuropath 
Diagnosis 
Control Male 53 44 Combined effects 
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Table 4.3: Anonymised details of the human post-mortem depression patients. PMI 
stands for post mortem interval (hours). 
Patients 
Category 
Gender Age PMI (h) Cause of Death Neuropath 
Diagnosis 
Depression Male 57 66 Multiple injuries. 
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Table 4.4: Anonymised details of the human post-mortem schizophrenia patients. PMI 
stands for post mortem interval (hours). 
Patients 
Category 
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Table 4.5: Anonymised details of the human post-mortem bipolar patients. PMI stands 
for post mortem interval (hours). 
Patients 
Category 
Gender Age PMI (h) Cause of Death Neuropath 
Diagnosis 



























tangles in locus 
coeruleus. 
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Table 4.6: Average age, gender ratio and PMI (post mortem interval (hours)) of human 
post-mortem depression, schizophrenia and bipolar samples. Using a Student’s t-test 
revealed that the PMI of bipolar patients was significantly higher (*, p<0.05) compared to 
control samples. 
Disorder Average Age Male/Female 
Ratio 
Average PMI 
Control 52.83 (± 6.71) 6/0 52.33 (± 5.68) 
Depression 42.5 (± 7.3) 3/3 59.33 (± 7.33) 
Schizophrenia 47.83 (± 4.67) 5/1 63.17 (± 9.38) 
Bipolar 42.4 (± 5.41) 2/3 86.2* (± 10.01) 
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mortem interval (PMI), cause of death and neuropathology diagnosis are given in 
tables 2-5. Table 6 shows the average age, PMI and gender ratio. A Student’s t-test 
revealed that the mean post mortem interval (PMI) of bipolar patients was 
significantly increased compared to control patients (p< 0.05). No other significant 
differences in the patient samples were recorded. 
 
4.2.2 Samples from patients with major depression displayed a 
significant reduction of syntaxin expression in cortex compared with 
controls 
To examine expression of CSPα and other proteins in mental illnesses, equal 
amounts of post mortem brain region lysates were resolved by SDS-PAGE. Proteins 
were then transferred to a nitrocellulose membrane and analysed by immunoblotting. 
Relative expression levels were quantified by densitometry and the highest value was 
arbitrarily set to 100 %, with all other values expressed relative to this. To limit gel-
to-gel variability, each set of samples was run three times and average values for 
relative expression were calculated. These values were used to calculate average 
protein expression for each disorder in four brain regions relative to control. 
Figure 4.2 shows that syntaxin expression was significantly decreased from ~90 % 
(control) to ~60 % in cortex of patients with major depressive disorder (Student’s T-
test, p<0.05). A scatter plot showing syntaxin expression levels in the cortex of 
individual patients is presented in Figure 4.3C. In contrast, statistical analysis 
revealed no significant differences in the expression of any proteins in cerebellum 
(Figure 4.1), hippocampus (Figure 4.3) and thalamus (Figure 4.4) from patients with 
major depression. 
 
4.2.3 Patients with schizophrenia showed no significant change in 
protein expression levels compared with controls 
Figures to 4.5-4.8 show quantified expression levels relative to controls in brain 
regions from schizophrenic patients. No significant differences were detected for any 
of these samples.  
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Figure 4.1: Protein expression in Cerebellum in depression disorder. Human brain 
samples were lysed, samples resolved by SDS-PAGE and transferred to nitrocellulose 
membranes, which were then probed with specific CSPα, α-Synuclein, HSP70, HSP60, 
HSP90, Synaptotagmin 1 and Syntaxin 1 antibodies. A. Shows representative immunoblots. 
Position of molecular weight standards are shown on the left of panels. B. Relative protein 
expression levels were quantified as described in section 4.2.2. Error bars show the 
standard error of the mean (n=3). Multiple Student’s t-tests revealed no significant difference 
in the expression of any protein in depression compared to control patients. 
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Figure 4.2: Protein expression in Cortex in depression disorder. Human brain samples 
were lysed, samples resolved by SDS-PAGE and transferred to nitrocellulose membranes, 
which were then probed with specific CSPα, α-Synuclein, HSP70, HSP60, HSP90, 
Synaptotagmin 1 and Syntaxin 1 antibodies. A. Shows representative immunoblots. Position 
of molecular weight standards are shown on the left of panels. B. Relative protein expression 
levels were quantified as described in section 4.2.2. Error bars show the standard error of 
the mean (n=3). * indicates a significant decrease (p<0.05) in syntaxin expression in 
depression which was compared to control samples using a Student’s t-test. C. The scatter 
plot shows the normalised Syntaxin 1 expression levels in cortex of individual depression 
patients. 
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Figure 4.3: Protein expression in Hippocampus in depression disorder. Human brain 
samples were lysed, samples resolved by SDS-PAGE and transferred to nitrocellulose 
membranes, which were then probed with specific CSPα, α-Synuclein, HSP70, HSP60, 
HSP90, Synaptotagmin 1 and Syntaxin 1 antibodies. A. Shows representative immunoblots. 
Position of molecular weight standards are shown on the left of panels. B. Relative protein 
expression levels were quantified as described in section 4.2.2. Error bars show the 
standard error of the mean (n=3). Multiple Student’s t-tests revealed no significant difference 
in the expression of any protein in depression compared to control patients. 
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Figure 4.4: Protein expression in Thalamus in depression disorder. Human brain 
samples were lysed, samples resolved by SDS-PAGE and transferred to nitrocellulose 
membranes, which were then probed with specific CSPα, α-Synuclein, HSP70, HSP60, 
HSP90, Synaptotagmin 1 and Syntaxin 1 antibodies. A. Shows representative immunoblots. 
Position of molecular weight standards are shown on the left of panels. B. Relative protein 
expression levels were quantified as described in section 4.2.2. Error bars show the 
standard error of the mean (n=3). Multiple Student’s t-tests revealed no significant difference 
in the expression of any protein in depression compared to control patients. 
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Figure 4.5: Protein expression in Cerebellum in schizophrenia disorder. Human brain 
samples were lysed, samples resolved by SDS-PAGE and transferred to nitrocellulose 
membranes, which were then probed with specific CSPα, α-Synuclein, HSP70, HSP60, 
HSP90, Synaptotagmin 1 and Syntaxin 1 antibodies. A. Shows representative immunoblots. 
Position of molecular weight standards are shown on the left of panels. B. Relative protein 
expression levels were quantified as described in section 4.2.2. Error bars show the 
standard error of the mean (n=3). Multiple Student’s t-tests revealed no significant difference 
in the expression of any protein in schizophrenia compared to control patients. 
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Figure 4.6: Protein expression in Cortex in schizophrenia disorder. Human brain 
samples were lysed, samples resolved by SDS-PAGE and transferred to nitrocellulose 
membranes, which were then probed with specific CSPα, α-Synuclein, HSP70, HSP60, 
HSP90, Synaptotagmin 1 and Syntaxin 1 antibodies. A. Shows representative immunoblots. 
Position of molecular weight standards are shown on the left of panels. B. Relative protein 
expression levels were quantified as described in section 4.2.2. Error bars show the 
standard error of the mean (n=3). Multiple Student’s t-tests revealed no significant difference 
in the expression of any protein in schizophrenia compared to control patients. 
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Figure 4.7: Protein expression in Hippocampus in Schizophrenia disorder. Human 
brain samples were lysed, samples resolved by SDS-PAGE and transferred to nitrocellulose 
membranes, which were then probed with specific CSPα, α-Synuclein, HSP70, HSP60, 
HSP90, Synaptotagmin 1 and Syntaxin 1 antibodies. A. Shows representative immunoblots. 
Position of molecular weight standards are shown on the left of panels. B. Relative protein 
expression levels were quantified as described in section 4.2.2. Error bars show the 
standard error of the mean (n=3). Multiple Student’s t-tests revealed no significant difference 
in the expression of any protein in schizophrenia compared to control patients. 
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Figure 4.8: Protein expression in Thalamus in Schizophrenia disorder. Human brain 
samples were lysed, samples resolved by SDS-PAGE and transferred to nitrocellulose 
membranes, which were then probed with specific CSPα, α-Synuclein, HSP70, HSP60, 
HSP90, Synaptotagmin 1 and Syntaxin 1 antibodies. A. Shows representative immunoblots. 
Position of molecular weight standards are shown on the left of panels. B. Relative protein 
expression levels were quantified as described in section 4.2.2. Error bars show the 
standard error of the mean (n=3). Multiple Student’s t-tests revealed no significant difference 
in the expression of any protein in schizophrenia compared to control patients. 
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Although CSPα mean expression was decreased by ~50% in hippocampus in 
schizophrenia, this was not found to be significant different (Figure 4.7). 
 
4.2.4 Significant changes in HSP70 and syntaxin expression in bipolar 
disorder 
Analysis of protein expression levels in brain regions of patients with bipolar 
disorder revealed no significant changes in cerebellum (Figure 4.9) or thalamus 
(Figure 4.12). However, HSP70 levels were significantly increased in cortex (Figure 
4.10, ~2 fold increase; scatter plot shown in Figure 4.10C) and hippocampus (Figure 
4.11, ~1.8 fold increase; scatter plot shown in Figure 4.11C). Interestingly, as with 
major depression, syntaxin expression was decreased in cortex in bipolar patients 
(Figure 4.10, ~1.6 fold decrease; scatter plot shown in Figure 4.10D). 
 
4.3 Discussion  
In this Chapter, the expression levels of CSPα and interacting partners in post-
mortem brain samples were examined. Whilst CSPα expression levels were 
markedly reduced in some brain regions from mental disorder patients (e.g. 
cortex/depression, hippocampus/schizophrenia and cerebellum/bipolar), these 
changes did not reach statistical significance. As the sample sizes used (6 
patients/condition) were relatively small it would therefore be interesting in future 
studies to investigate whether CSPα expression is significantly different using larger 
populations. Interestingly though, significant changes in the expression levels of 
HSP70 and syntaxin, interacting partners of CSPα (Chamberlain and Burgoyne, 
1997a; Chamberlain et al., 2001), were detected in specific disorders and brain 
regions. HSP70 expression was significantly increased in both the hippocampus 
(p<0.005) and cortex (p<0.05) of samples from patients with bipolar disorder. 
Syntaxin 1 was also perturbed in cortex samples from bipolar patients, showing a 
significant decrease in expression. Furthermore the levels of this protein were also 
significantly decreased in samples from patients who had been diagnosed with major 
depression 
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Figure 4.9: Protein expression in Cerebellum in Bipolar disorder. Human brain samples 
were lysed, samples resolved by SDS-PAGE and transferred to nitrocellulose membranes, 
which were then probed with specific CSPα, α-Synuclein, HSP70, HSP60, HSP90, 
Synaptotagmin 1 and Syntaxin 1 antibodies. A. Shows representative immunoblots. Position 
of molecular weight standards are shown on the left of panels. B. Relative protein expression 
levels were quantified as described in section 4.2.2. Error bars show the standard error of 
the mean (n=3). Multiple Student’s t-tests revealed no significant difference in the expression 
of any protein in bipolar compared to control patients. 
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Figure 4.10: Protein expression in Cortex in Bipolar disorder. Human brain samples 
were lysed, samples resolved by SDS-PAGE and transferred to nitrocellulose membranes, 
which were then probed with specific CSPα, α-Synuclein, HSP70, HSP60, HSP90, 
Synaptotagmin 1 and Syntaxin 1 antibodies. A. Shows representative immunoblots. Position 
of molecular weight standards are shown on the left of panels. B. Relative protein expression 
levels were quantified as described in section 4.2.2. Error bars show the standard error of 
the mean (n=3). * indicates a significant decrease (p<0.05) in syntaxin and significant 
increase in HSP70 expression in bipolar disorder, which was compared to control samples 
using a Student’s t-test. C-D. The scatter plots show the normalised HSP70 (C) and Syntaxin 
1 (D) expression levels in cortex of individual bipolar disorder patients. 
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Figure 4.11: Protein expression in Hippocampus in Bipolar disorder. Human brain 
samples were lysed, samples resolved by SDS-PAGE and transferred to nitrocellulose 
membranes, which were then probed with specific CSPα, α-Synuclein, HSP70, HSP60, 
HSP90, Synaptotagmin 1 and Syntaxin 1 antibodies. A. Shows representative immunoblots. 
Position of molecular weight standards are shown on the left of panels. B. Relative protein 
expression levels were quantified as described in section 4.2.2. Error bars show the 
standard error of the mean (n=3). ** indicates a significant increase (p<0.005) in HSP70 
expression in bipolar disorder, which was compared to control samples using a Student’s t-
test. C. The scatter plot shows the normalised HSP70 expression levels in hippocampus of 
individual bipolar disorder patients. 
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Figure 4.12: Protein expression in Cortex in Bipolar disorder. Human brain samples 
were lysed, samples resolved by SDS-PAGE and transferred to nitrocellulose membranes, 
which were then probed with specific CSPα, α-Synuclein, HSP70, HSP60, HSP90, 
Synaptotagmin 1 and Syntaxin 1 antibodies. A. Shows representative immunoblots. Position 
of molecular weight standards are shown on the left of panels. B. Relative protein expression 
levels were quantified as described in section 4.2.2. Error bars show the standard error of 
the mean (n=3). * indicates a significant decrease (p<0.005) in syntaxin expression in bipolar 
disorder which was compared to control samples using a Student’s t-test. C. The scatter plot 
shows the normalised Syntaxin 1 expression levels in thalamus of the individual bipolar 
disorder patients. 
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Importantly, the cortex and hippocampus are the brain regions that are typically 
affected in depression and bipolar disorder (Nikolaus et al., 2009; Brennaman and 
Maness, 2010) and are areas responsible for behaviour. Thus, the specific changes 
seen in HSP70 and syntaxin in these brain regions are of particular interest.  
Why are syntaxin and HSP70 levels altered in these disorders? There are several 
possibilities to explain these observations: (i) expression is affected by genetic 
mutations; (ii) the proteins are up- or down-regulated as an adaptive response; or (iii) 
medication taken by the patients has affected the expression of these proteins. HSP70 
is a chaperone, which has a multitude of cellular functions, many of which are 
achieved by interacting with co-chaperones, such as CSPα. HSP70 supports the 
folding of newly synthesised proteins, subcellular transport of proteins and vesicles, 
and degradation of unwanted proteins (Bercovich et al., 1997; Frydman, 2001; 
Schaffitzel et al., 2001; Pratt and Toft, 2003). HSP70 is also up-regulated in response 
to stress and binds to its protein substrates and stabilises them against aggregation or 
denaturation. Indeed, HSP70 levels are frequently elevated in multiple forms of 
cancer (Mosser and Morimoto, 2004) and neurodegenerative diseases, in which 
protein misfolding can occur as a result of oxidative stress (Kirkegaard et al., 2010). 
In fact, receantly it has been reported that mitochondrial dysfunction is observed in 
psychiatric disorders, such as schizophrenia, major depressive and bipolar disorder 
(Rezin et al., 2009). Mitochondrial dysfunction accounts for either apoptosis or 
generation of reactive oxygen species (ROS), which leads to oxidative stress and 
contributes to the pathophysiology of mood disorders (Ozcan et al., 2004; Sarandol 
et al., 2007). The increased expression of HSP70 specifically in bipolar disorder 
might therefore point to a difference in cellular stress in this condition compared with 
major depression and schizophrenia. One interesting aspect of HSP70 is that it forms 
multiprotein complexes with its co-chaperones (Wall et al., 1994), which are 
responsible for its activities (Suh et al., 1998; Mayer and Bukau, 2005; Swain et al., 
2007). Future work should reveal if its co-chaperones are also affected in mood 
disorders, such as other J-domain proteins, nucleotide exchange factors (NEFs) 
and/or tetratricopeptide repeat (TPR)-containing proteins, or heat shock chaperones 
in general. Due to the fact that oxidative stress contributes to mood disorders it 
would also be interesting to look at any changes in other stress-related proteins. 
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Finally, it is particularly important to note that recent work reported that HSP70 
levels were raised in patients, who have taken antidepressants (Guest et al., 2004). 
Unfortunately, here we were not able to obtain any information on patient medication 
intake.  
 
Bipolar disorder, also known as manic-depressive disorder, is linked to depression, 
due to the fact that depression is implied after an episode of euphoria (Kruger and 
Prager, 2007). Therefore it is particularly interesting that syntaxin 1 expression was 
significantly reduced in cortex in both depression and bipolar disorder (35% and 
30% respectively, Figure 4.2 and Figure 4.10). In addition to its essential function in 
exocytosis, syntaxin has also been shown to interact with serotonin transporters 
(Haase et al., 2001), which play a critical role in the maintenance of normal serotonin 
levels and release. Indeed, serotonin secretion has been shown to be abnormal in 
bipolar disease and major depression. Previous work on post-mortem samples of 
patients with schizophrenia has shown quantitative abnormalities of syntaxin in 
cortex (Gabriel et al., 1997; Honer et al., 1997; Honer et al., 2002). In contrast, our 
results showed no significant change in syntaxin levels in schizophrenic disorder, 
which nevertheless agree with a more recent publication (Castillo et al., 2010).  
It was previously observed that caseine kinase 2 (CK2) levels were decreased in 
patients with Alzheimer disease and schizophrenia (Aksenova et al., 1991). CK2 has 
been shown to phosphorylate syntaxin 1 on Ser14 (Hirling and Scheller, 1996; Foletti 
et al., 2000), and phosphorylation at this site regulates interactions with SNAP25 and 
Munc18 (Foletti et al., 2000; Castillo et al., 2010). Furthermore it has been reported 
that regulation of syntaxin 1 by CK2-mediated phosphorylation might play a role in 
the pathophysiology of schizophrenia, as altered phosphorylation of syntaxin 1 was 
detected in post-mortem brain samples of patients with schizophrenia disorder 
(Castillo et al., 2010). Therefore in future studies it would be interesting to look at 
the phosphorylation status of syntaxin in depression and bipolar disorder.  
Mental disorders have been linked to abnormalities in neurotransmitter release and 
over recent years it has been hypothesised that SNARE proteins, which serve a 
fundamental molecular mechanism to support neurotransmission (Sollner et al., 
1993a; Sollner et al., 1993b) and might be responsible for abnormal neuronal 
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connectivity, play a role in mental disorders (Jorgensen and Riederer, 1985; 
Johnston-Wilson et al., 2000; Eastwood and Harrison, 2001). Several publications 
have suggested that SNAP25 expression is altered in schizophrenia, with levels 
either decreased (hippocampus) or increased (cortex) (Gabriel et al., 1997; 
Thompson et al., 1998; Young et al., 1998; Mukaetova-Ladinska et al., 2002; Halim 
et al., 2003; Thompson et al., 2003a; Thompson et al., 2003b). Meta-Analysis of 
genome–wide linkage for schizophrenia showed significant linkage to the 
chromosomal region 20p12.3-11, which also contains SNAP25. Recently two genetic 
mouse models (hDISC transgenic mice and I67T missense in blind-drunk mutant 
mouse) have supported the involvement of SNAP25 in schizophrenia (Jeans et al., 
2007; Pletnikov et al., 2008).  
The data generated in this chapter showed general inconsistency in protein 
expression levels. All experiments were performed at least three times and six 
control and disorder patients were compared each time; however, this data is not 
sufficient to make robust conclusions about any protein and its effect in mental 
disorders. The only protein profiling that can be done to date is to study pathological 
processes in human brain in post-mortem brain tissues. This approach however, 
depends on high-quality representative selection of tissue samples to control for 
differences related to individuals, post-mortem handling of the tissue, effects of 
chronic medication, etc. The significant longer post mortem interval in bipolar 
patients compared to control patients has to be taken in account here. It might be that 
over time protein levels change due to post-mortem effects rather than disease 
pathology. Another aspect of our observed non-significant alterations in protein 
expression levels was probably due to the small number of patients that were 
analysed. Many examinations of post-mortem patients have been done with a much 
greater sample size, e.g. between 240 and 280 patients (Pae et al., 2009). Future 
work potentially has to be done on animal models to fully understand the impact of 
CSPα and its interacting partners HSP70 and synatxin, as well as changes in 
individual SNARE proteins and alterations in complex formation. Genetic mouse 
models, which were linked to schizophrenia, have been used so far (Jeans et al., 
2007; Pletnikov et al., 2008), as well as bipolar and major depression models (Jope 
and Roh, 2006; Zarate et al., 2006). However, to date generating animal models with 
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mental illnesses is problematic and results are not necessarily reliable. Mental 
illnesses seem to be uniquely human and cannot be convincingly modelled in 








CHAPTER FIVE:  
 
EXPRESSION AND LOCALISATION OF THE CYSTEINE STRING 
PROTEIN ISOFORMS CSPβ AND CSPγ 
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5.1 Introduction 
CSPα has been implicated to be involved in regulated exocytosis, as CSP null 
Drosophila exhibited embryonic lethality, and larvae displayed a defect in evoked 
presynaptic exocytosis (Umbach et al., 1994; Zinsmaier et al., 1994). Furthermore, 
CSPα has also been implicated in regulated exocytosis in mammalian cells based on 
work employing over-expression strategies (Brown et al., 1998; Chamberlain and 
Burgoyne, 1998; Zhang et al., 1998; Graham and Burgoyne, 2000). Recent work 
reported that CSPα inactivation reduced the life span of transgenic mice, with no 
CSPα-/- mice surviving beyond 3 months of age, and caused neurodegeneration of 
neuromuscular junctions and synapses, suggesting that CSPα has an important 
neuroprotective function (Fernandez-Chacon et al., 2004). However, no defect in 
synaptic vesicle exocytosis was evident in Calyx of Held synapses from P9-P11 
mice, suggesting that CSPα function is not essential for this membrane fusion 
pathway. 
Two novel CSP isoforms, CSPβ and CSPγ, were recently shown to be expressed in 
mammals (Evans et al., 2003; Fernandez-Chacon et al., 2004). Expression of these 
isoforms in mouse brain might explain the lack of an effect on synaptic transmission 
in CSPα knock out mice, since they might compensate the loss of CSPα. Northern 
blotting and quantitative real-time PCR however, revealed that CSPβ and CSPγ were 
only expressed in testis (Evans et al., 2003; Fernandez-Chacon et al., 2004).  
Recently a CSPβ antibody was generated against a C-terminal peptide from CSPβ; 
this antibody specifically identified the β isoform of CSP when recombinant proteins 
were analysed. Interestingly, this antibody did not detect a protein band 
corresponding to the size of CSPβ (~ 25 kDa), but it did consistently detect a 100 
kDa protein band in both testis and brain (Gundersen et al., 2010). More detailed 
analysis detected this putative CSPβ band in synaptosomes and synaptic vesicle 
fractions. This band was proposed to represent an oligomeric from of CSPβ, and a 
protein band appeared on SDS-PAGE gels, which was the approximate size of 
monomeric CSPβ, following boiling of cell lysates in a urea-containing buffer. The 
authors claimed therefore that expression of CSPβ in mouse brain could explain the 
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lack of an effect on synaptic vesicle exocytosis in CSPα-/- mice. Indeed, 
overexpression of CSPβ in frog oocytes led to a block of cortical granule exocytosis, 
and CSPβ was also shown to interact with the HSC70/SGT-complex (Boal et al., 
2007; Gundersen et al., 2010), suggesting that CSPβ might regulate exocytosis via 
the same protein-protein interactions as CSPα. 
Fractionations of pancreatic β cells over-expressing CSPβ showed that this isoform 
is membrane-associated, which is only disrupted by Triton X-100; however [3H]-
palmitic acid labelling experiments demonstrated that CSPβ was largely un-
palmitoylated, and in immunofluorescence studies CSPβ colocalised with markers 
(Vti1b) of the trans-Golgi network (Boal et al., 2007).  
Thus, if CSPβ is actually expressed in brain, it is unclear whether this protein could 
compensate for a loss of CSPα expression given the reported different localisations 
and palmitoylation stati of these two CSP isoforms. Another important issue is 
whether the relatively modest effect of CSPα knock down on regulated exocytosis in 
PC12 cells (Chapter 3) is confounded by expression of CSPβ or CSPγ in this cell 
type. 
The aim of this Chapter is to cast light on the possible functional roles of CSPβ and 




5.2.1 Characterisation of CSP isoform-specific antibodies 
At the time when this work was initiated, there were no published studies that had 
examined expression of CSPβ and CSPγ at the protein level. To generate a CSPβ 
antibody rabbits were immunised with the peptide sequences highlighted in the 
boxed region of Figure 5.1A. The resultant serum was affinity purified individually 
against each peptide.  
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Figure 5.1: Analysis of CSP isoform-specific antibodies. A. Alignment of the sequences 
of rat CSPα, -β and –γ. Conserved amino acids present in all 3 isoforms are coloured green, 
conserved residues present within 2 isoforms are coloured yellow. The peptides used to 
generate a CSPβ antibody are outlined with red (CSPβ) and blue (CSPγ) boxes. B. Aliquots 
of His6-tagged recombinant CSP (rCSP) proteins (20, 40 and 60 ng) were resolved by SDS-
PAGE and probed with antibodies against CSPα, CSPβ, CSPγ, and the hexahistidine tags. 
Positions of CSP monomers and oligomers are indicated. C. HEK293T cells grown in 24-well 
plates were transfected with 1 µg of GFP-tagged CSPs and probed with antibodies against 
the CSP isoforms or against GFP. The GFP-CSPα fusion protein migrates between the 46 
and 58 kDa markers as previously reported (Greaves and Chamberlain, 2006). Positions of 
molecular mass standards are shown on the left side of all figure panels. 
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The EQIRTDMEKDMDFPV peptide affinity purified antibody specifically 
recognised bacterially produced His6-tagged CSPβ and was not reactive against 
either His6-CSPα or His6-CSPγ (Figure 5.1B). In addition, an antiserum was 
generated against full-length His6-CSPγ, and this serum was specific for this CSP 
isoform. The commercial CSPα antibody used in this study was also highly specific 
for the alpha isoform (Figure 5.1B). An anti-His6 tag antibody was used to 
demonstrate similar gel-loadings of the His6-tagged CSP isoforms. The additional 
higher molecular weight bands that were detected by all antibodies used to probe 
bacterially expressed proteins (Figure 5.1B) represent dimers and higher molecular 
mass oligomers of CSPs (Swayne et al., 2003; Boal et al., 2004). 
The antibody specificity that was observed against bacterially expressed proteins was 
also reproduced when the antibodies were used to probe lysates of HEK293T cells 
that had been transfected with EGFP-tagged CSP proteins (Figure 5.1C). Here, the 
GFP antibody was used to confirm broadly similar loadings. 
The CSPγ antibody recognised multiple bands when used to probe tissue lysates with 
no clear indication of which (if any) band was CSPγ. Therefore, this antibody was 
not used further for tissue expression analysis.  
To examine the tissue distribution of the CSPβ protein, lysates were prepared from a 
panel of rat tissues, resolved on SDS gels and probed with CSPα and CSPβ 
antibodies. Figure 5.2A shows that CSPα is enriched in brain but is also expressed at 
varying levels in other non-neuronal tissues. In contrast, immunoreactivity against 
CSPβ was only detected in testis and was absent from brain (Figure 5.2A). CSPβ in 
testis migrated as two bands on SDS gels, one which was the same size as 
recombinant CSPβ (arrow) and another more prominent higher-molecular mass band 
(arrowhead). Note that a 100 kDa band similar to that reported by the Gundersen 
group (2010) was not recognised by this antibody. SNAP23 is ubiquitously 
expressed, and an antibody against this protein confirmed equal protein loading 
(Figure 5.2A). An antibody against the neuron-specific SNARE protein syntaxin 1A 
was used to confirm the integrity of brain lysate (Figure 5.2A).  
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Figure 5.2: Tissue distribution of CSP isoforms. A. Rat tissue lysates (10 µg) were 
resolved by SDS-PAGE and probed with the indicated antibodies; 20 ng of recombinant 
His6-CSPα or His6-CSPβ (rCSP) were used as positive controls. B. RNA purified from rat 
tissues was reverse transcribed to cDNA, and a PCR reaction was run with the appropriate 
CSPγ oligonucleotide primers (see table 2.3). Position of DNA size standard (in bp) is shown 
on the left side. C. Lysates (10 ng) were prepared from the indicated cell lines, resolved by 
SDS-PAGE beside a testis lysate, and probed using a CSPβ antibody. Positions of 
molecular mass standards are shown on left side of panels A and C. 
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To examine the tissue distribution of CSPγ, RNA purification, reverse transcription 
(RT) PCR and standard PCR was used to amplify CSPγ. Figure 5.2B shows that 
CSPγ mRNA was heavily enriched in testis. It was further examined if CSPβ is 
detectable in common cell lines, such as HEK293, NIH3T3, PC12 and INS1E cells, 
but no immunoreactivity was detected against CSPβ (Figure 5.2C). It is possible that 
CSPβ is expressed at low levels in specific brain regions (Schmitz et al., 2006) and 
that a signal might be detected following enrichment of these brain areas. Thus, a 
panel of samples containing different brain regions isolated from Sprague Dawley 
rats was obtained from Zyagen (San Diego, California, U.S.A). These samples were 
resolved by SDS-PAGE and probed with CSPα and CSPβ antibodies, and compared 
to the signal generated from an aliquot of the appropriate His6-tagged recombinant 
CSP isoform. Figure 5.3A shows that CSPα was expressed throughout the brain, with 
enrichment in the hippocampus and the cerebrum. In contrast, no signal was detected 
with the CSPβ antibody. To confirm the integrity of these commercial samples, a 
selection of brain areas were isolated from in-house bred Sprague Dawley rats, 
resolved on SDS-PAGE and probed with CSPα. This analysis showed the pattern of 
CSPα expression was broadly similar to the commercial samples, for example, with 
CSPα expression lower in cerebellum than either hippocampus or cerebrum (Figure 
5.3B). SNAP23 was used to confirm equal protein loading (Figure 5.3B). 
 
 
5.2.2 Membrane-association and palmitoylation of CSPβ 
In the following experiments, membrane association and palmitoylation of 
endogenous CSPβ were examined. In Figure 5.2A it was apparent that endogenous 
CSPβ migrated as two distinct bands. Figure 5.4A shows that the upper band detected 
by the CSPβ antibody (arrowhead in Figure 5.2A) co-fractionates with a purified 
membrane fraction whereas the lower band (arrow in Figure 5.2A) is cytosolic.  
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Figure 5.3: CSP expression in brain regions. A. Lysates from the various brain regions 
shown (10 µg), which were obtained from Zyagen Inc., were resolved by SDS-PAGE beside 
a 20 ng aliquot of His6-tagged CSPα or CSPβ (rCSP), and were probed with antibodies 
against CSPα or CSPβ. c.c. denotes the cerebral cortex. B. As A, except samples were 
isolated from in-house bred rats. The blots were probed with antibodies against CSPα and 
SNAP23. Positions of molecular mass markers are shown on the left side of the blots. 
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Probing these same samples with antibodies recognising GAPDH and HSP70, 
proteins that have large cytosolic pools, confirmed the efficiency of the fractionation 
procedure (Figure 5.4A). Given that CSPα is extensively palmitoylated, an obvious 
possibility to explain the increased apparent molecular mass of membrane-associated 
CSPβ is that this isoform is also highly palmitoylated. To test this possibility, 
membranes were isolated from testis and incubated overnight in either 1 M 
hydroxylamine (pH7) to cleave thioester linkages between fatty acids and cysteines, 
or 1 M Tris (pH7) as a control (Gundersen et al., 1994). Figure 5.4B reveals that 
hydroxylamine treatment decreased the apparent molecular mass of CSPα, as 
expected and previously reported (Gundersen et al., 1994). Similarly, hydroxylamine 
caused a marked downward shift in the migration of CSPβ, suggesting that this 
isoform is also highly palmitoylated. In contrast, no effect on migration of GAPDH 
was observed confirming that hydroxylamine is not promoting a shift in migration of 
all proteins (Figure 5.4B). Thus, Figure 5.4A and 5.4B strongly suggest that 
endogenous CSPβ is predominantly membrane-associated in testis and that this 
membrane-bound protein is palmitoylated.  
A higher-molecular mass band was detected by the CSPβ antibody (above 30 kDa 
marker) in all tissues (Figure 5.2A). Since CSPβ is palmitoylated (Figure 5.4B), it 
was possible that this band represented a differentially palmitoylated form of CSPβ. 
If this is true, then this band would be predicted to be membrane associated. 
However, fractionation of spleen revealed that this band was entirely cytosolic, 
suggesting that this band is not a palmitoylated form of CSPβ and most likely 
represents a cross-reacting protein. 
The observation that endogenous CSPβ is palmitoylated in testis in inconsistent with 
a previous report suggesting that HA-tagged CSPβ is largely un-palmitoylated when 
expressed in HIT-T15 pancreatic beta cells (Boal et al., 2007). To determine the 
extent to which CSPβ is palmitoylated when over-expressed, transfected PC12 cells 
were fractionated into cytosol and membrane fractions. Figure 5.5A shows that the 
majority of GFP-CSPα was membrane associated and also showed a marked 
upwards band shift in the membrane fraction, indicating palmitoylation (Figure 5.5A, 
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Figure 5.4: Membrane binding and palmitoylation of CSPα. A. Rat testis was fractionated 
into cytosol (cyt) and membrane (memb) fractions which were resolved by SDS-PAGE and 
probed with the indicated antibodies. B. Membranes isolated from testis were untreated (-), 
or treated with Tris or hydroxylamine (HA), and the samples were probed with the antibodies 
shown. C. Rat spleen was fractionated into cytosol (C) and membrane (M) fractions and 
resolved by SDS-PAGE beside a spleen homogenate (H) fraction and 20 ng of recombinant 
His6-CSPβ (rCSP), and probed with a CSPβ antibody. The positions of molecular mass 
standards are shown on the left side of each panel. 
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Figure 5.5: Palmitoylation and membrane binding of GFP-tagged CSP isoforms. 
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Figure 5.5: Palmitoylation and membrane binding of GFP-tagged CSP isoforms. A. 
EGFP-tagged CSPα, CSPβ and CSPγ (1 µg) were transiently transfected into PC12 cells 
growing on 24-well plates, followed by fractionation into cytosol and membrane fractions, 
which were resolved by SDS-PAGE. The distribution of the proteins between cytosol and 
membrane fractions was analysed by immunodetection with a GFP antibody. The 
arrowheads indicate unpalmitoylated CSP and the asterisks highlight palmitoylated CSP. 
Positions of molecular mass standards are shown at the left side of all blots. B. Quantified 
data (n=3) for the percent membrane-association (upper panel) and the percent 
palmitoylation of the membrane-associated protein (lower panel). Membrane binding of 
CSPα versus CSPγ, and CSPβ versus CSPγ were significantly different (**p < 0.005 each). 
Palmitoylation was also significantly different for CSPα versus CSPβ (*p < 0.05), and CSPα 
versus CSPγ (**p < 0.005) as determined by one-way ANOVA. 
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upper panel, asterisk). However, GFP-CSPβ was found equally in cytosol and 
membrane fractions, and in membranes was present as both a palmitoylated and an 
un-palmitoylated form (Figure 5.5A, middle panel, arrowhead and asterisk). In 
contrast, GFP-CSPγ was largely cytosolic and only a small amount was detected in 
the membrane fraction (Figure 5.5A, lower panel), with an indication of 
palmitoylation (Figure 5.5A, low panel, asterisk). Quantitative analysis illustrated 
that GFP-CSPα and GFP-CSPβ were approximately 80 % membrane associated, 
whereas only ~ 30 % of GFP-CSPγ was membrane-bound (Figure 5.5B, upper 
panel). Furthermore, GFP-CSPα in the membrane fraction was mainly palmitoylated 
(~ 80 %); CSPβ however, only displayed ~ 60 % and GFP-CSPγ only ~ 40 % 
palmitoylation of the membrane-bound pool. Thus, although the expression levels of 
endogenously expressed CSPβ in testis allow efficient membrane association and 
palmitoylation, it is clear that tagged forms of CSPβ and CSPγ are less efficiently 
palmitoylated than CSPα, when the proteins are over-expressed.  
As palmitoylation is central to the function of CSPα (Ohyama et al., 2007), chimeric 
constructs were created in an effort to understand the basis of the different 
efficiencies of CSPα and CSPβ palmitoylation in PC12 cells. Work from Lang and 
co-workers has shown that the different configurations of cysteines in the cysteine-
string domain of CSPα and CSPβ are not responsible for the observed differences in 
palmitoylation (Boal et al., 2007). Thus chimeric constructs were generated by 
interchanging the N-terminal domain of CSPα and CSPβ (CSPα-βNterm and CSPβ-
αNterm, Figure5.6A). These chimeric constructs were individually transfected into 
PC12 cells, which were then fractionated into cytosol and membrane fractions. The 
representative blots (Figure 5.6B) and quantified data from several experiments 
(Figure 5.6C) showed that the CSPα-βNterm chimera was significantly decreased in 
its membrane-association and palmitoylation similar to wild type CSPβ. CSPβ-
αNterm however, displayed an increased level of membrane binding and 
palmitoylation as observed for wild-type CSPα. Thus, the different N-terminal 
domains of CSPα and CSPβ are important in determining palmitoylation efficiency.  
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Figure 5.6: Membrane binding and palmitoylation of GFP-tagged CSPα and CSPβ 
chimeric constructs. A. Domain structure of CSPs and representation of the chimeric 
constructs which were synthesised. The numbers indicate amino acid positions. B. CSP 
constructs were transfected into PC12 cells, which were then fractionated into cytosol (C) 
and membrane (M) fractions. The distribution of the proteins between cytosol and membrane 
fractions was determined by immunoblotting with a GFP antibody. The arrowheads denote 
unpalmitoylated CSP and the asterisks palmitoylated CSP. Positions of molecular mass 
standards are shown at the left side of all blots. C. Quantified data (n=3) for the percent 
membrane association (upper panel) and the percent palmitoylation of the membrane-
associated fraction (lower panel). Membrane binding for CSPα and CSPα-βNterm was 
significantly different (**p < 0.005). Palmitoylation was also significantly different for CSPα 
and CSPβ (**p < 0.005), CSPα and CSPα-βNterm (***p < 0.0005), CSPβ and CSPβ-αNterm 
(**p < 0.005), and CSPβ and CSPα-βNterm (*p < 0.05) as determined by one-way ANOVA. 
 
 - 176 -
5.2.3 Localisation of CSPβ and CSPγ in germ cells 
To observe whether the three CSP isoforms were equally expressed in testis during 
development, testis samples from various ages of rat (ranging from post-natal day 8 
to 174) were analysed based on protein and mRNA expression. Figure 5.7A 
demonstrates that CSPα is expressed in testis throughout development. Surprisingly 
though, protein expression of CSPβ was not detected in p22 samples, but was present 
in p38 samples. SNAP23 detection confirmed equal protein loading. To confirm this 
developmental switch in CSPβ expression and also to examine CSPγ expression, the 
mRNA expression profile of all three mammalian CSP isoforms in rat testis was 
examined by reverse transcriptase PCR (RT-PCR). This analysis confirmed that 
CSPα is expressed throughout development and that CSPβ expression is detected at 
p38 but not p22. Interestingly, CSPγ also displayed a development switch in 
expression, being detected in samples from p22 but not p12 rats. Sexual maturation 
(puberty) in rats begins between p25 and p33 (Ojeda, 1994a; Hagenauer et al., 2011), 
and in males this is when spermatogenesis first occurs. As a first step to define the 
cell types that express CSP proteins in testis, expression was examined in rat sperm 
samples. Isolation of sperm and testis from two adult male rats and subsequent 
immunoblotting analysis revealed that CSPα is expressed in mature sperm (Figure 
5.8). CSPβ however, could only be detected in the testis fraction. 
Testes are comprised of three major cell types, germ (which mature into sperm), 
Sertoli and Leydig cells. As CSPβ was not detected in mature sperm, it was 
examined if CSPβ is expressed in rat Leydig (R2C), rat Sertoli (15P-1) or mouse 
Sertoli (MSC-1) cell lines. These cells where thus fractionated into cytosol and 
membrane fractions, which were analysed by immunoblotting with CSPα and CSPβ 
antibodies. Figure 5.9A revealed that CSPα was present in the membrane fractions of 
all cell lines that were analysed. In contrast, CSPβ showed no signal in either Leydig 
or Sertoli cells; the testis sample was used as a positive control for the 
immunoblotting procedure. Since no germ cell lines are available and also because 
cell lines may not express exactly the same proteins as primary cells,  
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Figure 5.7: Expression of CSP isoforms during testicular maturation. Rat testes were 
removed at the highlighted post-natal (p) age (in days). A. Testes were lysed, resolved by 
SDS-PAGE and probed with antibodies against CSPα, CSPβ and SNAP23. The position of 
molecular weight standards (in kDa) are shown on the left side of the blots B. RNA was 
purified from the testes, reverse transcribed to cDNA and a PCR reaction was run with the 
appropriate CSPα, CSPβ or CSPγ oligonucleotide primers (see table 2.3). Position of DNA 
size standards (in bp) are shown on the left side. 
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Figure 5.8: Expression of CSP isoforms in sperm. Whole testis and sperm from two adult 
rats (~ 3 months of age) were isolated, lysed, resolved by SDS-PAGE and probed with the 
indicated antibodies. Positions of molecular mass standards are shown on the left side of all 
blots. 
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Figure 5.9: Detection of CSP isoforms in Testis cell types. A. Rat Leydig (R2C), rat 
Sertoli (15P-1) and mouse Sertoli (MSC-1) cell lines were fractionated into cytosol (C) and 
membrane (M) fractions, and resolved by SDS-PAGE and probed with CSPα and CSPβ 
antibodies. B. Testis cell types were isolated as described in (see 2.6.8) (Anway et al., 
2006), resolved by SDS-PAGE and the distribution of proteins was detected with CSPα, 
CSPβ and SNAP23 antibodies. Testis samples were used as a positive control. Position of 
molecular mass standards are shown on the left of all panels. 
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distinct fractions were purified from testis that contain enrichment of each cell type, 
using a protocol described in detail by Anway et al. (2003) (see methods section). 
CSPα was detected in all three isolated fractions, but only a low signal was detected 
in the germ cell-enriched fraction (Figure 5.9B). These results for CSPα were also 
confirmed in Figure 5.10, were immunohistochemical detection of CSPα in testis 
section demonstrated that CSPα is expressed in every testis cell type. By contrast, 
CSPβ was mainly present in the germ cell fraction (Figure 5.9B). This result 
suggested that CSPβ might be expressed in germ cells during spermatogenesis but be 
switched off in mature sperm cells (Figure 5.8). The SNAP23 antibody was used to 
detect equal protein loading.  
The results presented in Figure 5.9 suggest that CSPβ is expressed in germ cells. To 
confirm this observation and also to examine expression of CSPγ, quantitative real 
time PCR (qRT-PCR, see 2.3.6) was performed. For this, 3-4 months old Sprague 
Dawley rats were treated with busulphan, which induces apoptosis in germ cells 
(Choi et al., 2004). Figure 5.11A shows that CSPα expression decreased marginally 
with busulphan, consistent with the data in Figures 5.9 and 5.10, showing weak 
expression in germ cells. In marked contrast to the expression of CSPα in busulphan-
treated mice, CSPβ and CSPγ mRNA expression levels both dropped dramatically 
and were virtually undetectable in busulphan treated samples (Figure 5.11B and 
5.11C). This finding provides strong evidence that both CSPβ and CSPγ are 
specifically expressed in germ cells. 
The detection of CSPβ and CSPγ in germ cells but not in mature sperm raised the 
question as to which specific stage during spermatogenesis CSPβ and CSPγ are 
expressed. Therefore adult mice were given a single injection of busulphan, which 
initiates apoptosis in spermatogonia within 1 week of treatment followed by a second 
wave of apoptosis in meiotic spermatocytes after 2 weeks and finally a loss of 
spermatids between 20 and 30 days, as existing spermatids mature and fail to be 
replaced (Choi et al., 2004). The mice were sacrificed after 5, 10, 15, 20, 30 and 50 
days of busulphan treatment and RNA purified from the testes. qRT-PCR on the 
corresponding cDNA revealed that CSPβ is robustly expressed following 20 days of 
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Figure 5.10: Localisation of CSPα in testis slices. 10 µm testis sections taken from a 6 
month old rat testis were incubated with CSPα (green) and GM130 (red) antibody, and 
stained with DAPI (blue) for nuclei detection. The lower panel shows the merged image. 
Scale bar, 100 µm. 
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Figure 5.11: Effect of busulphan treatment on CSP expression levels. 5 days after 
busulphan treatment (30 mg/kg), male rats were sacrificed and their testes were isolated. 
Testes RNA was purified, reverse transcribed to cDNA and qRT-PCR was performed with 
the appropriate oligonucleotide primers against each CSP isoform and succinate 
dehydrogenase (SDH) as an internal control (A-C) (see 2.3.6). 
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busulphan treatment but that expression is lost after 30 days (Figure 5.12A). 
Interestingly, CSPγ expression was reduced after 15 days and almost completely lost 
after 20 days treatment (Figure 5.12B), highlighting a difference in expression profile 




The results presented in this chapter demonstrate that CSPβ and CSPγ are highly 
enriched in rat testis compared with all other rat tissue examined (Figure 5.2A and 
5.2B). This result is consistent with previous analysis of the expression of CSPβ and 
CSPγ mRNA (Fernandez-Chacon et al., 2004). While there was no detection of 
CSPβ expression in any brain region tested, it cannot be completely ruled out that 
levels of this isoform were below the sensitivity of the generated antibody. However, 
by comparing antibody signal from known concentrations of recombinant CSPs with 
lysates from selected brain regions (Figure 5.3A), it is clear that CSPα is 
substantially more abundant in brain than CSPβ. The generated antibody did not 
recognise the high-molecular mass band reported in a recent study (Gundersen et al., 
2010). It is not clear why our antibody preparation did not detect this proposed CSPβ 
oligomeric assembly. This could be due to antibody masking, but it is also possible 
that the band detected by the Gundersen lab antibody is a cross-reacting protein and 
not CSPβ. 
In testis, CSPβ was mainly membrane-associated. Furthermore, when testis 
membranes were treated with hydroxylamine, CSPβ underwent a marked band shift, 
demonstrating that the endogenous form of this CSP isoform is palmitoylated. This 
observation is in apparent contrast to previous work suggesting that CSPβ is a non-
palmitoylated CSP isoform, a conclusion that was based on analyses of CSPβ 
transfected into pancreatic β cells (Boal et al., 2007).  
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Figure 5.12: Localisation of CSP isoforms in germ cell populations. A single injection of 
busulphan was given to male mice (30 mg/kg). The mice were sacrificed between 10-50 
days after injection and their testes were isolated. The control testes were from animals that 
had not been treated with busulphan. RNA was purified, reversed transcribed to cDNA and 
qRT-PCR was performed with the appropriate oligonucleotide primers against each CSP 
isoform and luciferase as an external control (A and B) (see 2.3.6). 
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However, the present work is in accordance with the study of Lang and co-worker, as 
it was shown that a GFP-CSPβ fusion proteins expressed in PC12 cells also exhibits 
a reduced efficiency of palmitoylation compared with that of CSPα (Figure 5.5) 
(Boal et al., 2007). There are two main possibilities that might explain the apparent 
lack of CSPβ palmitoylation in pancreatic β cells and PC12 cells. (i) Palmitoylation 
of CSPβ is less efficient than palmitoylation of CSPα, which becomes apparent 
when proteins are expressed at high levels. (ii) The palmitoyl transferase that 
palmitoylates CSPβ is expressed at higher levels in testis than in pancreatic β cells or 
PC12 cells. The first possibility may seem more likely; however, it will be interesting 
to examine whether different palmitoyl transferases modify CSPα and CSPβ 
(Greaves et al., 2008). 
It is interesting to note that Lang and colleagues employed mutagenic analysis to 
show that the inefficient palmitoylation of CSPβ in pancreatic β cells was most likely 
not caused by differences in the cysteine-string domains of CSPα and CSPβ (Boal et 
al., 2007). In support of these findings, the present study confirmed that switching 
the entire N-terminal regions of CSPα and CSPβ upstream of the cysteine-string 
domains, resulted in a loss of CSPα palmitoylation and an increased palmitoylation 
of CSPβ. These observations suggest that the N-terminal domains of the CSP 
isoforms regulate palmitoylation efficiency (Figure 5.6B and 5.6C). This finding is in 
agreement with recent studies that have shown that palmitoylation of substrate 
proteins can be influenced by residues that are somewhat displaced from the 
modified cysteines (Greaves et al., 2009). It was previously shown that amino acids 
both within and upstream of the cysteine-string domain are important for membrane 
interaction of CSPα prior to its palmitoylation (Greaves et al., 2008). Thus, it is 
possible that the different efficiencies of CSPα and CSPβ palmitoylation relate to 
differences in membrane interaction dynamics of the proteins in their un-
palmitoylated forms. Interestingly, CSPγ had an even lower level of membrane 
binding and palmitoylation than CSPβ; it is possible that these differences in 
membrane binding/palmitoylation may influence functional properties of the three 
CSP isoforms. 
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Expression analysis of the different CSP isoforms in testis samples revealed that 
CSPβ and CSPγ mRNA display distinct developmental profiles to CSPα, being 
turned on around the time of sexual maturation in rat (Figure 5.7) (Ojeda, 1994a); 
CSPα by contrast is constitutively expressed. Furthermore, treatment with busulphan 
provided strong evidence that CSPβ and CSPγ are specifically localised to germ 
cells, whereas CSPα is also expressed in other testis cell types (Figure 5.11). The 
exact expression pattern of the CSP isoforms in mouse germ cells (Figure 5.12A), 
analysed in mice samples treated with busulphan for various periods, suggested that 
CSPβ and CSPγ are specifically enriched in spermatids and spermatocytes, 
respectively. This conclusion was made, as the expression pattern is almost the same 
as seen in the work of O’Shaughnessy et al. (2008), where the role of germ cells in 
regulating Sertoli cell gene expression in vivo was examined. Furthermore 
O’Shaughnessy and colleagues looked at germ cell genes which are predominantly 
expressed in specific germ cell populations, by treating the mice with busulphan, 
which destroys fast replicating cells, such as germ cells (Choi et al., 2004; 
O'Shaughnessy et al., 2008). Furthermore, the expression of CSPγ in spermatocytes 
supports the results of the mRNA expression profiles of CSPβ and CSPγ during 
development (Figure 5.7B), where CSPβ expression appears later than expression of 
CSPγ. 
Meiosis is a unique process occurring in germ cells and involves one round of DNA 
replication followed by two consecutive cell divisions enabling diploid cells to form 
haploid cells (Cobb and Handel, 1998; Baarends et al., 2001). Spermatocytes are a 
population of germ cells which undergo a complex process of meiosis requiring 
many genes and proteins to develop from the diploid spermatocytes to the haploid 
spermatid (Hermo et al., 2010); since CSPγ was identified in spermatocytes (Figure 
5.12C), this CSP isoform might be involved in meiosis. The heat shock protein 
HSP70-2 (mouse) is expressed at high levels during meiosis (Rosario et al., 1992) 
and chaperones CDC2/cyclin B1 complex formation in spermatocytes (Zhu et al., 
1997). This complex is required to trigger the G2/M-phase transition in meiosis I, 
which is the phase between DNA synthesis and mitosis (Dix et al., 1997). Since it is 
known that CSPα and CSPβ interact with HSC70/HSP70 as co-chaperones and 
 
 - 187 -
activate HSC70/HSP70 ATPase activity, it is possible that CSPγ acts as a co-
chaperone for HSP70-2.  
In contrast, spermatids undergo several changes to metamorphose into spermatozoa, 
such as alterations and transformations of organelles, compaction and condensation 
of the nuclear chromatin and forming of the acrosome, which is partially formed by 
the Golgi apparatus (Clermont et al., 1994). The area in between the trans face of the 
Golgi apparatus and the developing acrosome contains vesicular and tubular profiles, 
which fuse with the acrosome (Burgos and Gutierrez, 1986). Thus, it is possible that 
CSPβ, which appears to be enriched in spermatids (Figure 5.12B), is involved in 
such membrane fusion reactions, occurring specifically in spermatids. From Figure 
5.1A it can be seen that CSPα, -β and -γ are most divergent in their C-terminal 
domains. Thus, it appears likely that these isoforms have evolved to function as 
common molecular chaperones that likely have distinct substrates that are specified 
by their C-terminal regions. 
In summary, this work is consistent with the notion of CSPβ being enriched in testis 
and suggests that if this isoform is expressed in brain then it is likely to be at levels 
substantially lower than that of CSPα. The higher-molecular mass CSPβ band 
reported by Gundersen and colleagues (Gundersen et al., 2010), was not detected 
here. However, as the antibody used here was raised against a peptide different from 
that used by Gundersen et al. (2010) to generate their antibody, it is possible that 
antigen masking prevented detection of this complex.  
Furthermore, we were able to localise CSPβ and CSPγ specifically to the germ cell 
population of spermatocytes and spermatids, respectively. It would be interesting to 
examine in future studies which organelles the CSP isoforms are localised to in the 
particular germ cell population and with which proteins they might interact with. 
CSPβ and CSPγ knock out mice would help to understand to what extend these 
isoforms are important for fertility and would permit a detailed analysis of the 








CHAPTER SIX:  
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6.1 Introduction 
The specific expression of CSPβ and CSPγ in testes suggests a key function for these 
novel CSP isoforms in this tissue. In addition, the only developmental abnormality 
that has been reported in CSPα knock out mice is bilateral intra-abdominal 
cryptorchidism (Fernandez-Chacon et al., 2004), which is the absence of both testes 
from the scrotum. This observation suggests that CSPα also has an essential function 
for normal testicular development. 
Cryptorchidism occurs frequently in humans, affecting about 12 % of male births 
(Hutson et al., 1994), and can cause infertility and increases the risks of germ cell 
tumours (Pettersson et al., 2007). Interestingly, previous work has shown that INSL3 
(insulin-like hormone) null mice exhibited bilateral cryptorchidism based on 
developmental abnormalities of the gubernaculum (Nef and Parada, 1999). INSL3 is 
specifically expressed in Leydig cells and this cell type also secretes testosterone 
which is essential for the development of internal and external male genitalia (Shalet, 
2009). As CSPα functions in exocytosis and prevents cryptorchidism, one possibility 
is that CSPα regulates secretion of INSL3. 
As a first step towards defining CSPα function in testis, the localisation and targeting 
of CSPα in R2C cells was investigated; in particular co-distribution with INSL3 was 
examined. The trafficking, exocytosis, and endocytosis of secretory vesicles and 
granules has been extensively characterised (Sudhof, 2004), however, the underlying 
mechanisms whereby proteins are targeted to vesicle membranes are not well 
defined. To date no motif that might serve as a universal vesicle targeting signal has 
been characterised. Thus, it has been suggested that different proteins use distinct 
pathways to be targeted to vesicles and that each vesicle protein controls trafficking 
through diverse signals (Bonanomi et al., 2006).  
CSPα is distributed on vesicles in the majority of mammalian cell types in which it 
has been studied (Mastrogiacomo et al., 1994b; Braun and Scheller, 1995; 
Chamberlain et al., 1996; Pupier et al., 1997). Vesicle and granule biogenesis and 
protein targeting to their limiting membrane has been generally studied in the model 
neuroendocrine system of PC12 cells. However, overexpression of CSPα in PC12 
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cells led to an accumulation of CSPα on the plasma membrane (Chamberlain and 
Burgoyne, 1998), and this mis-targeting made it difficult to determine the features of 
CSPα that contribute to its targeting in this cell type. In R2C cells, GFP-CSPα 
displays a very similar distribution to the endogenous protein and thus we have also 





6.2.1 Colocalisation of CSPα and INSL3 in R2C Leydig cells 
From the results presented in Chapter 5, it was apparent that CSPα is present in most 
cell types of the testes. As a first step towards investigating possible functions of 
CSPα in testes, the localisation of this protein in Sertoli and Leydig cell lines was 
studied. In both Sertoli cell lines (MSC-1 and 15P-1) and R2C Leydig cells, 
endogenous and EGFP-CSPα displayed a vesicular localisation. In addition both the 
endogenous and EGFP-CSPα were present at the plasma membrane and clustered 
around a perinuclear region in R2C cells. Co-localisation analysis of endogenous and 
EGFP-CSPα against the trans Golgi network (TGN) marker TGN38 showed that 
CSPα was clustered in vesicular like structures around the trans Golgi network 
(Figure 6.1B). It was noticeable in R2C cells that the localisation of EGFP-CSPα 
was very similar to that displayed by the endogenous protein. 
Given the possible link between CSPα and INSL3 in cryptorchidism, it was 
examined if CSPα localisation overlapped with that of INSL3. As no antibodies are 
available against rat INSL3, INSL3-EGFP was produced and co-transfected into R2C 
cells with mcherry-CSPα and their distributions examined in live cells using a wide-
field fluorescence microscope. The images presented in Figure 6.2 demonstrate that 
CSPα and INSL3 are co-localised on the same vesicular structure in R2C cells. 
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Figure 6.1: Detection of endogenous and over-expressed GFP-tagged CSPα in testis 
cell types. A. Sertoli cells from rat (15P-1) and mouse (MSC-1), were either transfected with 
EGFP-CSPα or directly fixed, permeabilised and incubated with a polyclonal anti-CSPα 
antibody to label endogenous CSPα, followed by incubation with an anti-rabbit secondary 
antibody conjugated to Alexa Fluor 488. B. R2C Leydig cells were either transfected with 
EGFP-CSPα (lower panel) or directly fixed, permeabilised and incubated with a polyclonal 
anti-CSPα antibody to label endogenous CSPα (upper panel) and a mouse anti-TGN38 
antibody to label the trans Golgi network. The cells were then incubated with anti-rabbit and 
anti-mouse secondary conjugated to Alexa Fluor 488 and Alexa Fluor 543, respectively. The 
highlighted region of the cell in the images has been enlarged and is shown on the right of 
the panels. Scale bar, 5 µm. 
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Figure 6.2: CSPα and INSL3 localisation on moving vesicles in R2C Leydig cells. 
Leydig cells were seeded on 30 mm coverslips and transfected with 0.5 µg of each cherry-
CSPα (A) and EGFP-INSL3 (B). The cells were imaged on an Olympus IX-81 microscope at 
60 x magnification over a period of 10 minutes, using microscope settings at 488 nm (EGFP 
tag) and 562 nm (mCherry tag). Shown are the images taken at 2 minute intervals. The area 
of interest is highlighted with a white box and enlarged, shown on the right of A. and B. 
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6.2.2 Analysis of targeting signals in CSPα 
As shown in Figure 6.1, the localisation of EGFP-CSPα and endogenous CSPα are 
very similar in R2C cells. To date, it has been difficult to study targeting signals 
present within CSPα as overexpression often leads to mistargeting, for example, in 
PC12 cells (Chamberlain and Burgoyne, 1998). Thus, we took the opportunity to 
examine the effect that defined mutations have on CSPα localisation. To alleviate 
any confounding effects of cell-to-cell variability in CSPα localisation, EGFP-tagged 
CSPα mutants were co-transfected with mcherry-tagged wild type CSPα to allow a 
comparison of intracellular localisations to be made in the same cell. Figure 6.3 
shows representative images for the localisations of defined N- and C-terminal 
truncations of EGFP-CSPα. CSPα(1-146) trafficked correctly (as wild type), 
suggesting that the C-terminus of CSPα does not contain specific signals involved in 
vesicle/plasma membrane targeting. In contrast, it was found that removal of the N-
terminal 69 amino acids (CSPα(70-198)) led to a loss of plasma membrane targeting, 
although the mutant still co-localised with wild type CSPα on intracellular 
membranes. The first 69 amino acids contain the majority of the J-domain and the 
entire N-terminal domain (amino acids 1-14). The loss of plasma membrane 
localisation could not be attributed to a loss of the N-terminal domain, as a CSPα 
mutant lacking this domain (CSPα(17-198)) had the same localisation pattern as wild 
type CSPα (Figure 6.3, right hand panel). All other N-terminal truncations 
downstream of amino acid 70 displayed the same loss of plasma membrane targeting 
as the CSPα(70-198) mutant. These findings implicate regions within the J-domain 
as important for plasma membrane targeting of CSPα in R2C cells, and shows that 
different features of CSPα differentially regulate targeting to the plasma membrane 
and intracellular membranes. 
The cysteine-string domain of CSPα is extensively palmitoylated and it is possible 
that this defining feature of CSPα is important for vesicular targeting. To test this 
idea, R2C cells were co-transfected with mcherry-CSPα wild type and three different 
cysteine mutants in which specific blocks of cysteines were mutated. 
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Figure 6.3: Analysis of CSPα targeting in R2C Leydig cells. A. Schematic diagram of the 
domains of mammalian CSPα. The amino acid numbers corresponding to domain 
boundaries are indicated. R2C Leydig cells were co-transfected with mcherry-CSPα (red) 
and EGFP-CSPα truncation mutants (green). The C-terminal truncation mutants indicate a 
truncation from the amino acid indicated, i.e. 1-136, 1-146, 1-156 and 1-166. B. The N-
terminal truncation mutants indicate a truncation from the amino acid indicated, i.e. 17-198, 
70-198, 84-198, 98-198 and 106-198. Scale bar, 5 µm.  
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It was clear from this analysis that the majority of cysteines in the cysteine-string 
domain were dispensable for intracellular targeting of CSPα (Figure 6.4); we were 
unable to examine cysteines 4-7, as their mutation blocks membrane binding 
(Greaves and Chamberlain, 2006). 
 
6.2.3 Successful depletion of CSPα in R2C cells 
As a first step towards probing the possible function of CSPα in Leydig cells, the 
effectiveness of siRNA in blocking CSPα expression in this cell type was examined. 
Figure 6.5 shows that this cell line is suited to siRNA depletion and CSPα was 
successfully depleted by 70 %, opening the way for studies probing the function of 
CSPα in this cell type. Since CSPα has been suggested to play a role in secretion 
(Umbach et al., 1994; Zinsmaier et al., 1994; Chamberlain and Burgoyne, 1998), it 




In this Chapter it was shown that CSPα is localised on mobile vesicles and at the 
plasma membrane in R2C Leydig cells (Figure 6.2). The vesicles decorated by CSPα 
showed clustering around the TGN but were clearly distinct from this compartment, 
as shown by co-localisation analysis against TGN38. As CSPα and INSL3 deletion 
in mice reveal the same phenotype of cryptorchidism (Nef and Parada, 1999; 
Fernandez-Chacon et al., 2004), we proposed the hypothesis that cryptorchidism in 
CSPα null mice may be caused by a loss of INSL3 secretion. As a first step towards 
examining this, we analysed the localisation of CSPα and INSL3 expressed in R2C 
cells. It was not only shown that CSPα is localised on mobile vesicles in Leydig 
cells, but also that this protein is localised on the same vesicles as INSL3 (Figure 
6.2), clearly suggesting that CSPα may be involved in the secretion of INSL3. It 
should be noted that it is not known how INSL3 gets secreted, and whether this is by 
a constitutive or a regulated exocytosis pathway. 
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Figure 6.4: Targeting of CSPα cysteine-string domain mutants in R2C Leydig cells. 
Schematic diagram of the cysteine-string domain of rat CSPα. Cysteine residues are shown 
in bold and mutations within the cysteine-string domain are highlighted in bold red. R2C 
Leydig cells were co-transfected with mcherry-CSPα (red) and EGFP-CSPα cysteine-string 
domain mutants (green). The EGFP-CSPα(C1-3A) mutant has the first 3 cysteines mutated 
to alanine. EGFP-CSPα(C8-10S) has cysteine residues 8-10 mutated to serines, and EGFP-
CSPα(C11-14) has cysteine residues 11-14 mutated to serines. Scale bar, 5µm. 
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Figure 6.5: siRNA-mediated depletion of CSPα in Leydig cells. A. Leydig cells seeded on 
24-well plates were incubated with 100 nM of siRNA molecules directed against CSPα or 
with non-targeting siRNA used as a control for 3 days. Cells were lysed, resolved by SDS-
PAGE and protein levels examined by immunoblotting with a CSPα antibody. Position of 
molecular weight standard is shown on the left. B. CSPα levels were quantified in control 
and siRNA treated cells (n=3) by densitometry. Expression in control cells was arbitrary set 
to 100 and expression in siRNA-transfected cells is shown relative to this. *** indicates a 
significant decrease (p<0.0001) in CSPα expression compared to control cells as analysed 
by a Student’s t-test. 
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In future work, we hope to investigate whether CSPα depletion has an effect on 
INSL3 secretion. Indeed, we have already successfully depleted CSPα using siRNA 
in Leydig cells. The results showed that CSPα expression can be knocked down by  
~ 70 % compared to control (Figure 6.5). This would make it possible to analyse 
directly in Leydig cells if CSPα is involved in the release of INSL3. However, these 
assays are presently difficult due to the low transfection efficiency achieved in R2C 
cells, and it has been difficult to detect INSL3-EGFP expression by immunoblotting. 
Thus in future work it will be important to optimise protocols for transfection 
efficiency. If this cannot be overcome, then single cell assays, such as TIRF 
microscopy, may prove useful to study INSL3 secretion. 
In addition to vesicle-like structures, CSPα was also present at the plasma membrane 
in Leydig cells (Figure 6.1B). Importantly, overexpression of EGFP-tagged CSPα 
appeared to result in exactly the same pattern of localisation as endogenous CSPα 
(Figure 6.1B), which awakened the interest to study CSPα targeting to intracellular 
membranes, as this has proved difficult in PC12 cells, where over-expressed CSPα 
mistargets (Chamberlain and Burgoyne, 1998; Greaves and Chamberlain, 2006). It 
was generally not clear to which intracellular compartment CSPα localised to in R2C 
cells. Though it looked as if CSPα was located to the trans Golgi network (TGN), 
enlargement of this area showed that CSPα is not colocalised to the TGN, but instead 
is present around the TGN on vesicular-like structures.  
Analysis of CSPα targeting, using various N- and C-terminal truncation mutants, 
showed that: (i) the C- terminal domain (146-198) was not required for intracellular 
targeting, (ii) the N-terminal truncation mutants GFP-CSPα(70-,84-, 98- and 106-
198) displayed a loss of plasma membrane targeting, and (iii) mutations in the 
cysteine string domain did not affect CSPα localisation.  
Analyses of the N-terminal mutants demonstrated that an intact J domain is 
important for plasma membrane targeting, but interestingly not for targeting to 
intracellular membranes. Further truncation mutants between amino acids 17-70 
should be generated to define the precise region which is responsible for plasma 
membrane binding. If this area is located, point mutations would map out the specific 
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amino acid(s) that are crucial for plasma membrane binding. In particular it will be 
interesting to examine if interaction with HSC70 is important for plasma membrane 
targeting. This could be achieved by studying mutants of the HPD tripeptide in the J-
domain. Mutations in the cysteine-string domain of CSPα (CSPα(C1-3A), 
CSPα(C8-10S) and CSPα(C11-14S)) did not display any obvious difference in 
localisation on either intracellular membranes or at the plasma membrane compared 
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Despite being identified more than 20 years ago, we still do not have a clear picture 
of the precise function of CSPα, and indeed there is still debate as to the actual 
pathway(s) that CSPα regulates. Early work on Drosophila provided strong evidence 
for an essential function of CSPα in presynaptic neurotransmitter release (Zinsmaier 
et al., 1994). Later work in mammalian cells also supported a function for CSPα in 
secretory vesicle exocytosis e.g. (Chamberlain and Burgoyne, 1998). The study 
describing the generation and analysis of CSPα knockout mice is the one report that 
does not support the idea that CSPα is an important component of the exocytotic 
machinery (Fernandez-Chacon et al., 2004). What might be the reason for this 
apparent inconsistency? It is possible that CSPα null mice develop compensatory 
mechanisms to overcome the loss of CSPα. There was no compensatory up-
regulation of other CSP isoforms or selected key components of the exocytotic 
machinery. Nevertheless, it is important to recognise that if the function of CSPα is 
to act as a molecular chaperone that regulates the folding of specific presynaptic 
proteins then its loss may be easily compensated for by a change in the turnover rate 
of CSPα substrates. Thus, it would be of significant interest to determine whether the 
half-life of specific presynaptic proteins is affected by CSPα inactivation.  
Given these discrepancies, a major aim of this work was to shed further light on the 
function(s) of this intriguing family of proteins. As most studies on mammalian 
systems have used over-expression strategies to study CSP function, the aim here 
was to examine the effects of CSP depletion in a more controlled system than a 
knockout mouse. Initially the role of CSPα in regulated exocytosis was examined by 
knocking down CSPα using siRNA in PC12 cells. Indeed CSPα depletion correlated 
with a significant decrease in regulated exocytosis, measured using the 3H-dopamine 
assay and human growth hormone assay. Depletion of CSPα did not affect 
expression of the SNARE proteins VAMP2 (Leveque et al., 1998; Boal et al., 2004; 
Weng et al., 2009), syntaxin 1 (Nie et al., 1999; Chamberlain et al., 2001) and 
SNAP25 (Chandra et al., 2005; Boal et al., 2011; Sharma et al., 2011), which were 
previously suggested to interact with CSPα. This analysis thus supports the view that 
CSPα plays an important role in regulated exocytosis. It was unfortunate that the 
effect on exocytosis was not large enough to pursue rescue experiments using 
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defined CSPα mutants, as this would have allowed a more detailed characterisation 
of the domains and putative protein-protein interactions that are important for CSPα 
function in this pathway. It is likely that a complete depletion of CSPα is needed to 
obtain a greater inhibition in exocytosis. It will be interesting in future work to 
perform experiments that test the acute function of CSPα in brain, without possible 
confounding compensatory effects. One approach to do this could be via injection of 
recombinant viruses expressing CSPα siRNA into specific rat brain regions followed 
by electrophysiological analysis of presynaptic exocytosis. 
Chemical cross-linking experiments with DSG and EGS showed that upon strong 
stimulation with ionomycin CSPα interacts with an as yet unknown protein, 
supporting a function for this protein in a Ca2+-regulated pathway (Chapter 3). It has 
been difficult to pin down the precise in vivo substrates of CSPα but SNAP25 has 
emerged recently as a protein whose expression is affected by CSPα depletion 
(Sharma et al., 2011). It is interesting to note that CSPα and SNAP25 are largely 
separated at an intracellular level. CSPα is present on vesicles and SNAP25 is 
mainly present at the plasma membrane. Thus, it is possible that CSPα may act on 
SNAP25 during a short window following synaptic vesicle fusion with the plasma 
membrane. However there is a small pool of SNAP25 on vesicles and this pool may 
be affected by CSPα.  
It is interesting that CSPα is expressed essentially in every cell type that has been 
studied to date (Chapter 3). This profile is inconsistent with a single function in 
regulated exocytosis and suggests that CSPα may have additional, more general, 
cellular functions. One possibility is that CSPα also functions in constitutive 
exocytosis pathways (which are present in all cell types). However the analysis 
performed here did not provide support for this idea. Other possibilities might be that 
CSPα is involved in additional membrane fusion pathway such as cytokinesis or 
endosomal trafficking. 
Recently two additional CSPα isoforms were identified in mouse and human testis, 
CSPβ and CSPγ (Evans et al., 2003; Fernandez-Chacon et al., 2004). One 
consequence of the identification of CSPβ and CSPγ is that they may complicate 
 
 - 204 -
analysis of the CSPα knock out mouse (Fernandez-Chacon et al., 2004). However, 
Fernández-Chacón et al. (2004) suggested that expression of CSPβ and CSPγ was 
mainly restricted to testis with very low levels in brain. Interestingly, a recent study 
reported the generation of a CSPβ antibody recognising a C-terminal peptide of this 
protein (Gundersen et al., 2010). Here, we wanted to examine and clarify the 
functional roles of CSPβ and CSPγ (Chapter 5). Work from Gundersen’s group 
suggested that the lack of effect on exocytosis in CSPα null mice might be explained 
by compensation by CSPβ. However, our work did not agree with their proposal that 
CSPβ is expressed in brain as an SDS-resistant oligomeric complex. Studies on 
tagged versions of CSPβ have provided no evidence to support the idea that CSPβ 
forms such complexes. Indeed, it is possible that the lower molecular weight band 
detected by Gundersen following boiling in urea is simply a breakdown product of a 
cross-reacting 100 kDa protein. By contrast, the antibody generated in our work 
recognised a protein of the correct size, and failed to recognise the 100 kDa 
‘complex’ described by Gundersen. We are confident that the CSPβ antibody used in 
this study specifically recognises CSPβ for the following reasons: (i) the band 
detected is exclusively found in testis in agreement with previous analysis of mRNA 
expression profiles; and (ii) the protein detected by the antibody is extensively 
palmitoylated as judged by increased mobility on SDS gels following hydroxylamine 
treatment. It was disappointing that the antibody raised, specific for recombinant 
CSPγ, failed to convincingly detect endogenous protein. This might reflect a low 
expression level of the gamma isoform compared with CSPβ, or that the gamma 
antibody is less useful for immunoblotting analyses. It would certainly be worthwhile 
in future studies to invest time to develop a new CSPγ antibody so that the 
expression profiles of all CSP isoforms could be collectively examined. RT-PCR 
analysis however, was consistent with the notion that CSPγ is also testis specific. 
Interestingly, expression analysis of the different CSP isoforms revealed that CSPβ 
and CSPγ mRNA display distinct developmental profiles compared to CSPα, which 
is expressed throughout development. Both isoforms are switched on around the time 
of sexual maturation in rat (Ojeda, 1994b) (Chapter 5). Treatment with busulphan 
suggested that CSPβ and CSPγ are localised to germ cells and are specifically 
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enriched in spermatids and spermatocytes, respectively. CSPα, in contrast, appears to 
be expressed throughout all testis cell types (germ, Sertoli and Leydig cells). Future 
work might allow germ cells to be cultured and confocal imaging could reveal 
exactly where CSPβ and CSPγ are localised in these germ cells, offering an insight 
into their exact function in spermatids and spermatocytes.  
The observed cryptorchidism phenotype of CSPα null mice is intriguing and one 
possibility is that this relates to a loss or inhibition of testicular molecules such as 
testosterone or INSL3. There is already genetic evidence showing that INSL3 
knockout leads to cryptorchidism in mice (Nef and Parada, 1999) and thus we have 
focussed recent efforts on this secretory pathway. Interestingly, it was found that 
CSPα and INSL3 co-localise on mobile vesicles in R2C Leydig cells, suggesting that 
CSPα might regulate the exocytosis of these vesicles. There is little known about 
how INSL3 is secreted (constitutive or regulated pathway) or what the intracellular 
signals would be for secretion (e.g. Ca2+). Thus, it will be important to perform a 
detailed characterisation of the INSL3 secretory pathway in R2C cells. Importantly, 
it was shown that siRNA is useful for depleting CSPα expression in these cells, 
opening up the potential for functional studies. Another interesting angle will be to 
analyse serum levels of INSL3 and testosterone from CSPα-/- mice to detect if these 
are any alterations in testosterone or INSL3 levels. Furthermore it would be 
interesting to test whether the CSPα-/- mice are fertile. A well-characterised pathway 
of regulated exocytosis is the acrosomal exocytosis in sperm, which is essential for 
successful fertilisation. As CSPα is expressed in mature sperm, it might be that this 
isoform has an important function in acrosomal exocytosis. It would be difficult to 
study fertility in CSPα knockout mice as these mice die at an early age (around 
puberty) (Fernandez-Chacon et al., 2004); however, fertility could be tested in CSPα 
knockout mice over-expressing α-synuclein, as these mice have a normal life-span 
(Chandra et al., 2005). Further obvious experiments would be to examine the effects 
of CSPβ and CSPγ knockout and how this affects testicular development and 
fertility. Combined knockouts of CSPα, -β and -γ would provide additional 
information on the interplay between these isoforms in testis. 
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R2C cells proved to be a useful system to study targeting of CSPα as EGFP-CSPα 
showed a very similar localisation to endogenous CSPα. It was interesting that 
plasma membrane and vesicular targeting of CSPα were able to be separated, the 
former being dependent upon the N-terminal 70 amino acids. This region of CSPα 
contains the J-domain and it would prove particularly interesting if the interaction 
with HSC70 was partly directing the subcellular localisation of CSPα; further work 
to look at this could involve analysis of CSPα HPD mutants, or CSPα localisation 
following depletion of HSC70. Alternatively, it might be that the J-domain of CSPα 
also interacts with other proteins and that these interactions are important for plasma 
membrane targeting of CSPα. The only other cell type studied to date where CSPα 
was markedly localised to the plasma membrane was in 3T3-L1 adipocytes 
(Chamberlain et al., 2001); thus adipocytes and R2C cells may express a common 
factor that differentially regulates CSPα targeting. 
It has been previously reported that there is a link between neurotransmitter release 
and development of mental disorders (Manji et al., 2001; Sierksma et al., 2010). 
Furthermore, previous work reported that lithium enhances CSPα gene expression in 
rat brain (Cordeiro et al., 2000). However, analysis of CSPα expression in post-
mortem brain samples of patients with mental disorders displayed a reduction by 
trend in some brain regions (e.g. cortex/depression, hippocampus/schizophrenia and 
cerebellum/bipolar), which however, were not statistically significant. HSP70 
(hippocampus and cortex in bipolar patients) showed a significant increase in its 
expression levels. HSP70 supports the folding, subcellular transport and degradation 
of proteins (Bercovich et al., 1997; Frydman, 2001; Schaffitzel et al., 2001; Pratt and 
Toft, 2003), and is up-regulated in response to stress (Mosser and Morimoto, 2004; 
Kirkegaard et al., 2010). The expression level of syntaxin 1 was significantly 
decreased in the cortex and thalamus in bipolar patients, and cortex in patients with 
major depression. Serotonin secretion has been shown to be abnormal in bipolar 
disease and major depression and syntaxin was shown to interact with serotonin 
transporters. Therefore it is particular interesting that syntaxin 1 expression levels 
were significantly reduced in cortex of both bipolar and depression disorder. It has 
been previously shown that CSPα interacts with HSC70 and syntaxin 1 
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(Chamberlain and Burgoyne, 1997b, a; Chamberlain et al., 2001). However, the data 
obtained in Chapter 4 showed general inconsistency, which was most likely due to 
the small sample size (6 patients/condition). Therefore no general conclusions could 
be made and future work is required with greater sample sizes or preferentially in 
genetic mouse models. 
The presented work supports the idea that CSPα has an important function in 
regulated exocytosis in neuroendocrine cells. In addition, this investigation has 
offered an intriguing insight into the expression of CSP isoforms in cells of the testis, 
and interesting angles for future work will be to examine in more detail whether 
CSPα is important for secretion of INSL3, and to more finely pinpoint the functions 
of CSPβ and CSPγ in germ cells. Finally, it should be emphasised that CSPα appears 
to be ubiquitously expressed and it is currently not clear what 'general' function 
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